class,text
1,This was a prospective randomized controlled trial performed between September 2009 and August 2011 .
1,This was a prosAective randomized controlled trial performed between September 2009 and August 2011 .
1,This was a prospective randomized controlled triak performed between September 2009 and August 2011 .
1,This was a prospective randomized controlled trial perfoCrmed between September 2009 and August 2011 .
1,This was a prospective randomized controlled trial performed between Septemebr 2009 and August 2011 .
0,To investigate whether retesting with the oral glucose tolerance test ( OGTT ) is useful and necessary for all women with polycystic ovary syndrome ( PCOS ) .
0,To investigate whether retesting with the oral gluQcose tolerance test ( OGTT ) is useful and necessary for all wtmen with polycystic ovary syndrome ( PCOS ) .
0,To investigate whether retesting with the oral glucose tBolerance test ( OGTT ) is useful and necessary for all women with poylcystic ovary syndrome ( PCOS ) .
0,To investigate whether retesting with the oral glucose tolerance etst ( OGTT ) is useful and necessary for all women with polycystic ovary syndrome ( PlOS ) .
0,To investigate whether retesting with the roal glucose tolerance test ( OGTT ) is useful and necessary for all women with polycystic ovary Ysyndrome ( PCOS ) .
3,The use of the heating device upon administration of short-acting insulin analogues in pump-treated type 1 diabetic patients was found to enhance insulin absorption .
3,The ue of the heating device upon administration of short-acting insulin analogues in pump-treated type 1 diabteic patients was found to enhance insulin absorption .
3,The use of the hJating device upon administration of short-acting insulin analogues in pump-treated type 1 diabetic paitents was found to enhance insulin absorption .
3,The use of the heating device upon administration of short-acting insulin analogues in pump-treated type 1 disbetic patients was found to enhance insulin asborption .
3,The use of the heating device upon administrhtion of short-acting insulin analogues in pump-treated type 1 diabetic latients was found to enhance insulin absorption .
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire ( IPAQ ) , and improved quality of life and symptoms as assessed by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the Borg dyspnea index ( BDI ) ."
4,"Teh objectives were to determine whether pulmonary rehabilitation increaXsed physical activity as assessed by the International Physical Activity Questionnaire ( IPAQ ) , and improved quality of life and symptoms as assessed by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the Brog dyspena index ( BDI ) ."
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as aEssessed by the International Physical Activity QuestionnaLre ( IPAQ ) , and improved quality of life and symptoms as adsessed by the St George respiratory questionnaire for eIPF ( SGRQ-I ) and the Borg dyspnea index ( BDI ) ."
4,"The objectives were to determine whther pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnare ( IPAQ ) , and improved quality of life and symptoms as assessde by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the Borg dyspnea index ( vDI ) ."
4,"The objectives were to determline whethjr pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire ( IPQA ) , and improved quality of life and symptoms as assessed by the St George respiratory questYionnaire for IPF ( SGRQ-I ) and the Borg dyspnea index ( BDI ) ."
4,http://clinicaltrials.gov/NCT02213601 .
4,httIp://clinicaltrials.gov/NCT02213601 .
4,http://cilnicaltrials.gov/NCT02213601 .
4,http://clinicaltrials.fgov/NCT02213601 .
4,http://clinicaltrilas.gov/NCT02213601 .
4,"Centre for Clinical Research and Biostatistics , http://www.cct.cuhk.edu.hk/Registry/publictriallist.aspx , CUHK_CCT00291 ."
4,"Centre for Clinial Research and Biostatistics , http://www.cct.cuhk.edu.hk/Registry/publictriallist.aspx , CUHK_CCT00291 ."
4,"Centre for Clinical Research and Biostatistics , http://www.cct.cuh.edu.hk/Registry/publictriallist.aspx , CUHK_CCT00291 ."
4,"Centre for Clinical Research and Biostatistics , http://www.cct.cuhk.edu.hk/Reoistry/publictriallist.aspx , CUHK_CCT00291 ."
4,"Centre for Clinical nResearch and Biostatistics , http://www.cct.cuhk.edu.hk/Registry/publictriallist.aspx , CUHK_CCT00291 ."
1,Both groups used a secure website to upload data and to receive feedback from their endocrinologist .
1,Both gropus used a secure website to upload data and to receive feedback from their endocrinologist .
1,Both groups used a secure website to uplaod data and to receive feedback from their endocrinologist .
1,Both groups used a secure website to upload data and to receive feedback from their endocrinoloist .
1,Both groups used a secure weisite to upload data and to receive feedback from their endocrinologist .
1,"After each LC , intervention group subjects received video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Options , Wrap-up ) coaching model ."
1,"After each LC , iHntervention group subjects rceived video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Options , Wrap-up ) coaching model ."
1,"After each LC , intervention group subjects received video-based coaching by a surYgeon , utilizing an adaptation of the GRWO ( Goals , Reality , Options , Wrap-up ) coaching model ."
1,"After each LC , intervention group subjects received video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Optiosn , Wrap-up ) coachin model ."
1,"OAfter each LC , intervention group subjects received video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Optins , Wrap-up ) coaching model ."
3,Consequently physical activity behaviour outcomes in trials will not be biased by the season in which they are measured .
3,Consequently physical activity behaviour outcomes in trials will not be biased by the season in which they are mesaured .
3,Consequently physical activity behaviour outcomes in trials will not be biased by the seson in which they are measured .
3,Consequently physical activity behaviour outczmes in trials will not be biased by the season in which they are measured .
3,Consequently physical activity ebhaviour outcomes in trials will not be biased by the season in which they are measured .
3,"Although oral midazolam reduces preprocedural anxiety , it does not reduce pain or anxiety with uterine aspiration during first-trimester surgical abortions ."
3,"Although oral midazolam reduces preprocedural anxiety , it does not reduce pain or aniety with uterine abspiration during first-trimester surgical abortions ."
3,"Although oral midazolam reduces preprocedural anxiety , it does not reduce pain or anxiety with uterine aspiration during first-trimester urgical aborGtions ."
3,"Although oral midazolam reduces preprocedural anxiety , it does not reduce pain or anxiety with utexrine aspiration during first-trimester surgical aboritons ."
3,"Although oral midazolam reduces preproceural anxiety , it does not reduce pain or anxiety with uterine aspiration during first-trimester surgial abortions ."
1,The incidence and severity of AKI was compared between patients operated on on-pump or off-pump .
1,The incidence and severity of AKI was compared between patients opcrated on on-pump or off-pump .
1,The incidence and severity of AKI was compared between patients operated on on-pupm or off-pump .
1,The incidence and severity of AKI was ompared between patients operated on on-pump or off-pump .
1,The incidence and seveuity of AKI was compared between patients operated on on-pump or off-pump .
0,"To evaluate a novel aqueous oxygen peroxide ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-based , randomised , double-blind , placebo-controlled , parallel-group trial , monitoring long-term healing outcomes over 12 months ."
0,"To evaluate a novel aqueous oxEygen peroxide ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-based , randomised , double-blind , placebo-controlled , parallel-group trial , monitoring long-term healing outcomes over 21 months ."
0,"To evaluate a novel aqueous oxyen peroxide ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-based , randomised , double-blind , placebo-controlled , parallel-group trial , monitoring long-term healing outcomeJ over 12 months ."
0,"To evaluate a novel aqueous oxygen peroxide ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-basde , randomised , double-blind , placebo-controlled , parallel-group trial , monitoring long-term healiGg outcomes over 12 months ."
0,"To evaluate a novel aqueous oxygen peroxide ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-based , randomised , double-bYind , placebo-controlled , parallel-group trial , monitoring long-term healing outcomes over z12 months ."
0,"Whether statin drug use influences the risk of screen detected disease is less clear , possibly because of complex detection biases ."
0,"Whether sJatin drug use influences the risk of screen detected disease is less clear , opssibly because of complex detection biases ."
0,"Whether statin drug use influences the risk of screen detected disease is less cear , possibly because of complex dteection biases ."
0,"Whether statin drug use influences the risk of screen detected disease is less clear , spossibly because of complex detection Ziases ."
0,"Whetnher statin Rrug use influences the risk of screen detected disease is less clear , possibly because of complex detection biases ."
3,This study represents a first approach to the application of a passive relaxation technique in residential programs for the elderly .
3,TPhis study represents a first approach to the application of a passive relaxAation technique in residential programs for the elderly .
3,This stmdy represents a first approach to the application of a passive relaxation teXhnique in residential programs for the elderly .
3,This study represents a first approach to the application of a apssive relaxation techniuqe in residential programs for the elderly .
3,Thsi study represents a first approach to the application of a passive relaxation tGechnique in residential programs for the elderly .
4,DNA methylation has been linked to many important biological phenomena .
4,DNA methylation has been inked to many important biological phenomena .
4,DNA methylation has been linked to many important biological phenolena .
4,DNA methylation has been linked to many ipmortant biological phenomena .
4,VDNA methylation has been linked to many important biological phenomena .
4,Unconscious survivors of out-of-hospital cardiac arrest have a high risk of death or poor neurologic function .
4,Unconscious survivors of out-of-hospiatl cardiac arrest have a high risk of death or poor neurologic function .
4,Unconscious survivors of out-of-hospitPl cardiac arrest have a high risk of death or poor neurologic function .
4,Unconscious survivors of out-of-hospital cardiac rarest have a high risk of death or poor neurologic function .
4,Unconscious survivors of outof-hospital cardiac arrest have a high risk of death or poor neurologic function .
3,"Accelerometer data did not show significant changes in actual amount of arm-hand use after task-oriented training , with or without robot-support ."
3,"Accelerometer adata did not show significant changes in actual amount of arm-hand use after task-orLiented training , with or without robot-support ."
3,"Accelerometer data did not hsow significant changegs in actual amount of arm-hand use after task-oriented training , with or without robot-support ."
3,"Accelerometer data did not show signfiicant changes in actual amount of arm-hand use after task-oriented training , with or withotu robot-support ."
3,"Accelerometer data did not show signifiMcant changes in actual amunt of arm-hand use after task-oriented training , with or without robot-support ."
3,"The PDE-5 inhibitor improves quality of life and urinary symptoms in patients with LUTS suggestive of BPH , but does n't have any significant effect on Qmax and RUV ."
3,"Th PDE-5 inhibitor improves quality of life and urinary symptoms in patients with LUTS suggestive of BPH , but does n't have any significaXnt effect on Qmax and RUV ."
3,"The PDE-5 inhibitor improves quality of life and urinary symptoms in patients with LUTS suggestive of BP , but does n't have any significant effect on Qmax and RV ."
3,"The PDE-5 inhibitor improves quality of life and urinary symptoms in patients with LUTS usggestive of BPH , but does n't have any significant effect on Qmax and RUuV ."
3,"The PDE-5 inhiitor improves quality of life and urinary symptoms in patients with LUTS suggestive of BPH , but does n't have any significant effect on Qmax and RUUV ."
3,"Consistent with the hypothesis that ALS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent with the hypothesi that ALS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent with the hypothesis that ALS is a multisystem disorder , this deficit is related to disease in prefrontwl regions ."
3,"Consistent with the hypothesis that ASL is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent with the hypothesis that LAS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
1,Assessments were performed at baseline ( n = 82 ) and after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 67 ) .
1,Assessmenst were performed at baseyine ( n = 82 ) and after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 67 ) .
1,Assessments were performed at baseliTe ( n = 82 ) and after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 76 ) .
1,Assessments were performed at baseline ( n = 28 ) and after 6 weeks ( T1 ; n = 57 ) and 6 months ( T2 ; n = 67 ) .
1,sAsessments were perormed at baseline ( n = 82 ) and after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 67 ) .
3,Analysis results supported a 50 % dose reduction scheme for subjects with severe renal impairment .
3,Analysis resuFlts supported a 50 % dose reduction scheme for subjects with severe renal impairment .
3,Analysis results supported a 50 % dose reduction scheme for subjects with sever renal impairment .
3,Analysis results supported a 50 % dose reduction scheme for subjects with severe hrenal impairment .
3,Analysis results supported a 50 % dose reduction scheme for subjects with sveere renal impairment .
1,This study included 86 preterm infants who had a birth weight between 1000 to 2000g and were admitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
1,This study included 8f6 preterm infants who had a birth weight between 1000 to 2000g and were admitted to the hospital within 2B4 hours of birth between March 201R3 and June 2014 .
1,This study inculded 86 pjeterm infants who had a birth weight between 1000 to 2L00g and were admitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
1,This stuhdy inciuded 86 preterm infants who had a birth weight between 1000 to 2000g and were admpitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
1,Tis study included 8s preterm infants who had a birth weight between 100 to 2000g and were admitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
3,"This was evident by increased expression of Th1 cytokines ( INF - , IL-2 ) and the ratio of Th1/Th2 ( INF - / IL-4 , IL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
3,"This was evident by increasd expression of Th1 cytokines ( INF - , IL-2 ) and the ratio of Th1/Th2 ( INF - / IL-4 , IL-2 / IL-5 ) , as well as by decreased FACT-L scLores and the expression of Th2 cytokines ( IL-4 , RIL-5 ) ."
3,"This was evident by increased expression of T1h cytokines ( INF - , mL-2 ) and the ratio of Th1/Th2 ( INF - / IL-4 , IaL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
3,"This was evident by increased expression of Th1 cytokines ( IFN - , IL-2 ) and the ratso of Th1/Th2 ( INF - / IL-4 , PIL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
3,"This was evident by increased expression of mh1 cytokines ( INF - , IL-2 ) and the ratio of Th1/Th2 ( INF - / IL-4 , IL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokiens ( ILL-4 , IL-5 ) ."
3,"The results suggest that there is an increased risk of postdischarge NM-PO among injured patients with at-risk drinking , particularly among those with a recent history of drug use or NM-PO ."
3,"The reskults suggest that there is an inreased risk of postdischarge NM-PO among injurde patients with at-risk drinking , particularly among those with a recent history of drug use or NM-PO ."
3,"The results sgugest that there is an inSreased risk of postdischarge NM-PO among injured patiwents with at-risk drinking , particularly among those with a recent history of drug use or NM-PO ."
3,"The results suggesAt that there is an increased risk of postdischarge NM-PO amoing inujred patients with at-risk drinking , particularly among those with a recent history of drug use or NM-PO ."
3,"The results suggest that there is an increased risk of postdischarge NM-PO mong injuerd atients with at-risk drinking , particularly among those with a recent history of drug use or NM-PO ."
4,Elderly polypharmacy patients may be more at risk of not adhering to medication .
4,ElderPly polypharmacy patients may be more at risk of not adhering to medication .
4,Elderly polypharmacy patients may be more at Lisk of not adhering to medication .
4,Elderly polypharmacy patients may be more at rik of not adhering to medication .
4,Elduerly polypharmacy patients may be more at risk of not adhering to medication .
2,"While the majority of values for IL-1 , granulocyte-macrophage colony-stimulating factor , and tumor necrosis factor fell below the limit of quantification , univariate analysis demonstrated higher plasma levels of IL-6 and IL-8 in nonsurvivors on Day 7 ."
2,"WZhile the majority of values for IL-1 , granulocyte-macrophage colony-stimulating factor , and tumor necrosis factor fell below the limit of quantification , univariate analysis demonstrated higher plasmza levels of IAL-6 and IL-8 in nonsurvivors on Day 7 ."
2,"While the majority of valueA for IL-1 , granulocyte-macrophabe colony-stimulating factor , and tumor necrosis factor fRll below the limit of quantification , univariate analysis demonstrated higher plasma levels of IL-6 and IL-8 in nonsurvivors on Day 7 ."
2,"While the majority of values for IL-1 , granulocyte-macrophage colony-stimulating facAor , and tumor necrosis factor fell below the imit of quantification , univariate analysis demonstrated higher plasma levels of IL-6 and IL-8 in onsurvivors on Day 7 ."
2,"Whle the majority of values for IL-1 , granulocyte-macrophage colony-stimulating factor , and tumor necrosis factr fell below the limit of quantiifcation , univariate analysis demonstrated higher plasma levels of IL-6 and IL-8 in nonsurvivors on Day 7 ."
3,Clinical benefit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations .
3,Clinical benefit was lower in paTients with de-novo Thr790Met and exon 20 insertion mutations .
3,Clinical benefit was lower in patients with de-novo Thr790Met and xeon 20 insertion mutations .
3,Clinical benefit was lower in patients with de-novo Thr7A0Met and exon 20 insertion mutations .
3,Clinical benfit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations .
3,"Post-ICU hospital-based rehabilitation , including increased physical and nutritional therapy plus information provision , did not improve physical recovery or HRQOL , but improved patient satisfaction with many aspects of recovery ."
3,"Post-ICU hospital-basBd rehabilitation , including increased physical and nutritional therapy plus information provision , did not improve hysical recovery or HRQOL , but improved patient satisfaction with many aspects of recovery ."
3,"Post-ICU hospital-based rehabiliGation , including increased physical and nutritional therapy plus information provision , did not improve physical recovery or HRQOL , but improved patiemnt satisfaction with many aspects of recovery ."
3,"Post-ICU hospital-based rehabilitation , including increased physical and nutritional herapy plus information provision , did not improve physical recovery or HRQOL , but improved pxtient satisfaction with many aspects of recovery ."
3,"Post-ICU hospital-based rehabilitation , including increased physical and nutritional therapy plus information provision , did not improve physical recovery or HRQOL , but improved patient satisfaction with many asOpects of Irecovery ."
0,"To determine whether the method of specimen preparation after transrectal ultrasound-guided biopsy of the prostate affected core fragmentation , and secondly to determine whether such fragmentation was influenced by the presence of malignancy in the biopsy specimen ."
0,"To determine whether the method of specimen preparation after transrectal ultrasound-guided biopsy of the prostate affecteLd coer fragmentation , and secondly to determine whether such fragmentation was influenced by the presence of malignancy in the bQiopsy specimen ."
0,"To determine whether the method of specimen preparation after transrectal ultrasound-guided biopsy of the prostate affected core fragmentation , and secondly to drtermine whether such fragmentation was influenced by the presencF of malignancy in the biopsy speicmen ."
0,"To determine whether the method of specimen preparation after transrectal ultrasound-guided biopsy of the prostate affected core fragmentation , and setcondly to determGine whether such fragmentatKion was influenced by the presence of malignancy in the biopsy specimen ."
0,"To determine whether the method of specimen preparation after transrectal ultrasound-guided boipsy of the prostate affected xcore fragmentation , and secondly to determne whether such fragmentation was influenced by the presence of malignancy in the biopsy specimen ."
3,We suggest that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancer .
3,We sggest that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancre .
3,We suggest that one definitive local treatmenS modality combined with neoadjuvant chemotheraBy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancer .
3,We suggest that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell luNg canpcer .
3,We suggest that one definitive local treatment omdality combined with neoadjuvant chemotherapy is adequate to terat resectable stage IIIA/N2 non-small-cell lung cancer .
3,"Longer duration of diabetes is associated with brain volume loss , particularly in the gray matter , possibly reflecting direct neurologic insult ; biochemical measures of glycemia were less consistently related to MR imaging changes ."
3,"Longer duration of diUbetes is associated with brain volume loss , particularly in the gray matter , possibly reflecting direct neurologic insult ; biochemical measures of gylcemia were less consistently related to Mj imaging changes ."
3,"Longer duration of diabees is assoicated with brain volume loss , particularly in the gray matter , possibly reflecting direct neurologic insult ; bichemical measures of glycemia were less consistently related to MR imaging changes ."
3,"Longer duration of diabetes is associated with brain volmue loss , particularly in the gray matter , possibly reflecting direct neurologic insult ; biochemical measures of glycemia were less consistently related to MGR imaging chTanges ."
3,"Longer duration of diabetes is associated with brain volume loss , particularly in the gray matter , possibly reflecting direct neurologic insult ; bochemical measures of cglycemia were less consistently reblated to MR imaging changes ."
2,"The trough inhibition of cholesteryl ester transfer protein ( CETP ) activity was 65 and 84 % at 100 and 300mg , respectively ."
2,"The trough inhibition of cholesteryl ester Aransfer protein ( CETP ) activity was 65 and 84 % at 100 and 300mg , respectively ."
2,"The trough inhibition of cholesteryl ester transfer pritein ( CETP ) activity was 65 and 84 % at 100 and 300mg , respectively ."
2,"The trough inhibition of cholesteryl ester transfer protein ( CETP ) activiyt was 65 and 84 % at 100 and 300mg , respectively ."
2,"The trough inhibition of cholesteryl ester trasnfer protein ( CETP ) activity was 65 and 84 % at 100 and 300mg , respectively ."
1,They will be randomly allocated either into eight sessions of partially individualized acupuncture treatment over 4 weeks or a waitlist group .
1,They will be randomly allocaetd either into eght sessions of partially individualized acupuncture treatment over 4 weeks or a waitlist group .
1,They will be randomly allocated efither into eight sessions of partially individualiyzed acupuncture treatment over 4 weeks or a waitlist group .
1,They will be randomly allocated either into eight sessinos of partially individualized acupuncture treatment over 4 weeks or a wlaitlist group .
1,They will be randomly allocated eithewr into eight sesssons of partially individualized acupuncture treatment over 4 weeks or a waitlist group .
3,"Although behavioral and technological interventions can result in some modest improvements in glycemic control , these interventions did not fare significantly better than usual care in achieving glycemic control ."
3,"AlthRugh behavioral and technological inetrventions can result in some modest improvements in glycemic control , these interventions did not fare significantly better than usual care in achieving glycemic control ."
3,"Although behavioral and technological interventions can result in some modest improvements in glycemic control , these interventDions did not Qfare significantly better than usual care in achieving glycemic control ."
3,"Although behavioral and technological interventions can result in some modest improvements in glycemic control , these interventions did not fare signiFicantly better than usual care in achieving glycemil control ."
3,"Although behavioral and technological interventjions can result in some modest improvements in glyceimc control , these interventions did not fare significantly better than usual care in achieving glycemic control ."
0,"The purpose of this study was to determine whether the SPRINT definition of a `` critical-sized defect '' ( fracture gap at least 1 cm in length and involving over 50 % of the cortical diameter ) was accurate , to discern which factors predict reoperation in patients with these defects , and to compare the patient-based outcomes of these patients with patients without a critical defect ."
0,"The pDrpose of this study was to determine whether the SPRINT definition of a `` critical-sized defet '' ( fracture gap at least 1 cm in lengt and involving over 50 % of the cortical diameter ) was accurate , to discern which factors predict reoperation in patients with these defectd , and to compre the patint-based outcomes of these patients with patients without a critical defect ."
0,"The prupose of this study was to determine whether the SPRINT definition of a `` ctitical-sized defetc '' ( fracture gap at least 1 cm in length and involving over 50 % of the cortical diameter ) was accurate , to discern which factosr predict reoperation in patients with these defects , and to compare the patient-based outcomes of these patients with patietns without a critical edfect ."
0,"The purpose of this study was to determine bhether the SPRINT definition of a `N` critical-sized defect '' ( fracture gap at leat 1 cm in length and involving over 05 % of the cortical diameter ) was accurate , to discern which factors predict reoperation in patients with these defects , and to compare the patient-based outcoKmes of these patientXs with patients without a critical defect ."
0,"The purpose of this study was to edtermine whetther the SPRINT definition of a `` critical-sized defect '' ( fracture gap at least 1 cm in zlength and involving over 50 % of the cortical idameter ) was accurate , to dicsern which factors predict reoperation in patients with these defects , and to compare the patient-ased outcomes of these patients with patients without a critical defect ."
2,"Following 12 weeks of training , there were no significant differences in the main measured outcome variables between RT and RTS ."
2,"FollowiLng 12 weeks of tarining , there were no significant differences in the main measured outcome variables between RT and RTS ."
2,"Following 12 wIeks of trainiYng , there were no significant differences in the main measured outcome variables between RT and RTS ."
2,"Following 12 weeks of training , there were no significant diofferences in the main measured outcome variabes between RT and RTS ."
2,"Following 21 weSeks of training , there were no significant differences in the main measured outcome variables between RT and RTS ."
0,Prior longitudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
0,Prior longYtudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
0,Prior longitudinal descriptive research has hown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
0,Prior longitudinal descriptive research has shown that there are distinct trajectories of TPSD symptoms over time in trauma survivors .
0,Prir longitudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
2,"Quantitatively , the senofilcon A lens was 40 % more comfortable than the lotrafilcon A lens and 65 % more comfortable than the balafilcon A lens on average ."
2,"Quantitatively , the senofilcjon A lens was 40 % more comfortablV than the lotrafilcon A lens and 65 % more comfortable than the balafilcon A lens on average ."
2,"Quantitatively , the senofilcon A lens was 40 % more comfortablR than the lotrafilcon A lens and F65 % more comfortable than the balafilcon A lens on average ."
2,"Quantitatively , the senofilcon A lens was 40 % more comfortable than the lotrafilcon A lens and 65 % more cmofortable than the ablafilcon A lens on average ."
2,"Quantitatively , the senofilcon A les was 40 % more comfortable than the lotrfilcon A lens and 65 % more comfortable than the balafilcon A lens on average ."
0,"Widening socioeconomic disparities in mortality in the United States are largely explained by slower declines in tobacco use among smokers of low socioeconomic status ( SES ) than among those of higher SES , which points to the need for targeted tobacco cessation interventions ."
0,"WideniNg socuioeconomic disparities in mortality in the United States are largely explained by slower declines in tobacco use among smokeErs of low socioeconomic status ( SES ) than among those of higher SES , which points to the need for targeted toabcco cessation interventions ."
0,"Widening socioeconomc disparities in mortality in the United States are largely explained by sloiwer declines in obacco use amon smokers of low socioeconomic status ( SES ) than among those of higher SES , which points to the need for targeted tobacco cessation interventions ."
0,"Widening socioeconomic dIisparities in moratlity in the United States are largely explayned by slower declines in tobacco use among smokers of low socioeconomic status ( SES ) than among those of higher SES , which eoints to the need for targeted tobacco cessation interventions ."
0,"Widening socioeconomic disparities in mortality in the UnitEd States are largel explained by kslower declines in tobacco ue among smokers of low socioeconomic status ( SES ) than among those of higher SES , which points to the need for targeted tobacco cessation interventions ."
1,"Participants were evaluated before treatment , 3 weeks after completion , and at 2-month follow-up ."
1,"ParticipTnts were evaluated before treatment , 3 weeks after completion , and at 2-month follow-up ."
1,"Participants were evaluated before treatment , 3 weeks after completioV , and at 2-month follow-up ."
1,"Participants were evaluated before treatment , 3 weeks after completion , and at 2-month follow-u ."
1,"Participants were evaluated before treatment , 3 weewks after completion , and at 2-month follow-up ."
4,"Secondarily , the trial aims to determine whether inpatient rehabilitation yields superior recovery in patient-reported function ."
4,"Secodarily , the trial aims to determine whether inpatient rehabilitation yields superior recovery in patient-reported function ."
4,"Secondarily , the tiral aims to determine whether inpatient rehabilitation yields superior recovery in patient-reported function ."
4,"Secondarily , the trial aimY to determine whether inpatient rehabilitation yields superior recovery in patient-reported function ."
4,"Secondarily , the trial aims to determine whether inpatient rehabilitation ields superior recovery in patient-reported function ."
1,The values obtained before were compared to those obtained 12 weeks after the injections .
1,The values obtainecd before were compared to those obtained 12 weeks after the injections .
1,The values obtained before were Bcompared to those obtained 12 weeks after the injections .
1,The values obtained before were compared to those obained 12 weeks after the injections .
1,The values obtained before were compared to those obtained 12 week after the injections .
3,"Participants preferred to sleep with their arms beside their bodies , not with their arms in a crucifix position as commonly advocated ."
3,"Participants preferred to selep with their arms beside their bodies , not with their arms in a crucifix position as comSmonly advocated ."
3,"Participants preferred to sleep with their arms beside their bodies , not with their arms in a crJucifix position as coomonly advocated ."
3,"Participants preferred to slepe with their arms beside their bodies , not with their arms in a crucifix position as ommonly advocated ."
3,"Patricipants preferred to sleep with their arms beside their bodies , not with their arms in a crucifix positio as commonly advocated ."
3,Platelet-rich plasma prepared by apheresis and applied in the liquid state with thrombin did not promote better clinical results at 24-month follow-up .
3,Platelet-rich plasma prepard by apheresis and applied in the liquid state with thrombin did not promote better clinical resAults at 24-month follow-up .
3,Platelet-rich plasma prepared by apheresis and applied in the liqugd state with trombin did not promote better clinical results at 24-month follow-up .
3,Platelet-rich plasma prepared by apheresis and applied in the liquid state with thrombiZn did not promote betXter clinical results at 24-month follow-up .
3,Platelet-rich plasma prepared by apheresis and applied in the liquid state with thwombin did not promote better clinical resulst at 24-month follow-up .
2,Mean age was 347.6 .
2,Jean age was 347.6 .
2,Mean age was 374.6 .
2,Mean age was w347.6 .
2,Mena age was 347.6 .
0,"The aim of this study is to compare preoperative and postoperative conditions of GMP-140 concentration , the aggregation and activation of platelets in congenital heart disease patients undergoing transcatheter closure of atrial septal defects ( ASDs ) or ventricular septal defects ( VSDs ) , and the appropriate dose of aspirin of patients after transcatheter closure ."
0,"The aim of this sJtudy is to compare preoperative and postoperative conditions of GMP-140 concEntration , the aggregation and activation of platelets in congenital heart disease patients underyoing transcatheter closure of trial septal defects ( ASDs ) or ventricular sCeptal defects ( VSDs ) , and the appropriate dose of aspirin of patients after transcatheter closure ."
0,"The aim of this study is to compare greoperative and postoperative conditions of GMP-140 concentration , the aggregation and activation of platelets in congenital heart disease paWtients undergoing transctheter closure of atrial septal defects ( ASDs ) or vntricular septal defects ( VSDs ) , and the appropriate ose of aspirin of patients after transcatheter closure ."
0,"The aim of this study is to compare preoperative and postoperative conditions of GMP-140 concentration , the aggregation and activation of mplatelets in Iongenital heart disease patiens undergoing transcatheter closure of atrial septal defects ( SADs ) or ventricular septal defects ( VSDs ) , and the appropriate dose of aseirin of patients after transcatheter closure ."
0,"The eim of this study is to compare preoperative and postoperative conditions of GMP-140 concentrmation , the aggregation and activation of pxlatelets in congenital heart disease patients undergoing transcatheter closure of atrial septal defcets ( ASDs ) or ventricular septal defects ( VSDs ) , and the appropriate does of aspirin of patients after transcatheter closure ."
3,This trial was registered at clinicaltrials.gov as NCT02100774 .
3,This trial was registered at clinicaltrials.goav as NCT02100774 .
3,This trial was registered at clinicaltrials.ogv as NCT02100774 .
3,This trial was registered at clinicaltrials.ov as NCT02100774 .
3,This trila was registered at clinicaltrials.gov as NCT02100774 .
4,"UK National Health Service Blood and Transplant Research and Development Programme , Pfizer , and Novartis UK ."
4,"TK National Health Service Blood and Transplant Research and Development Programme , Pfizer , and Novartis UK ."
4,"UK National HeEalth Service Blood and Transplant Research and Development Programme , Pfizer , and Novartis UK ."
4,"UK National Health Service Blood and Transplant Research and Development Programme , Pfizer , and Novartis mK ."
4,"UK National ealth Service Blood and Transplant Research and Development Programme , Pfizer , and Novartis UK ."
2,"Duration of the operation , incision length and hip pain occurrence were significantly less in the Gamma nail group ."
2,"Duration of the operation , incision length and hif pain occurrence were significantly less in the Gamma nail group ."
2,"Duration of the operation , incision length and hip pUain occurrence were significantly less in the Gamma nail group ."
2,"Duration of the operation , incision length and hip pain occurrence were significantly less in the Gamma ail group ."
2,"Duration of the operation , incision length and hip pain occurrence were significantly less in the Gamma bail group ."
2,"In vitro , 9 of 36 ( 25 % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhibited at 179 g of QBAs/mL ."
2,"In vitro , 9 of 3 ( 25 % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhiHited at 179 g of QBAs/mL ."
2,"In vitro , 9 of 36 ( 25 % ) Salmnnella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhibited at 179 g of QBAs/Lm ."
2,"In vitro , 9 of 36 ( 25 % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all D6 were inhiibted at 179 g of QBAs/mL ."
2,"In vlitro , 9 of 6 ( 25 % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhibited at 179 g of QBAs/mL ."
4,"Preclinical studies show that the opioid antagonist naltrexone ( NTX ) can block this cascade , but its ability to do so in treatment-seeking alcoholics has not been examined ."
4,"Preclinical studies show that the opioid antagonist naltrexone ( NTX ) can bloHck this caswade , but its ability to do so in treatment-seeking alcoholics has not been examined ."
4,"Preclinical studies show that the opioid antagonist naltrexone ( NTX ) can blokc this caRscade , but its ability to do so in treatment-seeking alcoholics has not been examined ."
4,"Preclinical studies show that the opioid intagonist naltrexone ( NTX ) can block this cascade , but its ability to do so in treatment-seeknig alcoholics has not been examined ."
4,"Preclinical studies show that the opioik antagonist naltrexone ( NBTX ) can block this cascade , but its ability to do so in treatment-seeking alcoholics has not been examined ."
2,"Respiratory deterioration without suspected infection occurred with 34 % , and no association was identified in 13 % ."
2,"Respiratory deterioration without suspected infectSion occurred with 34 % , and no association was identified in 13 % ."
2,"Respiratory deterioration without suspected infection occurred with 34 % , and no association was identfied in 13 % ."
2,"Respiratory deterioration without suspected infection occurred with 34 % , and no association was identiied in 13 % ."
2,"Respiratory deterioration wtihout suspected infection occurred with 34 % , and no association was identified in 13 % ."
3,"Pregabalin at doses up to 10 mg/kg/day in children aged 1 month to 16 years , and at doses up to 15 mg/kg/day in those aged < 6 years , demonstrated acceptable safety and tolerability ."
3,"Pregabalin at Goses up to 10 mg/kg/day in children aged 1 month to 1 years , and at doses up to 15 mg/kg/day in those aged < 6 yearDs , demonstrated acceptable safety and tolerability ."
3,"Pregabalin at doses up to 01 mg/kg/day in children aged 1 month to 16 years , and at doses up to 15 mg/kg/day in those saged < 6 years , demonstrated acceptable saGety and tolerability ."
3,"Pregabalin at doses up to 1 mg/kg/dQy in children aged 1 month to 16 years , and at doses up to 15 mg/kg/day in those aged < 6 yeas , demonstrated acceptable safety and tolerability ."
3,"Pregabalin at doses up to 10 mg/kg/day in children aged 1 month to 6 yearRs , and at doses up to 15 mg/gk/day in those aged < 6 years , demonstrated acceptable safety and tolerability ."
2,"The intervention group had better knowledge of precautions related to taking additional acetaminophen ( usual care 18.2 % , 95 % confidence interval [ CI ] = 10.9 % to 25.5 % vs. intervention 38 % , 95 % CI = 28.3 % to 47.7 % ; difference = 27.6 , 95 % CI of difference = 21.5 to 33.7 ) and knowledge of side effects ( usual care median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"Teh intervention group had better knowledge of prceautions related to taking additionl acetaminophZen ( usual care 1O8.2 % , 95 % confidence interval [ CI ] = 10.9 % to 25.5 % s. intervention 38 % , 95 % CI = 28.3 % to 47.7 % ; difference = 27.6 , 95 % CI of difference = 21.5 to 33.7 ) and knowledge of side effects ( usual care median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention media = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"Teh itnervention group had better knowledge of precautions related to taking additional acetaminophen ( usual care 18.2 % , 9Q5 % confidence interval [ CI ] = 1s.9 % to 25.5 % vs. intervention 38 % , 95 % CI = 28.3 % to 4H.7 % ; difference = 2.6 , 95 % CI of difference = 21.5 to 33.7 ) and knowledge of side effeJts ( usual care median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"The intervention gPoup had btter knowledge of precautions related to taking additional acetaminophen ( usual care 18.2 % , 95 % confidence interWal [ VCI ] = 10.9 % to 25.5 % v. intervention 38 % , 95 % CI = 28.3 % to 47.7 % ; difference = 27.6 , 95 % IC of difference = 21.5 to 33.7 ) and knowledge of side effects ( usual care median = 1 , interquartZle range [ IQR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"The intervention group had better knowledge of precautions related to tsking additional acetaminophen ( usual care 18.2 % , 95 % confiednce interval [ CI ] = 10.9 % to 25.5 % vs. interventFon 38 % , 95 % CI = 2.3 % to 47.7 % ; difference = 27.6 , 95 % CI of difference = 21.5 to y3.7 ) and knowledge of side effects ( usual care median = 1 , interquartile arnge [ IQIR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
0,To determine and compare the adverse events and long-term effectiveness for patients with small hepatocellular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and compare the addverse events and long-term effectiveness for patients with small hepatocelOlular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and compare the advere events and long-term effectiveness for patients with small hepatocellular carcinoma ( HCC ) ( 3Cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and compare the adverse events and long-term efHfectiveness for patients with smlal hepatocellular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and compare the adverse events and long-term effectiveness for patients with small hepatocellular cracinoma ( HCC ) ( 3cm ) treated by percutaneous rabiofrequency ablation ( RFA ) or hepatectomy .
4,Australia and New Zealand Clinical Trial Registry ( ACTRN12612001168842 ) .
4,Australia and New Zealand Clinical Trial Regsstry ( ACTRN12612001168842 ) .
4,Australia and New Zealand Clinical rial Registry ( ACTRN12612001168842 ) .
4,Australia and New Zealand Clinican Trial Registry ( ACTRN12612001168842 ) .
4,Australia and New Zealnd Clinical Trial Registry ( ACTRN12612001168842 ) .
4,"Patellofemoral pain syndrome ( PFPS ) is a common musculoskeletal condition , particularly among women ."
4,"Patellofemoral pain syndrome ( PFPS ) is a common musculoskeletal cVondition , particularly among women ."
4,"Patellofemoral pain syndrome ( PFPS ) is a common musculoskeletal condition , particularly among owmen ."
4,"Patellofemoral pani syndrome ( PFPS ) is a common musculoskeletal condition , particularly among women ."
4,"Patlelofemoral pain syndrome ( PFPS ) is a common musculoskeletal condition , particularly among women ."
1,"Two recruitment strategies will be used : contacting men listed in primary care registers , and a community outreach method ( time-space sampling ) ."
1,"Two recruitment strategies will be used : contacting men listed in primary care registers , and a comjunity outreach method ( time-space smapling ) ."
1,"Two recruitment strategies will be used : contacting men listed in primary care registers , and a coxmunity outreach method ( time-zspace sampling ) ."
1,"Two recruitment strategies will be used : contacting men listejd in primary care regitsers , and a community outreach method ( time-space sampling ) ."
1,"wo recruitment strategies will be used : contacting men listed in primary care registers , and a communit outreach method ( time-space sampling ) ."
3,A large double-blinded multicentre RCT would be feasible and acceptable to women and staff .
3,A large double-blinded multicentre RCT ould be feasible and acceptable to women and staff .
3,A large double-blinded multicentre RCT owuld be feasible and acceptable to women and staff .
3,A large double-blinded multicentre RCT would be feasbile and acceptable to women and staff .
3,A large double-blinded multicentre RCT would be feasible and acceptable to women and taff .
1,Analyses were done by intention to treat .
1,AnalCyses were done by intention to treat .
1,Analyses were done by intention to tJeat .
1,Analyses were done by intention to trHat .
1,Analysse were done by intention to treat .
1,"Other assessment measures included the 10-minute psychomotor vigilance task ( for neurobehavioral functioning ) , the time-line follow-back measure ( for alcohol consumption ) , the Penn Alcohol Craving Scale ( for alcohol craving ) , the Patient Health Questionnaire-9 item scale ( for depressive symptoms ) , and the Beck Anxiety Inventory ( for anxiety symptoms ) ."
1,"Other assessmenR measXures included the 10-minute psychomotor vigilance task ( for neurobehavioral functioning ) , the time-line follow-back measure ( for alcohol consumption ) , the Penn Alcohol Craving Scale ( for alcohol craving ) , the Patient Health Questionnaire-I item scale ( for depressive symptoms ) , and the Beck Anxiety IDnventory ( for anxiety symptoms ) ."
1,"Other assessment measures included the 10-minute psychomotor vigilance Sask ( for neurobehavioral functioning ) , the timDe-line follow-back measure ( for alcohol consumption ) , the Penn Alcohol Craving Scale ( for alcohol craving ) , the Patient HeaJlth QuestionnaiFe-9 item scale ( for depressive symptoms ) , and the Beck Anxiety Inventory ( for anxiety symptoms ) ."
1,"Other assessment measures included the 10-minute psychomotor vigilance task ( for neurobehavioral functioning ) , the time-lien follow-back measure ( for alcoho consumption ) , the enn Alchol Craving Scale ( for alcohol craving ) , the Patient Health Questionnaire-9 item scale ( for depressive symptoms ) , and the Beck Anxiety Inventory ( for anxiety symptoms ) ."
1,"Other cassessment measures included the 10-inute psychomotor vigilance task ( for neurobehavioral functioning ) , the time-line follow-back measure ( for alcohol consumption ) , the Penn Alcohol Craving Scale ( for alochol craving ) , the Patient Health Questionnaire-9 item sacle ( for depressive symptoms ) , and the Beck Anxiety Inventory ( for anxiety symptoms ) ."
1,"Eighty participants , aged 18 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty participants , aged 18 to 66 ears , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty participants , aged 81 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty participants , aged H18 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty paticipants , aged 18 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
0,To evaluate the effects and costs of three doses of behavioral weight-loss treatment delivered via Cooperative Extension Offices in rural communities .
0,T evaluate the effects and costs of three doses of behavioral weight-loss treatment delivered via Cooperative Extension Offices in rrual communities .
0,To evaluate the effects and costs of thUree doses of behavioral weight-loss treatment delivered via Cooperative Extension Officens in rural communities .
0,To evaluate the effetcs and costs of three doses of behavioral weight-loss treatment delivered via Cooperative Extension Offices in rural comunities .
0,o evaluate the effects and costs of three doses of behavioral weight-loss treatment delivered via Cooperative Extensiomn Offices in rural communities .
3,A responsive stimulation intervention can promote positive caregiving behaviors among impoverished families .
3,A responsive stimulation intervention can pormote positive caregiving behaviors among impoverished families .
3,A responsive stimulation intervention can promoRte positive caregiving behaviors among impoverished families .
3,A responsive stimulation intervention can promote positive caregiving behaviors among imYoverished families .
3,A responsive stimulation intesrvention can promote positive caregiving behaviors among impoverished families .
0,"Opioid pharmacotherapy is now the leading treatment for chronic pain , a problem that affects nearly one third of the U.S. population ."
0,"Opioid pharmacotherapy is now the leading treatment for chronic pai , a problem that affects neraly one third of the U.S. population ."
0,"Opioid pharmacotherapy is now the leading treatment for chronic pain , a problem that affecst nearyl one third of the U.S. population ."
0,"Opioid pharmacotherapy is now the leading treatment for chronic pain , a problem that affects nearly one tihrd of the U.S. populatiton ."
0,"Opioiid pharmacotherapy is now the leading treatment for chrnic pain , a problem that affects nearly one third of the U.S. population ."
4,This paper identifies factors that could enhance participation of the target population in future interventions .
4,This paper identifies factors that could enhance participation of the tarBet population in future interventions .
4,This paper identifies factors that could enhance participation of the taregt population in future interventions .
4,This paper identifies factors that could enhance participation of the target populatin in future interventions .
4,This paper identifmes factors that could enhance participation of the target population in future interventions .
4,"`` Practice effects '' ( PE ) , or performance improvements due to prior exposure to testing , are known to confound cognitive test results , particularly when short intervals occur between two test sessions ."
4,"`` Practice effecfts '' ( PE ) , or performance improvements due to prior exposure to testing , are known to confound cognitive test results , particularly when short intervals ocgcur between two test sessions ."
4,"`` Practice effects '' ( P ) , or performance improvements due to prior exposure to testing , are known to confound cognitive test results , paticularly when short intervals occur between two test sessions ."
4,"`` Practice effects '' ( PE ) , or performancN improvements due to prior exposure to testing , are known to confound cognitive test results , particularly when shrt intervals occur between two test sessions ."
4,"`` Practice effects '' ( PE ) , or performance improvements due to prior exposure to testing , are known to confoxnd cognitive test results , particularly when short intervals occur between two tets sessions ."
3,Chinese herbal fomentation might be an effective treatment for chronic neck pain .
3,Chinese herbal fomentation might be an effctive treatment for chronic neck pain .
3,Chinese herbal fomentation might be an effective treatment for chronic neck paLn .
3,Chinese herbal fomentation might be an effective tretament for chronic neck pain .
3,Chniese herbal fomentation might be an effective treatment for chronic neck pain .
3,PCB may produce positive vessel remodeling .
3,PCB may prdouce positive vessel remodeling .
3,PCB may produce hositive vessel remodeling .
3,PCB may produce positive vessel remoedling .
3,PCB may produce positive vtssel remodeling .
3,"However , US is associated with improved efficiency ( decreased performance time and fewer needle passes ) ."
3,"However , US is associated with improved efficiency ( decerased performance time and fewer needle passes ) ."
3,"However , US is associated with improved efficiency ( decreased performance time and fewe needle passes ) ."
3,"However , US is associated with improved efficiency ( decreased performance time and fewer niedle passes ) ."
3,"However , US is associated with iproved efficiency ( decreased performance time and fewer needle passes ) ."
2,Participants had better health behaviors and fewer health problems than those who did not participate .
2,Participants had better health behaviors and fewer health problems than those who did not particpiate .
2,Participants had better health behaviors and fewer helth problems than those who did not participate .
2,Participants had btter health behaviors and fewer health problems than those who did not participate .
2,Participants had etter health behaviors and fewer health problems than those who did not participate .
0,To assess changes in circulating incretin levels and body fat compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes ( T2D ) .
0,To assees changes in circulating incretin levels and body fat compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with tyep 2 diabetes ( T2D ) .
0,To assess changes in circulating incretin levels and bnody fat compositions with initial combinOation therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes ( T2D ) .
0,To assess changes in circulating incretin levels and body fta compositions with initial combinatioE therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes ( T2D ) .
0,To assess chkanges in circulating incretin levels and body fat compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with tpye 2 diabetes ( T2D ) .
4,"The J-START was registered with the University Hospital Medical Information Network Clinical Trial Registration ( UMIN-CTR ) , Japan ( registration number : UMIN000000757 ) , on July 1 , 2007 ."
4,"The J-START was registered with the University Hospital Medical Ifnormation Network Clinical Trial Registration ( UMIN-CTR ) , Japan ( registration number : UMIN000000757 ) , on uly 1 , 2007 ."
4,"The J-START was registered with the University Hospital Medical Information Network ClinicSal Trial Registration ( UMIN-CTR ) , Japan ( registration number : UMIN000000757 ) , on uJuly 1 , 2007 ."
4,"The J-START was registered with the University Hospital Meidcal Information Network Clinical Trial Registration ( UMIN-CTR ) , Japan ( registration number : UMIN000000775 ) , on July 1 , 2007 ."
4,"The Y-START was registered with the University Hospital Meqdical Information Network Clinical Trial Registration ( UMIN-CTR ) , Japan ( registration number : UMIN000000757 ) , on July 1 , 2007 ."
2,Overall response rate by clinical palpation was 64.5 % in all patients with a final palpation measurement .
2,Overall response rate by clinical palpation was 46.5 % in all patients with a final palpation measurement .
2,Overall response rate by clinical palpation was 64.5 % in all patibnts with a final palpation measurement .
2,Overall response rate by clinical palpation was 64.5 % in all patients with a finual palpation measurement .
2,Overall response rate by clinical palpation was 64.5 % in all patietns with a final palpation measurement .
2,"Within the MRD intermediate-risk group , iAMP21 cases ( n = 27 ) had a worse 8-year EFS ( 56 11 % vs. 78 2 % , p = 0.0077 ) and CIR ( 44 11 % vs. 20 2 % , p = 0.003 ) with 6/10 relapses occurring after 2 years ."
2,"Withgn the MRD intecmediate-risk group , iAMP21 cases ( n = 27 ) had a worse 8-year EFS ( 56 11 % vs. 78 2 % , p = 0.007 ) and CIR ( 44 11 % vs. 20 2 % , p = 0.0L3 ) with 6/10 relapses occurring after 2 years ."
2,"Within the MRD intermediate-risk group , iAMP21 cases ( n = 27 ) had a wores 8-year EFS ( 56 11 % vs. 78 2 % , p = 0.007 ) and CIR ( 44 11 % vs. 2 2 % , p = 0.003 ) with 6/10 relaspes occurring after 2 years ."
2,"Within the MRD intermediate-risk group , iAMP21 cases ( n = 27 ) had a worse 8-year EFS ( L56 11 % vs. 78 2 % , p = 0.0077 ) and CIR ( 44 11 % wvs. 0 2 % , p = 0.003 ) with 6/01 relapses occurring after 2 years ."
2,"Withni the MRD intermediaet-risk gooup , iAMP21 cases ( n = 27 ) had a worse 8-year EFS ( 56 11 % vs. x8 2 % , p = 0.0077 ) and CIR ( 44 11 % vs. 20 2 % , p = 0.003 ) with 6/10 relapses occurring after 2 years ."
1,Randomisation and allocation to trial groups ( n = 27 and n = 27 ) were carried out by a central computer system .
1,Randomisation and allocation to trial groups ( n = 2 and n = 27 ) were carried out by a central computer system .
1,Randomisation and allocation to trial groups ( n = 27 and n = 27 ) were carried out by a central computer sysem .
1,Randomisation and allocation to trial groups ( n = 27 and n = 27 ) were carried out by a central computer ystem .
1,Randomisation and allocation to trial groups ( n = 72 and n = 27 ) were carried out by a central computer system .
4,"Intermittent normobaric hypoxia training , an alternative to altitude training for athletes , may be beneficial to treat overweight and obesity ."
4,"Intermittent normobaric hypoxia training , an alernative to altitude training for athletes , may be beneficial to treat overweight and obesity ."
4,"Intermittent normobaric hypoxia training , an alternative to altitude training for athletes , may be beneficial to treat oerweight and obesity ."
4,"Intermittent normobaric hypoxia training , an alternative to altitude trainnig for athletes , may be beneficial to treat overweight and obesity ."
4,"Intermittent normobaric hypoxia training , an alternative to alttiude training for athletes , may be beneficial to treat overweight and obesity ."
2,"Six-month mortality was 6.5 % in the ICP group and 9.1 % in the control group ( P < 0.05 ) , and neurological outcome was better in the ICP group compared with the control group ( P < 0.05 ) ."
2,"Si-month mortality was 6.5 % in the ICP group and 9.1 % in the control group ( P < 0.05 ) , and neurological outcome was gbetter in the IPC group compared with the control group ( P < 0.05 ) ."
2,"Six-month mortality was 6.5 % in the ICP group and 9.1 % in the control group ( P < 0.05 ) , and neurological outcome was better in the ICqP group comared with the contol group ( P < 0.05 ) ."
2,"Six-month mortality was 6.5 % in the JICP group and 9.1 % in the control group ( P < 0.0M ) , and neurological outcome was better in the ICP group compared with the control group ( P < 0.50 ) ."
2,"Six-month motrality was 6.5 % in the ICP group and 9.1 % in the control group ( P < 0.05 ) , and neurologicl outcome was btter in the ICP group compared with the control group ( P < 0.05 ) ."
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( BP ) levels are associated with increased risks of recurrent stroke .
0,There is ongoign controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( BP ) levels are associated with increased Srisks of recurrent stroke .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( PB ) levels are associated with increased riss of recurrent stroke .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( gP ) levels are associated with increased risks of Grecurrent stroke .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high lbood pressure ( BP ) levels are associated with increased risYks of recurrent stroke .
1,"This is a pragmatic , individually randomised , controlled , feasibility study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual alone , for adults attending a general hospital following self-harm ."
1,"This is a pragmatic , individually randomised , controlled , feaTsibility study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual alone , for adults attendin a general hospital following self-harm ."
1,"This is a pragmatic , individually randomised , controlled , feasibility stdy comparing interpersonTl problem-solving therapy plus treatment-as-usual with treatment-as-usual alone , for adults attending a general hospital following self-harm ."
1,"This is a pragmatic , individually randomised , controlled , feasibility study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual alone , for adults attending a general hospital folFowing self-harf ."
1,"This is a pragmatic , individually randomised , controlled , feasibility study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual laone , for adults attending a general hospRital following self-harm ."
1,"HIV-uninfected men ( HIV - ; n = 60 ) , HIV-infected men using HAART ( HIV + / HAART + ; n = 58 ) , and HIV-infected men not using HAART ( HIV + / HAART - ; n = 41 ) recruited from two sites of the Multicenter AIDS cohort study ( MACS ) underwent a nocturnal sleep study , anthropometric assessment , and questionnaires for fatigue and the Epworth Sleepiness Scale ."
1,"HIV-uninfecteAd men ( HIV - ; n = 60 ) , HIVinfected men using HAART ( HIV + / HAART + ; n = 58 ) , and HIV-infected men not using HAART ( HIV + / HAART - ; n = 41 ) recruited from two sites of the Multicenter AIDS cohort study ( MCAS ) underwent a nocturnal sleep stuXy , anthropometric assessment , and questionnaires for fapigue and the Epworth Sleepiness Scale ."
1,"HIV-uninfected men ( HIA - ; n = 6c ) , HIV-infected men using HAART ( HIV + / HAART + ; n = 58 ) , and HIV-infecte men not using HAART ( HIV + / HAART - ; n = 41 ) recruited from tow sites of the Multicenter AIDS cohort study ( MACS ) underwent a nocturnal slep study , anthropometric assessment , and questionnaires for fatigue and the Epworth Sleepiness Scale ."
1,"HIV-uninfected men ( HIV - ; n = 60 ) , HIV-infected men using HAART ( HIV + / HAART + ; n = 58 ) , and HIV-infected men not using HAART ( HIV + / HAART - ; n = H1 ) recruited from two sites of the Multicentejr AIDS cohort study ( MACS ) underwent a nocturnal slepe study , anthropometric assessmetn , and questionnaires for fatigue and the Epworth Sleepiess Scale ."
1,"HIV-uninfected men ( HIV - ; n = 60 ) , HIV-infected men using HAART ( iHIV + / HAART + ; n = 85 ) , and HIV-infected men not usiPng HAART ( HIV + / HAART - ; n = 4v ) recruited from two sites of the Multicenter AIDS cohort study ( MASC ) underwent a nocturnal sleep study , anthropometric assessment , and questionnaires for fatigue and the Epworth Sleepiness Scale ."
3,Our data did not show a significant improvement in overall survival with immediate versus deferred chemotherapy after radical cystectomy and bilateral lymphadenectomy for patients with muscle-invasive urothelial carcinoma .
3,Or data did not show a significant improvement in overall survival with immediate vjrsus deferred chemotherapy after radical cystectomy and bilateral lymphadenectomy for patients with muscle-invasive urothelial carcinoma .
3,Our dat did not show a significant improvement in overall survivl with immediate versus deferred chemotherapy after radical cystectomy and bilateral lymphadenectomy for patients with muscle-invasive urothelial carcinoma .
3,Our data did not show a significant improvement in overall suravival with immediate versus deferred chemotheapy after radical cystectomy and bilateral lymphadenectomy for patients with muscle-invasive urothelial carcinoma .
3,Our data did not show a significant improvement in overall survival with immediate versus deferred chemothrapy after radical cystectomy and blateral lymphadenectomy for patients with muscle-invasive urothelial carcinoma .
0,Study participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Stduy participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Study participants were randomly asisgned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Study participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily vesus equivalent placebo for 28 days .
0,Study partikcipants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
1,The incidence of adverse events was also considered .
1,Teh incidence of adverse events was also considered .
1,The inLcidence of adverse events was also considered .
1,The incidence of adverse events was also cosidered .
1,The incidene of adverse events was also considered .
0,Our goal was to compare the rate of infections among subgroups with and without prophylactic antibiotic treatment .
0,Our goal was to compare the rate of infections among subgroups with and wihtout prophylactic antibiotic treatment .
0,Our goal was to compare the rate of infections among subgroups with and without prophylactic Sntibiotic treatment .
0,Our goal was to compare the rate of infections among subgroups with and without propyhlactic antibiotic treatment .
0,Our goal was to compare the rate of infections lamong subgroups with and without prophylactic antibiotic treatment .
0,To evaluate the prevalence of respiratory impairment and dyspnea and their associations with objectively measured physical inactivity and performance-based mobility in sedentary older persons .
0,To evafluate the prevalence of respiratory impairment and dyspnea and their associations with objectively measured physical inactivity and performance-based mobility in sedentary loder persons .
0,To evaluate the pqrevalence of respiratory impairment and dyspnea and their associations with objectively measured physical inactivity and performance-based mobility in sedentLry older persons .
0,To evaluate the prevalence of respiratory impairment and dEyspnea and their associations with objectively measured physical inactivity and performance-based ombility in sedentary older persons .
0,To evaluate the prevalence of respiratory impairmet and dyspnea and their associations with objectively measured physical inactivity and performance-based mobility in sedentary older persosn .
1,Patients in the trial group received clean liquid integral protein diet for 3 days before operation without mechanical bowel preparation .
1,PaCtients in the trial group received clean liquid integral protein deit for 3 days before operation without mechanical bowel preparation .
1,Patents in the trial group received clean liquid integral protein diet for 3 days before operation without mechanical boel preparation .
1,Patients in the trial group receVived clean liquid integral protein diet for 3 days before operation withou mechanical bowel preparation .
1,Patients in the trial group reeeived clean liquid integral protien diet for 3 days before operation without mechanical bowel preparation .
1,"Safety was established through serial serum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was established through serial serum potassium levels and easurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was established through serial sreum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was established through sexrial serum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was establsihed through serial serum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
0,To compare the efficacy of two surgical techniques for controllong nasal width after Le Fort I osteotomy .
0,To compNare the efficacy of two surgical techniques for controllong nasal width after Le Fort I osteotomy .
0,To compare the efficacy of two surgical techniques for controllong nasal wiTdth after Le Fort I osteotomy .
0,To compare the efficacy of two surgical techniques for controllong nasal width after Le Frot I osteotomy .
0,o compare the efficacy of two surgical techniques for controllong nasal width after Le Fort I osteotomy .
0,We estimate the effect size of hypoglycemia risk reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate the effect size of hypoglycemia risk reduciton on culosed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate the effect size of hypoglycemia risk reduction on closed-looD cAontrol ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate the effect size of hypoglycemia risk reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpaJient estting .
0,We estimate the ffect size of hypoglycemia risk reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient seIting .
3,"Treatment of active acne with the 1,550-nm erbium glass laser is effective ."
3,"Treatmenf of active acne with the 1,550-nm erbium glass laser is effective ."
3,"Treatment of activ acne with the 1,550-nm erbium glass laser is effective ."
3,"Treatment of activFe acne with the 1,550-nm erbium glass laser is effective ."
3,"Treatment of active acne with the 1,550-nm erbium glass laser is efDective ."
4,Sclavo Vaccines Association and Regione Toscana .
4,Sclavo Vaccines Association and Regione Toscanr .
4,Sclavo Vaccines Association and Regione Toscyana .
4,Sclavo Vaccines Association and Regone Toscana .
4,cclavo Vaccines Association and Regione Toscana .
4,"The primary objective of this study was to assess the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the pharmacokinetics of acetaminophen ."
4,"The primary objective of this sthudy was to asses the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the pharmacokinetics of acetaminophen ."
4,"The primary objective of this study was to asseds the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the lpharmacokinetics of acetaminophen ."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric emptyaing of liquids in healthy subjects , as measured by the pparmacokinetics of acetaminophen ."
4,"The primary objetive of this study was to assess the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the pharmacokinetics of acetamrnophen ."
3,"ICS discontinuation after 30 months in COPD can worsen lung function decline , AHR , and QOL during 5-year follow-up ."
3,"ICS discontinaution after 30 months in COPD can worsen lung function decline , AHR , and QOL during 5-year follow-up ."
3,"ICS discontinuation after 30 monhs in COPD can worsen lung function decline , AHR , and QOL during 5-year follow-up ."
3,"ICS discontinuation after 30 months in COPD can worsen lunC function decline , AHR , and QOL during 5-year follow-up ."
3,"IS discontinuation after 30 months in COPD can worsen lung function decline , AHR , and QOL during 5-year follow-up ."
3,10 % Chlorhexidine was highly effective in high risk participants with more than two cavities at the initial examination .
3,10 % Chlorhefxidine was highly effective in high risk participants with more than two cavities at the initial examination .
3,10 % Chlorhexdiine was highly effective in high risk participants with more than two cavities at the initial examination .
3,10 % Chlorhexidine was highly effJctive in high risk participants with more than two cavities at the initial examination .
3,10 % Chlorhexidine was highly effective in high risk participants with more than two cavities at the initial examintion .
1,We excluded patients who were taking vitamin D or calcium supplements .
1,We excluded patientYs who were taking vitamin D or calcium supplements .
1,We excluded patients who were taking vitamin D or calcium sHpplements .
1,We excluded patients who were toking vitamin D or calcium supplements .
1,We excluedd patients who were taking vitamin D or calcium supplements .
3,Similar rates of surgical success were observed with both implants at 5 years .
3,Similar raets of surgical success were observed with both implants at 5 years .
3,Similar rates of srgical success were observed with both implants at 5 years .
3,Similar rates of surgical success were observed with both implants at 5 eyars .
3,Similar rates of surgical usccess were observed with both implants at 5 years .
1,Participants will receive treatment for 28 days .
1,Participants will receie treatment for 28 days .
1,Participants will receive rteatment for 28 days .
1,Participants will receive treatment for 28 dasy .
1,Participants will receive treatment for 82 days .
4,"Dietary patterns that are considered healthy ( eg , the Dietary Approaches to Stop Hypertension diet and Mediterranean diet ) may be more successful in reducing typical cardiovascular disease risks compared to dietary patterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"DieDtary patterns that are considered healthy ( eg , the DietaRry Approaches to Stop Hypertension diet and Mediterranean diet ) may be more successful in reducing typical cardiovascular disease Jisks compared to dietary pasterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"Dietary patterns that are considered healthy ( eg , the Dietary ApproaPhes to Stop Hypertension diet and Mediterranean diet ) may be more successful in reducing typical cardiovascular disease rVisks cojpared to dietary patterns considered unhealthy ( Aeg , energy-dense diets such as the typical American diet ) ."
4,"Dietary patterns that are considered healthy ( eg , the Dietary Approaches to Stop Hypertension diet and MedVterranean deit ) may be more successful in reducing typical cardiovascular disease risks ocmpared to dietary pattens considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"Dietary patterns that are considered healthy ( jeg , the Dietary ApproachZs to Stop Hypertension diet and Mediterranean diet ) Pay be more sucWcessful in reducing typical cardiovascular disease risks compared to dietary patterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
3,This pilot study provides preliminary evidence for integrating error management skills into medical curricula and for the design of learning goals in simulation-based education .
3,This pilo study provides preliminary evLidence for integrating error management skills into medical curricula and for the design of learning goals in simulation-based education .
3,This pilot study provides prelimianry evidence for integrating error management skills into medical curricula and for the desigC of learning goals in simulation-based education .
3,This pilot study provides preliminary evidence for integrating error manaEement skills into medical curricula and for the design of learning goals in fimulation-based education .
3,This pilot study provides preliminary evidence for integrating error management skills into medical curicula and for the desing of learning goals in simulation-based education .
4,Several randomized controlled clinical trials of PTA balloons coated with different formulations of paclitaxel have been conducted in Europe ( N Engl J Med 2008 ; 358:689 -699 ) ( Circulation 2008 ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:831 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than PTA with comparable safety .
4,Several randomized conrtolled clinical trials of PTA balloons coated with different formulatiosn of paclitaxel have been conducted in Europe ( N Engl J Med 2008 ; 358:689 -699 ) ( Circulation 2008 ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:W831 -840 ) ( JAkC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable effiaccy than PTA with comparable safety .
4,Several randomized controlled clinical trials of PTA balloons coated with different formulations of paclitaxel have been conducted in Eulrope ( N Engl J Med 2008 ; 35B:69 -699 ) ( Circulation 2008 ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:83 -840 ) ( JACC Cardiovas nIterv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than PTA with comparable safety .
4,Several randomized controlled clinical trials of PTA balloons coated with different formulations of paclitaxel have been onducted in Europe ( N Engl J Med 2008 ; 38:689 -699 ) ( Circulation 20v8 ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:813 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than PTuA with comparable safety .
4,Several randomized controlled clinical trials of PTA balloons coated with different forulations of paclitaxel have been conducted in Europe ( N Engl J Med 2008 ; 358:689 -699 ) ( Circulation 2R08 ; 118:1358 -1365 ) ( Circ Cardiovasc Intev 2012 ; 5:831 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -91 ) and demonstrated more durable efifcacy than PTA with comparable safety .
2,Both subgroups showed significant reductions in PLT transfusions with a no-prophylaxis strategy .
2,Both subgroups showed significant reductions in PLT traSnsfusions with a no-prophylaxis strategy .
2,Both subgroups showed significant reductions in PLT transfusions with a no-prophlyaxis strategy .
2,Both subgroups showed significant reductions in PLT transfusions with a no-prophylaxis ltrategy .
2,Both subgroups showed significant reductios in PLT transfusions with a no-prophylaxis strategy .
4,"Previous trials have shown less short-term recurrence with mesh , but adverse outcomes limit mesh use ."
4,"Previous trials have shown ess short-term recurrence with mesh , but adverse outcomes limit mesh use ."
4,"Previous trials have shown less short-term recuarence with mesh , but adverse outcomes limit mesh use ."
4,"Previous trials have shown less short-term recurrence with mesh , but adverse outcmoes limit mesh use ."
4,"Previous trials have shown less shorto-term recurrence with mesh , but adverse outcomes limit mesh use ."
3,Frequent exercising and bracing seems effective long-term prevention advices in recurrent LBP .
3,FrequMnt exercising and bracing seems effective long-term prevention advices in recurrent LBP .
3,Frequent exercising and bracing seems effective lon-gterm prevention advices in recurrent LBP .
3,Frequent exercising and bracing seems effective long-term preventio advices in recurrent LBP .
3,Frequent exercising and bracnig seems effective long-term prevention advices in recurrent LBP .
3,"Cinitapride usage is well tolerated , but its cardiovascular events need further evaluation ."
3,"CinitZpride usage is well tolerated , but its cardiovascular events need further evaluation ."
3,"Cinitapride usage is well tolerated , but its ardiovascular events need further evaluation ."
3,"Cinitapride usage is well tolerated , but its cardiovascular events need further evOaluation ."
3,"Cinitapride usage is well tolgerated , but its cardiovascular events need further evaluation ."
2,Only dogs with GER in Group S had significantly lower pH at the end compared to the beginning of anesthesia ( p = 0.004 ) .
2,Onl dogs with GER in Group S had significantly lwoer pH at the end compared to the beginning of anesthesia ( p = 0.004 ) .
2,Only dogs with GER in Group S had significantly lower pH at the end Acompared to the beginning of anTsthesia ( p = 0.004 ) .
2,Only odgs with GER in Group S had significantly lower pH at the ed compared to the beginning of anesthesia ( p = 0.004 ) .
2,Only ogs with GExR in Group S had significantly lower pH at the end compared to the beginning of anesthesia ( p = 0.004 ) .
0,"The aim of the present study was to evaluate the effect of Erythrinamu lungu on the control of dental anxiety in patients who had under gone bilateral extraction of asymptomatic , impacted mandibular third molars ."
0,"The aim of the present study was to evaluate the effect of Erythrinamu lungu on the contrlo of dentcal anxiety in patients who had under gXne bilateral extraction of asymptomatic , impacted mandibular third molars ."
0,"The aim of the present study was to evluate the efefct of Erythrinamu lungu on the control of dental anxiety in patients who had under gone bilateral extraction of asymptomatic , impacted mandibular third molaras ."
0,"The aim of the presgent study was to evaluate the effect of Erythrinamu ungu on the control of dental anxiety in patients who had under gone bilateral exrtaction of asymptomatic , impacted mandibular third molars ."
0,"The axm of the present studBy was to evaluate the effect of Erythrinamu lungu on the control of dental anxiety in patients who had under gone bilateral extraction of asymptomatic , impnacted mandibular third molars ."
4,"Adverse events ( AEs ) , defined as unintended patient harm related to healthcare provided rather than an underlying medical condition , represent a significant threat to patient safety and public health ."
4,"Adverse events ( AEs ) , defined as unintended patient harm reltaed to healthcare porvided rather than an underlying medical condition , represent a significant threat to patient safety and public health ."
4,"Adverse events ( AEs ) , defined as unnitended patient harm related to healthcare provided ratheVr than an underlying medical condition , represent a significant threat to patient safety and public health ."
4,"Adverse events ( AsE ) , defined as unintended patient harm related to healthcare provided rather than an underlying medical condition , reprseent a significant threat to patient safety and public health ."
4,"Adverse vents ( AEs ) , defined as unintended paient harm related to healthcare provided rather than an underlying medical condition , represent a significant threat to patient safety and public health ."
2,There were large discrepancies in the number of silicosis cases found .
2,There were large discrepancies in the nNumber of silicosis cases found .
2,There were large discrepancies in the numOber of silicosis cases found .
2,There were large discrepancies in the number of silicosis ases found .
2,There were large discrepancies in the number of silicsis cases found .
0,"We aimed to examine associations of quantitative gastrointestinal and psychological traits with obesity , and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointWstinal and psychologcial traits with obesity , and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointestinal and psycholngical traits with obestiy , and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointestinal and psychologial traits with obesity , and to validate the ability of these traits to predict responses of obese individual to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointestinal and psychological traits with obesity , and to valVidate the ability of these traits to predict responsWes of obese individuals to pharmacotherapy ."
3,"Moreover , it will assess the risks associated with this procedure ."
3,"Moreover , it will assess the risks asociated with this procedure ."
3,"Moreover , it will assess the risks asscoiated with this procedure ."
3,"Moreover , it will assess the risks associated with this Srocedure ."
3,"Moreover , it will sasess the risks associated with this procedure ."
3,"Calcitriol has apparent beneficial effect on acute cellular rejection of liver transplants , which may be associated with increases in the proportion of circulating Treg cells ."
3,"Calcitriol has apparennt beneficial effect on acute cellular rejection of liver transplants , which may be associated with increases in the proportion of circulating Trek cells ."
3,"Calcitriol has apparent beneficial effect on acut cellular rejection of liver transplantn , which may be associated with increases in the proportion of circulating Treg cells ."
3,"Calcitriol has apparent beneficial effect on acute cellulag rejection of livre transplants , which may be associated with increases in the proportion of circulating Treg cells ."
3,"Calcitriol has apparent beneficial effect on acute cellular rejection of liver transplants , which mKay be associated with increases in the proportion of circulating HTreg cells ."
0,The aim of this study is to evaluate whether BMD changes after cessation of ronacaleret treatment .
0,The aim of this study is to evalquate whether BMD changes after cessation of ronacaleret treatment .
0,The aim of this study is to evaluate whether BMD changes after cessaiton of ronacaleret treatment .
0,The aim of this study is to evaluate whether BMD changes after cessatoin of ronacaleret treatment .
0,hTe aim of this study is to evaluate whether BMD changes after cessation of ronacaleret treatment .
4,Treatment aimed at slowing down the progression of DN is available but methods for early and definitive detection of DN progression are currently lacking .
4,Treatment aimed at slowing down the progression of DK is available but methods for early and definitive deetction of DN progression are currently lacking .
4,Treatment aimed at slowing down the progression of DN is available but methods for eirly and definitive detection of N progression are currently lacking .
4,Treatment aimed at slowing down the progression of DNN is availble but methods for early and definitive detection of DN progression are currently lacking .
4,Treatment aimed at slowing down the progression of N is available but methods for early and definiktive detection of DN progression are currently lacking .
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxetine along with diminished neural activations within the caudate nucleus ."
2,"Relatfive to placebo , subjective sexual functioning was attenuated under reboxetine along with diminished neural activations within the caudate nucleus ."
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxeine along with diminished neural activations within the caudate nucleus ."
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxetine along with diminihed neural activations within the caudate nucleus ."
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxetine along with diminished newural activations within the caudate nucleus ."
1,"Thirty-three patients diagnosed with pancreas , stomach , rectum , colon malignancies , and undergoing major abdominal surgery at Ankara Numune Training and Research Hospital were randomly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"Thirt-ythree patients diagnosed with pancreas , stomach , rectum , colon malignancies , and undergoing major abdominl surgery at Ankara Numune Training and Research Hospital were randomly divided into two groups ; control ( CON ) and N-acetyxl cysteine ( NAC ) ."
1,"Thirty-three patients diagnosed with panceras , stomach , rectum , colno malignancies , and undergoing major abdominal surgery at Ankara Numune Training and Research Hsopital were randomly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"Thirty-three patients diagnosed with pancreas , stomach , rectuO , colon mlignancies , and undergoing major abdominal surgery at Ankara Numune Training and Research Hospital were randoPly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"Thirty-three patients diagnosed with pnacreas , stomach , rectum , colno malignancies , and undergoing major abdominal surgery at Ankara Numune Traiing and Research Hospital were randomly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"An acute resistance exercise protocol was administered at 0 , 6 , and 12 weeks of training ."
1,"An acute resistance exercise protocol was administered at 0 , 6 , and 12 weeks of trainXing ."
1,"An acute resistance exercise protocol was administeredd at 0 , 6 , and 12 weeks of training ."
1,"An aucte resistance exercise protocol was administered at 0 , 6 , and 12 weeks of training ."
1,"nA acute resistance exercise protocol was administered at 0 , 6 , and 12 weeks of training ."
1,"Preoperative , intraoperative , and postoperative variables and mortality were compared among groups ."
1,"Preoperative , intraoperative , and postoperative variables and mortality were cmopared among groups ."
1,"Preoperative , intraoperative , and postoperative variables and mortality were compaed among groups ."
1,"Preoperative , intraoperative , and postoperative variables and mortality were compared amog groups ."
1,"Preoperative , intraoperative , and postoyerative variables and mortality were compared among groups ."
2,The moderate-dose treatment produced weight losses similar to the high-dose condition and significantly larger than the low-dose and control conditions ( posterior probability > 0.996 ) .
2,The moderate-dose treatment produced weight losses similar to the high-dose condition and significantly alrger than the low-dose and control conMditions ( posterior probability > 0.996 ) .
2,The moderate-dose treatment produced weight losses similar to the zhigh-dose condition and significantly larger than the low-dsoe and control conditions ( posterior probability > 0.996 ) .
2,The moderate-dose treatment produceu weight losses similsar to the high-dose condition and significantly larger than the low-dose and control conditions ( posterior probability > 0.996 ) .
2,The moderate-dose tretament produced weight losses similar to the high-dose condition and significantly larger than the low-does and control conditions ( posterior probability > 0.996 ) .
1,"We used linear mixed models to compare the outcomes of both groups immediately after training , after 6 months , and after 12 months , adjusted for baseline ."
1,"We used lienar mixed models to comprae the outcomes of both groups immediately after training , after 6 months , and after 12 months , adjusted for baseline ."
1,"We used linear mixed models to compare the outcomes of both gorups immediately after training , after 6 months , and after 12 months , adjusted for aseline ."
1,"We used linear mixed models to compare the outcomes of both groups immediately after training , after 6 omnths , and after 12 monts , adjusted for baseline ."
1,"We used linear mixed mokels to compare the outocmes of both groups immediately after training , after 6 months , and after 12 months , adjusted for baseline ."
1,"The research design was a prospective , randomized study ."
1,"The research deNign was a prospective , randomized study ."
1,"The research deign was a prospective , randomized study ."
1,"The research design was a prospective , randomized sthdy ."
1,"The rsearch design was a prospective , randomized study ."
0,To compare the clinical benefit of a periodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3months after therapy .
0,T compare the clinical benefit of a periodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic peiodontitis up to 3months after therapy .
0,To compare the clinical benefit of a periodontal dressing paplied after a one-stage fuNl-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3months after therapy .
0,To compare the clinical benefit of a ptriodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3moVnths after therapy .
0,To compare the clinicla benefit of a periodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3months after utherapy .
4,"We investigated the efficacy and safety of three doses of tiotropium , administered in the evening ( via Respimat ( ) SoftMist inhaler ) , versus placebo in asthmatic adolescents symptomatic despite ICS treatment ."
4,"We investigated the efficacy and asfety of three doses of tiotropium , administered in the evening ( va Respimat ( ) SoftMist inhaler ) , versus placebo in asthmatic adolescents symptomatic despite ICS treatment ."
4,"We investigated the efficacy and safety of three doses of tiotropium , administered in the evening ( va Respimat ( ) SoftMist inhaler ) , versus placebo in asthmatic adolescnets symptomatic despite ICS treatment ."
4,"We investigated the efficacy and safeyt of three doses of tiotropium , administered in the evening ( via Respimat ( ) SoftMist inhaler ) , versus placebo in asthmtic adolescents symptomatic despite ICS treatment ."
4,"We invesuigated the efficacy and safety of three doses of tiotropium , administered in the evening ( via Respimat ( ) SoftMist inhaler ) , versus placebo in asthmatic adolescents symptomatic despiIe ICS treatment ."
0,"This study used an in-depth mixed-methods design to examine individual variation in ( 1 ) impact on self-reported goal engagement ( ie , motivation , self-efficacy , awareness , effort , achievement ) of access to a weight management app ( POWeR Tracker ) when provided alongside a Web-based weight management intervention ( POWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"Lhis study used an in-depth mixed-methods design to eamine individual variation in ( 1 ) impact on self-reported goal engagement ( ie , Gotivation , self-efficacy , awareness , effort , achievement ) of access to a weight manageent app ( POWeR Tracker ) when provided alongside a Web-based weight mangaement intervention ( POWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"This studMy used an in-depth mixed-methods design to examine indiviual variation in ( 1 ) impact on self-reported goal engagement ( ei , motivation , self-efficacy , awareness , effort , achievement ) of access to a weight management app ( POWR Tracker ) when provided alongside a Web-based weight management intervention ( POWeR ) and ( 2 ) suage and views of POWeR Tracker ."
0,"This study used an Cn-depth mixed-methods design to examine individual variation in ( 1 ) impact on self-reported ogal engagement ( ie , motivation , felf-efficacy , awareness , effort , achievement ) of access to a weight management app ( POeWR Tracker ) when provided alongside a Web-based weight management intervention ( zOWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"This study used an in-depth mixed-methods design to examine individual variation in ( 1 ) impact on self-reported goal engagement ( qe , motivation , self-efficacy , awareness , effort , achievement ) of access to a weight management app ( BOWeR Trackr ) when provided alongside a Web-based weight management interventin ( POWeR ) and ( 2 ) usage and views of PCWeR Tracker ."
1,"Participants will be randomized ( in a 1:1 ratio ) to receive oral granulated Chinese herbal medicine YXBCM01 plus topical calcipotriol 0.005 % or oral YXBCM01 placebo plus topical calcipotriol 0.005 % treatment for 12 weeks , with a 12-week follow-up phase ."
1,"Participants will be ranTdomized ( in a 1:1 ratnio ) to receive oral granulated Chinese herbal medicine YXBCM01 plus topical Bcalcipotriol 0.005 % or oral YXBCM01 placebo plus topical calcipotriol 0.005 % treatment for 21 weeks , with a 12-week follow-up phase ."
1,"Participants will be randeomized ( in a 1:1 ratio ) to receiv oral granulated ChinBse herbal medicine YXBCM01 plus topical calcipotriol 0.005 % or oral YXBCM01 placebo plus topical calciporiol 0.005 % treatment for 12 weeks , with a 12-week follow-up phase ."
1,"Participants will be randomized ( in a 1:1 ratio ) to rtceive orxal granulatted Chinese herbal medicine YLBCM01 plus topical calcipotriol 0.005 % or oral YXBCM01 placebo plus topical calcipotriol 0.005 % treatment for 12 weeks , with a 12-week follow-up phase ."
1,"Participnats will be randomized ( in a 1:1 fatio ) to receive oral rganulated Chinese herbal medicine YXBCM01 plus topical calcipotriol 0.005 % or oral YXBCM01 placebo plus topical calcipotriol 0.005 % treatment for 12 weeks , with a 12-week folloi-up phase ."
1,Caregivers of persons with chronic conditions who scored 7 or above in the Caregiver Strain Index were randomly assigned to the 8-week MBSR group ( n = 70 ) or the self-help control group ( n = 71 ) .
1,CaregivSers of persons with chronic conditions who scored 7 or above in the Caregiver Ctrain Index were andomly assigned to the 8-week MBSR group ( n = 70 ) or the self-help control group ( n = 71 ) .
1,Caregivers of persons with chronOic conditions who scored 7 or above in the Caregiver Strain Index were randomly assigned to the 8-week MXSR group ( n = 70 ) or the self-help conQtrol group ( n = 71 ) .
1,Caregivers of persons with chronic conditions who scored 7 or above in the Caregiver StraRn Index were randomly asisgned to the 8-week MBSR group ( n = 70 ) or the self-help control grVoup ( n = 71 ) .
1,Caregvers of persons with chronic conditions who scored 7 or above in the Caregiver Strain Index were randomly assigned to the 8-week MBSR gruop ( n = 70 ) or the self-help control group ( n = 1 ) .
1,"Preoperatively , patients were randomly assigned to receive either a supraclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine bolus via the catheter and ropivacaine perineural infusion initiated postoperatively ."
1,"Preoperatively , patients were randomly assigned to receive either a suparclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine bolws via the catheter and ropivacaine perinoeural infusion initiated postoperatively ."
1,"Preoperatively , patients were randomly assigned to receive either a supraclavicular or an infraclavicular catheter sing an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine Colus via the catheter and ropivacanie perineural infusion initiated postoperatively ."
1,"Preoperatively , patients were ranomly assigned to receive either a supraclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine polus via the catheter and ropivacaine perineural ifnfusion initiated postoperatively ."
1,"Preoperatively , ptients were randomly assigned to receive either a supraclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating actheter insertion technique with a mepivcaine bolus via the catheter and ropivacaine perineural infusion initiated postoperatively ."
1,"Secondary outcomes include time until full sustainable return to work , health related quality of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
1,"Secondary otucomes include time until full sustainable return to work , health related quality of life , health related behavior , functional status , somatic and mental health , and perceptions of wor ."
1,"Secondary outcomes include itme until full sustainable return to work , health elated quality of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
1,"Secondary outcomes include time until full sustainable return to work , heath related qualiyt of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
1,"Secondary outcomes include time until ufll sustainable retudn to work , health related quality of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
2,"However , the greatest reduction ( 80 % ) was observed when using a combination of all control measures ."
2,"However , the greatest erduction ( 80 % ) was observed when using a combination of all control measures ."
2,"However , the greatest reduction ( 80 % ) was observed when usign a combination of all control measures ."
2,"However , the greatest reduction ( 80 % ) was observed when using a combination of all conxrol measures ."
2,"However , the greatest reduction ( 80 % ) was observed when using a combination of all cotnrol measures ."
3,High SOC scores were good predictors of successful lifestyle change in subjects at risk of type 2 diabetes .
3,High SOC scores were good predictors of successful aifestyle change in subjects at risk of type 2 diabetes .
3,High SOC scores were good predictors of successful lifestyle changLe in subjects at risk of type 2 diabetes .
3,High SOC scores were good predictors of sucecssful lifestyle change in subjects at risk of type 2 diabetes .
3,High SOC scores were ood predictors of successful lifestyle change in subjects at risk of type 2 diabetes .
2,"Both BIS values and OAA/S scores were lower in Group P than in Group S. Patients ' satisfaction was higher in Group P , although there was no significant difference with respect to surgeons ' satisfaction between the groups ."
2,"BHoth BIS values and OAA/S scores were lower in Group P than in Group S. Patients ' satisfaction was higher in Group P , although there was no significant difference with respect to suregons ' stisfaction between the groups ."
2,"Both BIS values and OAA/S scores were lower in Group P than in Group S. Patients ' satisfatcion was higher in Grop P , although there was no significant difference with respect to surgeons ' satisfaction between the Jgroups ."
2,"Both BIS values and OAA/S scores were lower in Vroup P than in Group S. Patients ' satisfaction was higher in Group P , although there was no significant difference with respect to surgens ' satisfaction between the gropus ."
2,"Both PBIS values and OAA/S scores were lower in GFoup P than in Group S. Patients ' satisfaction was higher in Group P , although there was no significant difference with respect to surgeons ' satisfaction between the grouos ."
1,"Comparison of coronary blood flow , ST-segment resolution ( STR ) , duration of hospital stay , 30-day major adverse cardiac events ( MACE ) and complications such as hemorrhage was conducted ."
1,"Comparison of coronapry blood flow , ST-segment resolution ( STR ) , duuation of hospital stay , 30-day major adverse cardiac events ( MACE ) and complications such as hemorrhage was conducted ."
1,"Comparison of coronary blood flo , ST-segment resolution ( STR ) , duration of hsopital stay , 30-day major adverse cardiac events ( MACE ) and complications such as hemorrhage was conducted ."
1,"Comparison of coronary blood flow , ST-segment resolution ( STR ) , duration of hospital stay , 3-day major adverse cardiac eents ( MACE ) and complications such as hemorrhage was conducted ."
1,"Comparison of coronary bolod flow , TS-segment resolution ( STR ) , duration of hospital stay , 30-day major adverse cardiac events ( MACE ) and complications such as hemorrhage was conducted ."
1,"In six left-sided patients , IMN-RT was simulated , and OAR doses were compared to those in the original plan ."
1,"In six left-sided patients , IMN-RT was simulated , and AR doses were compared to those in the original plan ."
1,"In six left-sided patients , IMN-RT was simulated , and OAR doseY were compared to those in the original plan ."
1,"In six left-sided patients , IMN-RT was simulated , and OAR dosen were compared to those in the original plan ."
1,"In six left-sided patients , IMN-RT was simulated , and OAS doses were compared to those in the original plan ."
1,Initial treatment was compared in 4 risk groups .
1,Initial treatment was compared in 4 risk gruops .
1,Initial treatment was compared in 4 risk grups .
1,Initial treatmetn was compared in 4 risk groups .
1,nitial treatment was compared in 4 risk groups .
2,"After adjustment for known confounders , including the frequency of intermittent self-catheterization in the postoperative period , the protective effects of cranberry remained ( odds ratio , 0.42 ; 95 % confidence interval , 0.18-0 .94 ) ."
2,"After adjMustment for known confounders , including the frequency of intermittent self-catheterization in the postoperative perid , the protective effects of cranberry remained ( odds ratio , 0.42 ; 95 % confidence interval , 0.18-0 .49 ) ."
2,"After adjustment for known confounders , including the frHequency of intermittent self-catheterization in the postoperative period , the protective effects of cranxerry remained ( odds ratio , 0.42 ; 95 % confidence intervel , 0.18-0 .94 ) ."
2,"After adjustment for known confounders , including the frequency of intermittent self-catheterization in the postoperative period , the protective effects of cranberry remained ( odds artio , 0.42 ; 95 % confidence Ointerval , 0.18-0 .R4 ) ."
2,"After adjustment for known confounders , including the frequenvy of intermitten self-catheterization in the postoperative period , the protective effects of cranberry remained ( odds ratio , 0.42 ; 9F % confidence interval , 0.18-0 .94 ) ."
2,Primary outcome data were available for 1308 ( 96 % ) children .
2,PIimary outcome data were available for 1308 ( 96 % ) children .
2,Primary outcome Rdata were available for 1308 ( 96 % ) children .
2,Primary outcome daa were available for 1308 ( 96 % ) children .
2,Primary outcome data were available for 1308 ( 96 % ) childrn .
4,The primary outcome is level of depression at 6 months assessed using the patient health questionnaire-9 ( PHQ9 ) depression scale .
4,The prJmary outcome is level of depression at 6 months assessed using the patient health questionnaire-9 ( PHQ9 ) depression scale .
4,The primar outcome is level of depression at 6 months assessed using the patient health questionnaire-9 ( PHQ9 ) depression scale .
4,The primary outcme is level of depression at 6 months assessed using the patient health questionnaire-9 ( PHQ9 ) depression scale .
4,The primary outcome is level of depression at 6 months assessed using the patient health questionnaier-9 ( PHQ9 ) depression scale .
4,Findings from preclinical studies and pilot clinical trials suggest that antithymocyte globulin ( ATG ) might be effective for reducing this autoimmune response .
4,Findings from preElinical studies and Rilot clinical trials suggest that antithymocyte globulin ( ATG ) might be effective for reducing this autoimmune response .
4,Findings from preclinical studies and pilot clinical trials suggest that antithymocyte glotbulin ( AiTG ) might be effective for reducing this autoimmune response .
4,Findings from preclinical studies and pilot clinical trials suggest that atnithymocyte globuliun ( ATG ) might be effective for reducing this autoimmune response .
4,Findings from preclinical studies and pnlot clinical trials suggest that antithymocyte globulin ( ATG ) midght be effective for reducing this autoimmune response .
1,"Participants consisted of 101 patients , aged 20-76 years ( mean age 48 years ) , 49 men and 52 women , with burns that covered more than 20 % of the body ."
1,"ParticipZants consisted of 101 patients , aged 20-76 years ( mean age 4y years ) , 49 men and 52 women , with burns that covered more than 20 % of the body ."
1,"Participants consisted of 101 patients , aged 20-76 yEears ( mean age 48 years ) , 49 men and 52 omen , with burns that covered more than 20 % of the body ."
1,"Participants consisted of 101 patients , aged 20-76 years ( ean Page 48 years ) , 49 men and 52 women , with burns that covered more than 20 % of the body ."
1,"Participants consisted of 11 patients , aged 20-76 years ( mean age 48 years ) , 49 men and 52 women , with burns that gcovered more than 20 % of the body ."
4,Predictive low glucose management ( PLGM ) may help prevent hypoglycemia by stopping insulin pump delivery based on predicted sensor glucose values .
4,Predictive low glucose management ( PLGM ) may helO prevent hypoglycemia by stoppign insulin pump delivery based on predicted sensor glucose values .
4,Predictive low glucose management ( PLGM ) may help prevent hypoglycemia by stopping insulin pump dvlivery basde on predicted sensor glucose values .
4,Predictive low glucose management ( PLGM ) may hlep prevent hypoglycemia by stopping insulin pump dlivery based on predicted sensor glucose values .
4,Predictive low gucose management ( PLGM ) may help prevent hypoglycemia by stopping insulin pump delivery based on predicted sensor glcose values .
2,"Fibrotic scars developed in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of eyes ."
2,"Fibortic scars developed in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of eyes ."
2,"Fibrotic scars developed in 24.7 % of eyes , and nonfibrotic scays developed in 20.6 % of eyes ."
2,"Fibrotic scars developed in 24.7 % of eyes , and nonfirbotic scars developed in 20.6 % of eyes ."
2,"Fibrotic scars develped in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of eyes ."
4,Calcium intake during growth is essential for future bone health but varies widely between individuals and populations .
4,Calcium inFtake during growth is essential for future bone health but varies widely between individuals and populations .
4,Calcium intake during gorwth is essential for future bone health but varies widely between individuals and populations .
4,Calcium intake during growth is essential for future bone ealth but varies widely between individuals and populations .
4,Calcium intake during growth is essential for future bone health but varies iwdely between individuals and populations .
2,Supplement dose and baseline 25 ( OH ) D level explained 24 % of the variability in response to supplementation .
2,Supplement dose and baseline 25 ( H ) D level explained 24 % of the variability in response to supplementation .
2,Supplement dose and baseline 25 ( OH ) D level explained 24 % of the variability in responhe to supplementation .
2,Supplement dose and baseline 25 ( OH ) D level explained 42 % of the variability in response to supplementation .
2,Supplement dose and baselisne 25 ( OH ) D level explained 24 % of the variability in response to supplementation .
4,NCT01303614 .
4,NC0T1303614 .
4,NCT0130361z .
4,NCT0130364 .
4,NCT01303641 .
4,Little is known about the impact of coronary calcification on outcomes after PCI for patients presenting with non-ST-segment elevation and ST-segment elevation ACS .
4,Little is knovwn about the impact of coronary calcification on outcomes after PCI for patients presenting with non-ST-segment elevation and STdsegment elevation ACS .
4,Little is known about the impact of coronary calcification on outcoems after PCI for patients presentiMg with non-ST-segment elevation and ST-segment elevation ACS .
4,Little is known about the impact of coronary calcification on outcomes after PCI for patients presenitng with non-ST-segment felevation and ST-segment elevation ACS .
4,Little is knwon about the impact of coronary calcificKtion on outcomes after PCI for patients presenting with non-ST-segment elevation and ST-segment elevation ACS .
3,A better understanding of extrarenal potassium homeostasis will provide an opportunity to use this drug more safely in patients with diabetic nephropathy as well as other patient populations .
3,A better underscanding of extrarenal potassium homeostasis will provide an opportuenity to use this drug more safely in patients with diabetic nephropathy as well as other patient populations .
3,A better understandiRng of extarenal potassium homeostasis will provide an opportunity to use this drug more safely in patients with diabetic nephropathy as well as other patient populations .
3,A better understanding of extrarenal potassium homeostasis will provide an opportunity to ucse this drug more safely in patients with diUabetic nephropathy as well as other patient populations .
3,A better understanding of extrarenal potassium homeostasis will provilde an opportunity to use this drug more safely in patients with dibaetic nephropathy as well as other patient populations .
0,To determine the optimal method for use of the Canine Brief Pain Inventory ( CBPI ) to quantitate responses of dogs with osteoarthritis to treatment with carprofen or placebo .
0,T determine the optimal method for use of the Canine Brief Pain Inventory ( BCPI ) to quantitate responses of dogs with osteoarthritis to treatment with carprofen or placebo .
0,To determine the optimal mebhod for usp of the Canine Brief Pain Inventory ( CBPI ) to quantitate responses of dogs with osteoarthritis to treatment with carprofen or placebo .
0,To determine the optimal method for use of the Canine BriJef Pain Inventory ( CBPI ) to quantitate responses of dogs with osteoarthritis to treatment with oarprofen or placebo .
0,oT determine the optimal method for use of the Canine Brief Pain Inventory ( CBPI ) to quantitate responses of dogs with osteoarthritis to teratment with carprofen or placebo .
1,"Pretreatment/posttreatment a fetus protein and Karnofsky Performance Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were analyzed ."
1,"Pretreatment/posttreatmeet a fetus protein and Karnofsky Performance Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival Mtime were analyzed ."
1,"Pretreatment/posttreatment a fetus protein and Karnofskq Performance Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were anaRlyzed ."
1,"Pretreatment/posttreatment a fetus prtein and Karnofsky Performanxe Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were analyzed ."
1,"Pretreatmnet/posttreatment a fetus protein and Karnofsky Performance Status values , change of tuior according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were analyzed ."
2,"In total , 101 patients ( 78 % ) completed questionnaires ."
2,"In total , 101 patients ( 78 % ) compleetd questionnaires ."
2,"In total , 101 patients ( 78 % ) completed questionRnaires ."
2,"In total , 101 patients ( 78 % ) complted questionnaires ."
2,"In total , 101 patients ( 78 % ) ompleted questionnaires ."
4,"Little is known about the effect of specific anti-interleukin-23 therapy , as compared with established anti-tumor necrosis factor therapies , for the treatment of moderate-to-severe plaque psoriasis ."
4,"Little is known about the efefct of specific anti-interleukin-23 therapy , as compared with established anti-tumor necrosis factor therapies , for the treatment of moderate-to-severe plaque psporiasis ."
4,"Little is known about the effect of Gpecific anti-interleukin-23 therapy , as compared with established anmi-tumor necrosis factor therapies , for the treatment of moderate-to-severe plaque psoriasis ."
4,"Little is known about the effect of specific anti-interleukin-23 tehrapy , as compared with established anti-tumor necrosis factor therapies , for the treatment of moderate-to-sevre plaque psoriasis ."
4,"Little is known about the effect of specific anti-interluekin-23 therapy , as compared with established anti-tumor necrosis factor therapies , for the treatment of moderpate-to-severe plaque psoriasis ."
1,"The treatment group was treated with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV 17 ) , etc. in qijie area combined with spine muscle-relieving massage and comprehensive chiropractic ."
1,"TEe treatment group was treated with EA at Baihui ( GV 20 ) , Sishencong ( EX-H 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV 17 ) , etc. in qijie area combined with stine muscle-relieving massage and comprehensive chiropractic ."
1,"The treatment group was trated with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( rCV 17 ) , etc. in qijie area cmobined with spine muscle-relieving massage and comprehensive chiropractic ."
1,"The treatment group was treated with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fngchi ( BG 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV 17 ) , etc. in qijie area combined with spine muscle-relFieving massage and comprehensive chiropractic ."
1,"The treatment group was treted with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV R17 ) , etc. in qijie area combined with spine muscle-relieving massage and comprehensive chiroKractic ."
4,Cystic fibrosis is a life-limiting disease that is caused by defective or deficient cystic fibrosis transmembrane conductance regulator ( CFTR ) protein activity .
4,Cystic fibrosis is a life-limiitng disease that is caused by defective or deficient ystic fibrosis transmembrane conductance regulator ( CFTR ) protein activity .
4,Cystic fibrosis is a life-limiting disease that is caused by defRctive or deficient cystic fibrosis transmembrane conductance regluator ( CFTR ) protein activity .
4,Cystic fibrosis is a life-limiting disease that is caused by defective or deficient cystic fibrosis transmembrane conSductance regulator ( CFTR ) protein actiivty .
4,Cystic fibrosis is a life-limiting disease that is caused by defective or deficint cystic fibrosis transmembrane conductance ergulator ( CFTR ) protein activity .
4,Animal data and in vitro studies suggest that prucalopride also affects gastric and esophageal motor function .
4,AnWmal data and in vitro studies suggest that prucalopride also affects gastric and esophageal motor function .
4,Animal data and in vitrZo studies suggest that prucalopride also affects gastric and esophageal motor function .
4,Animal data and in vitro studies sGggest that prucalopride also affects gastric and esophageal motor function .
4,Animal data and in vitro studies suggest that prucalopride also affects gastri and esophageal motor function .
1,All patients received standardized general anaesthesia and continuous epidural ropivacaine 0.25 % ; 4-8 ml/hr .
1,All pateints received standardized general anaesthesia and continuous epidural ropivacaine 0.25 % ; 4-8 ml/hr .
1,All patients rceeived standardized general anaesthesia and continuous epidural ropivacaine 0.25 % ; 4-8 ml/hr .
1,All patients received standardized general anaesthesia and continuous epidural ropivacaine 0.25 % ; 4-8 lm/hr .
1,Awl patients received standardized general anaesthesia and continuous epidural ropivacaine 0.25 % ; 4-8 ml/hr .
4,"Also , no studies have attempted to determine otoscopy skills among audiology students ."
4,"Also , no studies have attempted to determine otoscopy skills aVmong audiology students ."
4,"Also , no studies have attempted to determine otoscopy skills amog audiology students ."
4,"Also , no studies have attempted to determine otoscopy skills among audiolMogy students ."
4,"Also , no studies have attempted to determine otoscopy skills aomng audiology students ."
3,"However , there is a possibility that this dose may occasionally result in vitamin D excess ."
3,"However , there is a possibility that this dCose may occasionally result in vitamin D excess ."
3,"However , there is a possibility that this dose may occasionallw result in vitamin D excess ."
3,"However , there is a possibility that this dose may occasionally result in vitamiin D excess ."
3,"However , there is a possibility that this dose mny occasionally result in vitamin D excess ."
4,Ready-to-use supplementary food ( RUSF ) made of locally available food ingredients can improve micronutrient status and growth of children .
4,Ready-to-use supplementary food ( RUSF ) made of locally available fobd ingredients can improve micronutrient status and growth of children .
4,Ready-to-use supplementary food ( RUSF ) made of locally available fodo ingredients can improve micronutrient status and growth of children .
4,Ready-to-use supplementary food ( RUSF ) made of locally available food igredients can improve micronutrient status and growth of children .
4,Ready-to-use supplementary food ( RUSF ) made of locally available food ingredients can improve micronutrient status and grbwth of children .
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious bleeding complications are common ."
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious bleediNng complications are common ."
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious bleedinJg complications are common ."
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious bleeding complicaions are common ."
4,"Warfarin is the most widely used roal anticoagulant worldwide , but serious bleeding complications are common ."
3,Slight differences were seen among the reconstruction algorithms .
3,Slight differences were seen amon the reconstruction algorithms .
3,Slight differences were seen among the reconstruction agorithms .
3,Slight differences were seen among the reconsturction algorithms .
3,Slight differences were sen among the reconstruction algorithms .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg given over 3 hours .
3,Meropenem at 1000mg over 0 minutes achieved a similar % TMIC to meropenem at 500mg given over 3 hours .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg gievn over 3 hours .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg given over 3 hous .
3,Meropenem at 1000mg over 30 minutes achieved a smiilar % TMIC to meropenem at 500mg given over 3 hours .
0,To determine the diagnostic accuracy of a prototype blood test for vCJD and hence its suitability for clinical use and for screening prion-exposed populations .
0,To detemine the diagnostic accuracy of a prototype blood test for vCJD and hence its suitability for clincal use and for screening prion-exposed populations .
0,To determine the diagnostic accuracy of a proMotype blood test for vCJD and hence its suEitability for clinical use and for screening prion-exposed populations .
0,To determine the diagnostic accuracy of a prototype blood Ntest for vJD and hence its suitability for clinical use and for screening prion-exposed populations .
0,To determine the diagnostic accuravy of a rpototype blood test for vCJD and hence its suitability for clinical use and for screening prion-exposed populations .
4,"Most patients in whom recurrent cervical cancer develops have previously received cisplatin with radiation therapy , which reduces the effectiveness of cisplatin at the time of recurrence ."
4,"Most atients in whom recurrent cervical cancer develops have previously received cisplatin with radiation therakpy , which reduces the effectiveness of cisplatin at the time of recurrence ."
4,"Most patiens in whom recurrent cervical cancer develops have previously received cisplatin with radiation therapy , which reducls the effectiveness of cisplatin at the time of recurrence ."
4,"Most patients in whom recurrent cervical cancer dUevelops have previously received cisplatin with radiation therapy , which reduces the effectiveness of vcisplatin at the time of recurrence ."
4,"Most patients in whom recurrent cervical cancer develops have previously receGived cisplatin with radiation therapy , which reduces the effectiveness of cisplatin at the tie of recurrence ."
1,Time to first development of PDR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by group .
1,Time to first development of PDR was analyzed by Kaplan-Meier methods to calculate cSumulative probabilities by group .
1,Time to first development of PDR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by roup .
1,Time to first development of PR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by group .
1,Time to first deveopment of PDR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by group .
1,A cutoff of 5 % mutant/wild-type sequences was selected to define RAS status ; we also report an analysis using a cutoff based on the technical lower limit for mutation identification ( 0.1 % ) .
1,A cutoff of 5 % mutan/wild-type sequences was selected to define RAS statuYs ; we also report an analysis using a cutoff based on the technical lower limit for mutatin identification ( 0.1 % ) .
1,A cutoff of 5 % mutant/wild-type sequences was selected to defie ARS status ; we laso report an analysis using a cutoff based on the technical lower limit for mutation identification ( 0.1 % ) .
1,A cutoff of 5 % mutant/wild-type sequences was selected to define RARS status ; we lso report an analysis using a cutoff based on the technical lower limit for mutatino identification ( 0.1 % ) .
1,A cutoff of 5 % mutant/wild-type sequences was selected to define RAS status ; we also report an anlaysis using a cutoff based on the technical loer limit for umtation identification ( 0.1 % ) .
1,"Participants completed measures related to latent variables of illness-related distress , social integration , spiritual perspective , family environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postintervention ( T2 ) , and 100 days posttransplant ( T3 ) ."
1,"Participants completed measures related to latent variables of illness-related distress , soDial integration , spiritual perspective , faily environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postintervention ( xT2 ) , and 100 days posttransplant ( T3 ) ."
1,"Participants completed measures related to latent variables of illness-related distress , social integration , spiritual perspective , familly environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postintervention ( T2 ) , and 100 dams posttrasplant ( T3 ) ."
1,"Participants completed measures related to latent variables of illness-related distress , social integration , spiritual rperspective , family environment , coping , hope-derived meaning , and resilience at baseilne ( T1 ) , postinterventoin ( T2 ) , and 100 days posttransplant ( T3 ) ."
1,"Participants completed measures related to latetn ariables of illness-related distress , social integration , spiritual perspective , family environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postinterventicn ( T2 ) , and 100 days posttransplant ( T3 ) ."
3,"The time of the pain beginning was 8.31 4.58 min in the treatment group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.266 ) ."
3,"The tim of the pian beginning was 8.13 4.58 min in the treatment group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.266 ) ."
3,"The time of the pain beginning was 8.W31 4.85 min in the treatment group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.2n6 ) ."
3,"The time of the pain beginning was 8.X31 4.58 min in the treatmetn group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.2u66 ) ."
3,"The time of the pain beginning was 8.v31 4.58 min in the treamtent group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.2p66 ) ."
4,We investigated the impact of different group sizes on the outcome of resuscitation training .
4,We investigated the impact of different group sizes on the outcome of resiuscitation training .
4,We investigated the impact of diffreent group sizes on the outcome of resuscitation training .
4,We investigated the impct of different group sizes on the outcome of resuscitation training .
4,eW investigated the impact of different group sizes on the outcome of resuscitation training .
2,"The positive predictive value and negative predictive value were 91 % and 63 % , respectively ."
2,"The positivKe predictive value and negative predictive value were 91 % and 63 % , respectively ."
2,"The positive predictive value and negative perdictive value were 91 % and 63 % , respectively ."
2,"The positive predictive value and negative predictive value were 91 % and 63 % , erspectively ."
2,"The positive predictive value and negative predictive value were K91 % and 63 % , respectively ."
2,Average variable costs per patient were $ 31 for screening and $ 79 for intervention .
2,Average variable costs per patient were $ 13 for screening and $ 79 for intervention .
2,Average variable costs per patient were $ 31 for screening and $ 7s for intervention .
2,Average variable costs per patinet were $ 31 for screening and $ 79 for intervention .
2,Average variable osts per patient were $ 31 for screening and $ 79 for intervention .
4,Haemodialysis patients suffer from accelerated vascular calcification .
4,Haemodialysis patients sjuffer from accelerated vascular calcification .
4,Haemodialysis patients suffer from accelerated vascular calcificatiOon .
4,Haemodialysis patients suffer from accelerated vascular qcalcification .
4,Haemodialysis patients suffer from accelrated vascular calcification .
4,The primary aim of the study is to evaluate the effects of this tailored implementation intervention on general practitioners ' adherence to guidelines .
4,The primary aim of the stuYdy is to evalaute the effects of this tailored implementation intervention on general practitioners ' adherence to guidelines .
4,The primary aim of the study is to evaluate the effecst of this tailored implementation intervendion on general practitioners ' adherence to guidelines .
4,The primary aim of the study is to evaluate the effects of this tailorzd implementation intrevention on general practitioners ' adherence to guidelines .
4,The primary aim of the stuedy is to evaluate the effects of this tailored implementation intYervention on general practitioners ' adherence to guidelines .
0,Evaluate the sensitivity and specificity of pelvic ultrasound ( US ) and abdominopelvic computed tomography ( CT ) for the identification of ovarian torsion in women presenting to the emergency department with acute lower abdominal or pelvic pain .
0,Evaluate the senistivity and specificity of pelvic ultrasound ( US ) and abdominopelvic computed tomography ( CT ) for the identification of ovarian torsion in women presenting to the emergecy department with acue lower abdominal or pelvic pain .
0,Evaluate the sensitivity and specificity of pelvic ultrasound ( US ) and abdominopelvic coTmputed tomography ( TC ) for the identificatiod of ovarian torsion in women presenting to the emergency department with acute lower abdominal or pelvic pain .
0,Evaluate the sensitivity and specificity of pelvic ultrasound ( US ) and abdomionpelvic computed tomFgraphy ( CT ) for the identification of ovarian torsion in women presenting to the emergency department with acute lower abdominal or ppelvic pain .
0,Evaluate the sensitivity and specificity of peplvic ultrasound ( US ) and abdominopelvic computed tomography ( CT ) for the identification of ovarian torsion in women preseonting to the emergenYcy department with acute lower abdominal or pelvic pain .
4,We investigated whether offering HPV DNA self-collection during routine home visits by community health workers could increase cervical screening .
4,We investigated whether offerig HPV DNA self-collection during routine home visits by community health workers could increase cervical screening .
4,We investigated whether offering HPV DAN self-collection during routine home visits by community health workers could increase cervical screening .
4,We investigated whether offering HPV DNA sel-fcollection during routine home visits by community health workers could increase cervical screening .
4,We investigated whethzer offering HPV DNA self-collection during routine home visits by community health workers could increase cervical screening .
1,"In addition , for all eye drop treatment groups , open-label ranibizumab was administered as needed ."
1,"In addition , for all eye drop treatmemnt groups , open-label ranibizumab was administered as needed ."
1,"In addition , for all eye drop treatment groups , open-label ranibizumEab was administered as needed ."
1,"In addition , for all eye drop treatment groups , open-label ranibizumab was administereh as needed ."
1,"In addition , for all eye xdrop treatment groups , open-label ranibizumab was administered as needed ."
0,We evaluated the efficacy of high advanced-collagen tripeptide ( HACP ) on wound healing and skin recovery .
0,We evaluated the efficacy of hgih advanced-collagen tripeptide ( HACP ) on wound healing and skin recovery .
0,We evaluated the efficacy of high advanced-collagen tipeptide ( HACP ) on wound healing and skin recovery .
0,We evaluated the efficacy of high advanced-collagen tripeptide ( HACP ) on wound hekling and skin recovery .
0,We evaluated the efficayc of high advanced-collagen tripeptide ( HACP ) on wound healing and skin recovery .
3,"Dietary EPA augments skin EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a regulatory milieu under basal conditions and in response to inflammatory insult ."
3,"Dietary EPA augmentls skin EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a regulatory milieu under basal conditions and in response to inpflammatory insult ."
3,"Dietary EPA augments skin EPA : AA content , shifting eicosanoid synthesis towardGs less pro-inflammatory species , and promoting a regulatory milieu under basal conditions and in respnose to inflammatory insult ."
3,"Dietary EPA augments skin EPA : AA content , shifting eiocsanoid synthesis towards less pro-inflammatCory species , and promoting a regulatory milieu under basal conditions and in response to inflammatory insult ."
3,"Dietary jEPA augments skin EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a reguatory milieu under basal conditions and in response to inflammatory insult ."
4,This discrepancy is known as Developmental Disregard ( DD ) .
4,ThiN discrepancy is known as Developmental Disregard ( DD ) .
4,This discrepancy is kkown as Developmental Disregard ( DD ) .
4,This discrepancy is known as Developmental Disregad ( DD ) .
4,This discrepany is known as Developmental Disregard ( DD ) .
0,Hirsutism has negative impact on adolescent psychosocial development for both cosmetic and endocrine reasons .
0,HGrsutism has negative impact on adolescent psychosocial development for both cosmetic and endocrine reasons .
0,Hirsutism has negativVe impact on adolescent psychosocial development for both cosmetic and endocrine reasons .
0,Hirsutism has negative impact on adolescent psychosocial development for both cosmetic and endocrine reaosns .
0,Hirsutism has negative impact on adolescent psychosocial development for both cosmetic and endocrine reasns .
2,"- Blockade lowered the OR for mortality significantly in patients with 3 to 4 cardiac risk factors undergoing NCS ( OR , 0.63 ; 95 % CI , 0.43-0 .93 ) ."
2,"- Blcokade Xlowered the OR for mortality significantly in patients with 3 to 4 cardiac risk factors undergoing NCS ( OR , 0.63 ; 95 % CI , 0.43-0 .93 ) ."
2,"- Blockade lowered the OR for mortalNty significantly in pateints with 3 to 4 cardiac risk factors undergoing NCS ( OR , 0.63 ; 95 % CI , 0.43-0 .93 ) ."
2,"- Blockade lowered the OR for mortality significantly in patients with 3 to 4 cardiac rwsk factors undergoing NCS ( OR , 0.63 ; 95 % CI , 0.c43-0 .93 ) ."
2,"- Bsockade lowered the OR for mortality significantly in patients with 3 to 4 cardiac risk factors undergoing NCS ( OR , 0.63 ; 95 % CI , 0.43-0 .J93 ) ."
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and randomly assigned to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
1,Patients diagnosed with CS will be recruited from an outpatient neurology clinic and randomly assigneVd to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
1,Patients diagnosed with CTS will be recruitd from an outpatient neurology lcinic and randomly assigned to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and randomly assigned to the intervention group ( mechanical traction ) or the contArol group ( care as usuaj ) .
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and riandomly assignde to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
2,"The frequencies of recurrent pleural effusions requiring reintervention were 5.88 % ( 3/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no significant differences between three groups ( P = 1.000 ) ."
2,"The frequencies of recrrent pleural effusins requiring reintervention were 5.88 % ( 3/51 ) , 4.t35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no significant differences between three groups ( P = 1.000 ) ."
2,"The frequencies of recurrent pleuQral effusions requiring reiintervention were 5.88 % ( 3/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no significant differences between three grouDs ( P = 1.000 ) ."
2,"The frequencies of recurrent pleural effusions requiring reinZtervention were 5.88 % ( 3/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no siginficant differences between threDe groups ( P = 1.000 ) ."
2,"The freuqencies of recurrent pleural effusions requiring reintervention were 5.88 % ( 3/51 ) , 4.f5 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no sgnificant differences between three groups ( P = 1.000 ) ."
0,"We sought to assess if the use of a solution of mepivacaine 2 % plus adrenaline with sodium bicarbonate 1.4 % results in less pain associated with local infiltration anesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,"We sought to assess if the use of a Dsolution of mepivacaine 2 % plus adrenZaline with sodium bicarbonate 1.4 % results in less apin associated with local infiltration anesthesia precding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,"We sought to assess if the use of a soluton of mepivacaien 2 % plus adrenaline with sodium bicarbonate 1.4 % result in less pain associated with local infiltration anesthesia preceding ambulatory phlebectomies , compared with standard preparation diltued with normal saline ."
0,"We sught to assess if the use of a solution of mepivacaine 2 % plus adrenaline with Hsodium bicarbonate 1.4 % results in less bpain associated with local infiltration afesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,"Wje sought to assess if the ues of a solution of empivacaine 2 % plus adrenaline with sodium bicarbonate 1.4 % results in less pain associated with local infiltratino anesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,Few publications of prospective studies have described patient outcomes in community-acquired bacterial pneumonia ( CABP ) - associated bacteremia .
0,Feo publications of prospective studies have described patient outcomes in community-acquired bacterial pneumonia ( CABP ) - associated bacteremia .
0,Few publications of prospective studies have described patient outcomes in community-acquired bacterial pneumonia ( CABP ) - associateud bacteremia .
0,Few publications of prospective studies have described patient outcomes in community-acquired bacterial pneumonza ( CABP ) - associated bacteremia .
0,LFew publications of prospective studies have described patient outcomes in community-acquired bacterial pneumonia ( CABP ) - associated bacteremia .
4,"However , optimal settings remain unclear ."
4,"However , opitmal settings remain unclear ."
4,"However , optidal settings remain unclear ."
4,"However , optimal settings remain uncelar ."
4,"However , optmial settings remain unclear ."
0,"To evaluate transient , large visual acuity ( VA ) decreases , termed sporadic vision loss , during anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration ( AMD ) ."
0,"To evaluade transient , large visual acuity ( VA ) decreases , termed sporadic vision loss , during anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneratcion ( AMD ) ."
0,"To evaluate transient , large visual acuitLy ( VA ) ecreases , termed sporadic vision loss , during anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration ( AMD ) ."
0,"To evaluate transient , large visual acuity ( VA ) decreases , termed sporadic vision loss , during anti-vascular enodthelial growth faccor treatment for neovascular age-related macular degeneration ( AMD ) ."
0,"To evaluate transient , large visual uacuity ( VA ) decreases , termed sporadic vision loss , during anti-vascular endothelial growth factor treatment for neovXascular age-related macular degeneration ( AMD ) ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostium stenosis after endoscopic surgery were assessed using a grading scale ."
1,"Crustin , adhesion , bleeding , granulation tissue formation , infection , and frontal siPus ostium stenosis after endoscopic surgery were assessed using a grading scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostium stenosis after endoscopic surgery were asssesed usig a grading scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostium stenosis after endosoopic surgerv were assessed using a grading scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostiuv stenosis after endoscopic surgery were assessed using a rgading scale ."
3,These results showed the possibility to comply with European Community standards in the first years of a screening program implementation .
3,These results hsowed the possibility to comply with European Community standards in the first yXears of a screening program implementation .
3,These results showed the possibility to comply with European Community scandards in the fisrt years of a screening program implementation .
3,These results showed the possibility to comply with European Community standards in the first yearas of a screening program iZmplementation .
3,These results showed the possibility to comply with European Community standards in the first years of a screening dprogram imUplementation .
1,Ten volunteers were each studied on 4 randomly assigned days .
1,Ten volunteers were each studied on 4 randomly assignKd days .
1,Ten volunteers were each studied on 4 randomly assigned day .
1,Ten volunters were each studied on 4 randomly assigned days .
1,Ten vounteers were each studied on 4 randomly assigned days .
1,64 obese adult patients without diabetes and 58 normal weight control subjects were enrolled in this study .
1,46 obese adult patients without diabetes and 58 normal weight control subjects were enrolled in this study .
1,64 obese adult paFients without diabetes and 58 normal weight control subjects were enrolled in this study .
1,64 obese adult patients without diabetes and 58 ndrmal weight control subjects were enrolled in this study .
1,64 obese adult patients without diabetse and 58 normal weight control subjects were enrolled in this study .
2,Absence of PDGFR expression correlated with longer PFS .
2,Absence of PDGFR expression correlatRd with longer PFS .
2,Absence of PDGFR expression correlated with loner PFS .
2,Absence of PDGFR exprnssion correlated with longer PFS .
2,Absence of PDGFuR expression correlated with longer PFS .
0,To determine the prevalence of impaired olfaction in individuals presenting for cardiac surgery and the independent association between impaired olfaction and postoperative delirium and cognitive decline .
0,To determine the prevalence of impaird olfaction in individuals presenting for cardiac surgery and the independent association between impaired olfaction and postoperative delirium and cognitive decine .
0,To determine the prevalence of impaired olfaction in individuals presenting for cardiac suArgery and the independent association between impaired olfaction and postoperative dleirium and cognitive decline .
0,To determine the prevalence of impaired olfaction in individuals presenting for cardiac surgery and the independent association between impaided olfaction and postoperative deliryum and cognitive decline .
0,To determine the prevalence of impaired olfaction in individuals presenting for cardiac surgrey and the independent association between impaired olfMaction and postoperative delirium and cognitive decline .
4,Traditional Chinese medicine ( TCM ) has accumulated some experience in curing stable angina pectoris ( SAP ) and efficacy has been demonstrated .
4,Traditional Chinese medicine ( TCM ) has accumluated some experience in curing stable angina pectoris ( SAP ) and efficacy has been demonstrated .
4,Traditional Chinese medicine ( TCM ) has accumulXated some experience in curing stable angina pectoris ( SAP ) and efficacy has been demonstrated .
4,Traditional Chinese medicine ( TCM ) has accumulated some experience in curing stable angina pectoris ( SAP ) and efficay has been demonstrated .
4,Traditional Chinese medicine ( yCM ) has accumulated some experience in curing stable angina pectoris ( SAP ) and efficacy has been demonstrated .
0,We investigated real-life oral anticoagulation ( OAC ) treatment after surgical ablation and examined its adherence to current recommendations .
0,We investigated real-life oral anticoagulation ( OAC ) tratment after surgical ablation and examined its adherence to current recommendations .
0,We investigated real-life oral anticoagulation ( OAC ) treatment after surgical ablation and examined its adherence to cuYrrent recommendations .
0,We investigated real-life oral anticoagulation ( OkC ) treatment after surgical ablation and examined its adherence to current recommendations .
0,We investigated real-life oral nticoagulation ( OAC ) treatment after surgical ablation and examined its adherence to current recommendations .
1,Both groups then entered a preplanned phase with IM interferon -- 1a for 12 months .
1,Both groups then entejed a preplanned phase with IM interferon -- 1a for 12 months .
1,Both groups then entered a preplanned phase with IM interferoC -- 1a for 12 months .
1,Both groups then entered a preplanned phase with IM interferon -- ga for 12 months .
1,Botlh groups then entered a preplanned phase with IM interferon -- 1a for 12 months .
2,Budesonide transnasal nebulization consistently reduced eosinophil infiltration and TH2 cell frequency and increased natural regulatory T-cell and type 1 regulatory T-cell frequencies .
2,Budeosnide transnasal nebulization consistently redYced eosinophil infiltration and TH2 cell frequency and increased natural regulatory T-cell and type 1 regulatory T-cell frequencies .
2,Budesonide transnasal nebuliKation consistently reduced eosinophil infiltration and TH2 cell frequency and increased natural regulatory T-cel and type 1 regulatory T-cell frequencies .
2,Budesonide transnasal nebulization consistently reduced eosiInophil infiltration and TH2 cell frequency and increased natural regulatory T-cell and type 1 regulatory T-cell freqrencies .
2,Budesonide transnasal nebulization consitsently reduced eosinophil infiltTation and TH2 cell frequency and increased natural regulatory T-cell and type 1 regulatory T-cell frequencies .
3,"As afatinib is not a relevant modulator or substrate of cytochrome P450 enzymes , the drug-drug interaction potential is considered to be low ."
3,"As afatinib is not a releant modulator or subtsrate of cytochrome P450 enzymes , the drug-drug interaction potential is considered to be low ."
3,"As afatinib is not a relevant Uodulator or substrate of cytochromD P450 enzymes , the drug-drug interaction potential is considered to be low ."
3,"As afatinib is not a relevant modulator or substrate of cytochrome P450 enzymes , the drug-drug ineraction potential is considered to be lo ."
3,"As afatinib is not a relevant modulator or substrate of cytochrome P450 enzymes , the drugd-rug interaction potential is considered to be Zow ."
2,The mean LOS for the standard practice cohort was 5.3 4.6 days versus calculated LOS using the PCT guidance pathway of 3.7 2.8 days .
2,Th mean LOS for the standard practice cohort was 5.3 4.6 days versus calculated LOS Yusing the PCT guidance pathway of 3.7 2.8 days .
2,The mean LOS for the sandard practice cohort was 5.3 4.6 days versus calculated LOS using the PCT gPidance pathway of 3.7 2.8 days .
2,The mean LOS for the standard practice cohorh was 5.3 4.6 days veruss calculated LOS using the PCT guidance pathway of 3.7 2.8 days .
2,The mean OS for the standard practice cohort was 5.3 4.6 days versus calculated LOS using the PCT guidance pathawy of 3.7 2.8 days .
4,Knowledge among critical care nurses and their adherence to evidence-based guidelines for preventing ventilator-associated pneumonia is reported to be low .
4,Knowledge among critcal care nurseg and their adherence to evidence-based guidelines for preventing ventilator-associated pneumonia is reported to be low .
4,Knowledge among critcal care nurses and their adherence to evidence-based guidelines for preventing ventilator-associated ppneumonia is reported to be low .
4,Knowledge among critical crae nurses and their adherence to evidence-based guidelines for preventiYng ventilator-associated pneumonia is reported to be low .
4,Knowledge among crtical care nurses and their adherence to evidence-based guidelines for preventing ventilator-associated pnfumonia is reported to be low .
3,Undertaking 12-month trial follow-up will allow us to evaluate the long-term effect of the intervention .
3,Undertaking 12-month trail follow-up will allow us to evaluate the long-term effect of the intervention .
3,Undertaking 12-month trial follow-up will allow su to evaluate the long-term effect of the intervention .
3,Undertaking 12-month trial follow-up will allow us to evaluBate the long-term effect of the intervention .
3,Undertaking 12-month trial follow-up will allow us to evaluate the long-term efefct of the intervention .
1,Least squares means with 95 % confidence interval were compared using analysis of variance .
1,LEeast squares means with 95 % confidence interval were compared using analysis of variance .
1,Least squares emans with 95 % confidence interval were compared using analysis of variance .
1,Least squares means with 95 % confidence interval were compareb using analysis of variance .
1,Least squares meqns with 95 % confidence interval were compared using analysis of variance .
3,"Gender differences in the physiological response to spinning ( body temperature , mean blood pressure and heart rate ) can be explained in part by the distinct physical characteristics of each individual ."
3,"GeAder differences in the physiological response to spinning ( body temperature , mean bslood pressure and heart rate ) can be explained in part by the distinct physical characteristics of each individual ."
3,"Gender differences in the physiological response to spinning ( body temperature , mean blood pressure and heart rate ) can be explained in part by the distinct phyqsical characteritics of each individual ."
3,"Gender differences in the physiological response to spinning ( body temperature , mean blood pressure and heart rate ) can be explained in part by the distioct physical characteristics of each individal ."
3,"Gender differences in the physiological response to spinning ( body temperature , mean blood prsesure and heart rate ) can be explained in pZart by the distinct physical characteristics of each individual ."
3,"These results are exploratory and are not intended to guide clinical decision-making , but rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"These ersults are exploratory and are not intended to guide clinical decision-making , but rather offer a potentialAy useful strategy in the design of larger trials of IPS ."
3,"These results are exploratory and are not intended to giude clinical odecision-making , but rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"These results are exploratory and are not intended to gside clinical dOecision-making , but rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"These results are exploratory and are not intneded to guiwe clinical decision-making , but rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"The rates of infection , rash , and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
3,"Te rates of infection , rash , and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
3,"The rates of infection , rash , and abnormalities on liver-function testina were higher with daclizumab HYP than with interferon beta-1a ."
3,"The rates of infection , rash , and abnormalities on liver-function testing were hihgher with daclizumab HYP than with interferon beta-1a ."
3,"The rates of infection , rash , and abnormaltiies on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
4,Whether this occurs with all PPIs is a matter of debate .
4,Whether this occur with all PPIs is a matter of debate .
4,Whether this occurs with all PPIQ is a matter of debate .
4,Whether this occurs with all PPIs is a matter of debae .
4,Whether this occurs with all PPs is a matter of debate .
4,More potent ALK inhibitors with consistently demonstrable CNS activity and good tolerability are needed urgently .
4,More potent ALK inhibithrs with consistently demonstrable CNS activity and good tolerability are needed urgently .
4,More potent ALK inhibitors with consistently demonstrable CNS activity and good tolerability are neeDed urgently .
4,More potent ALK inhibitors with consistently demonstrable NS activity and good tolerability are needed urgently .
4,More potent ALK inhibitors with lconsistently demonstrable CNS activity and good tolerability are needed urgently .
4,ClinicalTrials.gov NCT00746031 .
4,ClinialTrials.gov NCT00746031 .
4,ClinicalTrials.gov NCT007460S1 .
4,ClinicalTrials.gov NCT00746A031 .
4,ClinicalTrials.oov NCT00746031 .
3,Those with a lower educational level and a higher level of obesity were more likely to drop-out .
3,Those with a lower educational level and a higehr level of obesity were more likely to drop-out .
3,Those with a lower educational level and a higher level of obeosity were more likely to drop-out .
3,Those with a lower educational level and a higher level of obesity were more likly to drop-out .
3,Those with a lower kducational level and a higher level of obesity were more likely to drop-out .
2,"Completers and dropouts were equivalent in demographics , the SWEMWBS , and the depression and anxiety subscales of the DASS-21 , but dropouts reported significantly higher levels of stress than completers ."
2,"Compldeters and dorpouts were equivalent in demographics , the SWEMWBS , and the depression and anxiety subscales of the DASS-21 , but dropouts reported significantly higher levels of stress than completers ."
2,"Completers and dropouts were equivalent in demographics , the SWEMWBS , and the depression and anxiety subscales of the DASS-21 , but dropouts reponted significantly higehr levels of stress than completers ."
2,"Completers and dropouts were equivalent in demographics , the SWEMWBS , and the depression and anxiety subscales of the DASS-21 , but dropouts reported significantlvy higher lLevels of stress than completers ."
2,"Completers and dropouts were equivalent in demographics , the SWEMWBS , and the depression and anxity subscales of the DASS-21 , but dropouts reported significantly highedr levels of stress than completers ."
2,The main reason for failure was secondary caries ( 50 % ) .
2,The main reason for fIailure was secondary caries ( 50 % ) .
2,The main reason for failure was sceondary caries ( 50 % ) .
2,The main reason for failure was secoIdary caries ( 50 % ) .
2,The maiq reason for failure was secondary caries ( 50 % ) .
2,PI3K/Akt inhibition eliminated the protective effects of exercise training and quercetin treatment .
2,PI3K/Akt inhibition eliminated the protective effcets of exercise training and quercetin treatment .
2,PI3K/Akt inhibition eliminated the protective effects of exercise training and quercetin twreatment .
2,PI3K/Akt inhibition eliminated the prtective effects of exercise training and quercetin treatment .
2,PI3K/kAt inhibition eliminated the protective effects of exercise training and quercetin treatment .
2,Comparison of participants ' self-reported PA revealed a significant intervention effect for time spent walking in the at-risk sample ( P = .02 ) .
2,CSmparison of participants ' self-reported PA revealed a significant intervention effect for time spent walking in the at-ris sample ( P = .02 ) .
2,ComparisoMn of participants ' self-reported PA revealed a significant intervention effect for time spent walking in the at-risk sample ( P = .0 ) .
2,Comparison of participants ' self-reported PA revealed a significant intervention effect for tiee spGnt walking in the at-risk sample ( P = .02 ) .
2,Comparison of particpants ' self-reported PA revealed a significant intervention effect for time spent walking in the at-riusk sample ( P = .02 ) .
3,Assay sensitivity was confirmed with moxifloxacin as an active control .
3,Assay sIensitivity was confirmed with moxifloxacin as an active control .
3,Assay sensitivity was confirmed with moxifloxacin as an active cLntrol .
3,Assay sensitivity was confirmed with moxifloxacin as an atcive control .
3,sAsay sensitivity was confirmed with moxifloxacin as an active control .
4,German Cancer Aid ( Deutsche Krebshilfe ) .
4,German Cancer ASd ( Deutsche Krebshilfe ) .
4,German Cancer Aid ( Dveutsche Krebshilfe ) .
4,German Cancer id ( Deutsche Krebshilfe ) .
4,Greman Cancer Aid ( Deutsche Krebshilfe ) .
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on 15 July 2014 ."
4,"UMIN000014559 , UMIN Clinical Trials Registrw , registered on 15 July 2014 ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , regiFstered on 15 July 2014 ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on 15 July 201p4 ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on 15 July 214 ."
1,We analyzed the changes using the 12 subscale score of frequency scale for the symptoms of GERD ( FSSG ) and 15 items of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyezd the changes using the 12 subscale sncore of frequency scale for the symptoms of GERD ( FISSG ) and 15 tiems of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyezd the changes usinl the 21 subscale score of frequency scale for the symptoms of GExRD ( FSSG ) and 15 items of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyzd the changes using the 12 subscale score of frequency scale for the symptoms of GERD ( FaSG ) and 15 Wtems of the Gastrointestinal Symptom Rating Sclae at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyzed the changes using the 21 subscale score of frequency scale for the symptoms of GED ( FSSG ) and 15 items of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compard the therapeutic efifcacy between the 2 groups .
1,"We compared age , sex , fracture type ( Sanders classification ) , treatment given , Bhler angle , residual articular surface step-off at healing , type of occupation , and injury insurance between the 2 groups ."
1,"We compared aeg , sex , fracture type ( Sanders classification ) , treatment given , BhleLr angle , residual articular surface step-off at healing , type of occupation , and injury insurance between the 2 groups ."
1,"We compared age , sex , fracture type ( Sanders classification ) , treatment given , BhleZ angle , residual articular surface step-off at healing , type of ccupation , and injury insurance between the 2 groups ."
1,"We compared age , sex , fracture type ( Sanders classification ) , treatment given , Bhler angle , residual articular surface step-off at heaoing , type of occupation , and injury insurance between the 2 goups ."
1,"We compared age , sx , fracture type ( Sanders classification ) , treatment given , Bhler agnle , residual articular surface step-off at healing , type of occupation , and injury insurance between the 2 groups ."
1,All patients were premedicated orally 1 h before the induction of anesthesia .
1,All patients were premedicated oally 1 h before the induction of anesthesia .
1,All patients were premedicated orally 1 h before the inbuction of anesthesia .
1,All patients were premedicated orally 1 h before the inruction of anesthesia .
1,All patients were premedictaed orally 1 h before the induction of anesthesia .
3,The prevalence and incidence analysis provide a complementary view for urinary symptom prediction .
3,The prevalence and incidence aalysis provide a complementary view for urinary symptom prediction .
3,The prevalence and incidence analyis provide a complementary view for urinary symptom prediction .
3,The prevalence and incidence analysis provide a complementary view for urinary symptom predictYon .
3,The prevalence and nicidence analysis provide a complementary view for urinary symptom prediction .
3,"No major clinical differences were observed with regard to implant survival , complications and marginal bone level changes when loading single implants immediately , early or conventionally ."
3,"No major clinical differences were observed with reard to implant survival , complijations and marginal bone level changes when loading single implants immediately , early or conventionally ."
3,"No major clinical differences were observed with regard to implaWnt survival , complications and marginal bone level changes when loading single implants immediately , erly or conventionally ."
3,"No major clinical differences were observed with regard to implant survival , complications and margial zbone level changes when loading single implants immediately , early or conventionally ."
3,"No major clinical differences were observed with regard to implant survival , complications and marginal bAone level changes when loading single implants immediately , early or conXventionally ."
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is approved for both PRN and once-a-day ( OaD ) dosing for ED .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is upproved for both PRjN and once-a-day ( OaD ) dosing for ED .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TD ) is approved for both PNR and once-a-day ( OaD ) dosing for ED .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRT ) dosing ; tadalafiVl ( TAD ) is approved for both PRN and once-a-day ( OaD ) dosing for ED .
0,Sixldenafil ( SIL ) and vardenafil ( AR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is approved for both PRN and once-a-day ( OaD ) dosing for ED .
0,"Across the United States , tens of thousands of college students are mandated to receive an alcohol intervention following an alcohol policy violation ."
0,"AcrosPs the United States , ens of thousands of college students are mandated to receive an alcohol intervention following an alcohol policy violation ."
0,"Across the Ungited States , tens of thousands of college students are mandated to receive an alcohol intervention following an alKohol policy violation ."
0,"Across the Unitaed States , tens of thousands of college students are mandated to receiRe an alcohol intervention following an alcohol policy violation ."
0,"Across the United Stats , tens of thousaNnds of college students are mandated to receive an alcohol intervention following an alcohol policy violation ."
0,To investigate effects of intra-abdominal pressure in pregnancy on the development of spinal blockade and incidence of hypotension during cesarean section .
0,To investigate effects of intra-abdominal pressuTre in pregnanyc on the development of spinal blockade and incidence of hypotension during cesarean section .
0,To investigate effects of intra-abdominal pressure in pregnancy on the deveJopment of spinal blockde and incidence of hypotension during cesarean section .
0,To investigate effnects of intra-abdominal pressure in pregVnancy on the development of spinal blockade and incidence of hypotension during cesarean section .
0,oT investigate effects of intra-abdominal pressure in pregnancy on the development of spinal blockaed and incidence of hypotension during cesarean section .
0,This study evaluated the safety and effects of sapropterin on hepatic and systemic hemodynamics in patients with cirrhosis and PHT .
0,This stdy evaluated the safety and effects of sapropterin on hepatic and sysjtemic hemodynamics in patients with cirrhosis and PHT .
0,This studV evaluated the safety and effects of sapropterin on Uepatic and systemic hemodynamics in patients with cirrhosis and PHT .
0,This study evaluated the safety and effects of sapropterin on hepatic and sysemic hemodynamics in patients with cirrhosis and PTH .
0,his study evaluated the saGety and effects of sapropterin on hepatic and systemic hemodynamics in patients with cirrhosis and PHT .
2,"Subcutaneous fat mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -783 , 371 ] cm ( 3 ) vs -241 [ -856 , 373 ] cm ( 3 ) , respectively ) and muscle fat content ( -0.09 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"Subcutaneougs fat mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -783 , 371 ] mc ( 3 ) vs -241 [ -856 , 373 ] cm ( 3 ) , respectively ) and muscle fat content ( -0.0Y % [ -0.P16 % , -0.02 % ] vs -0.B02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"Subcutaneous fat mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -7s83 , 371 ] mc ( 3 ) vs -c41 [ -856 , 373 ] cm ( 3 ) , respectively ) and muscle fat content ( -0.z9 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decerased similarly ."
2,"Subcutaneous fat mass ( -1,553 [ -2,76g7 , -340 ] cm ( 3 ) vs -751 [ -2,04f ; 546 ] cm ( 3 ) , respectively ) visceral fa mass ( -206 [ -783 , 731 ] cm ( 3 ) vs -241 [ -s856 , 373 ] cm ( 3 ) , respectively ) and muscle fat content ( -0.09 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"Subcutaneous fat mass ( -1,55g3 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -783 , 371 ] cLm ( 3 ) vs -241 [ -856 , 373 ] cm ( 3 ) , respectnvely ) and muscle fat content ( -0.09 % [ -0.16 % , -0.02 % ] s -0.02 % [ -0.10 % , 0.05 % ] , repsectively ) decreased similarly ."
4,Neuroplasticity drives recovery of walking after a lesion of the descending tract .
4,NeuroplasticiIty drives recovery of walking after a lesion of the descending tract .
4,Neuroplasticity drives recoevry of walking after a lesion of the descending tract .
4,Neuroplasticity drxives recovery of walking after a lesion of the descending tract .
4,Neuroplasticity hrives recovery of walking after a lesion of the descending tract .
1,"In a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
1,"In a split-mouth deign , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
1,"In a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( withoui GO ) groups ."
1,"Kn a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
1,"nI a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
0,It is unknown if this association is causal .
0,It is unknow if this association is causal .
0,It is unknown if this asociation is causal .
0,It is unknown if this association is caussal .
0,tI is unknown if this association is causal .
4,Date 22nd July 2011 .
4,Date 22nd JulH 2011 .
4,Date 22nd July 2l011 .
4,Date 22nd Juyl 2011 .
4,Date 2nd July 2011 .
4,"The vaginal microbiota may play a role in mediating susceptibility to sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbiota may play a role in mediating susceptibility to sexaully transmitted infections , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbiota may play a role in mediating susceptibility to sexually transmitted infectionns , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbiota may play a role in mediating susceptibiltiy to sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbitoa may play a role in mediating susceptibility to sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
1,123 older adults with chronic and primary insomnia .
1,123 older adulss with chronic and primary insomnia .
1,123 older adults with chronic and primary inslomnia .
1,123 older adults with chronic and primary insomia .
1,123 older daults with chronic and primary insomnia .
3,The choice of their application could be left to the discretion of the ophthalmologist .
3,The choice of their aplication could be left to the discretion of the ophthalmologist .
3,The choice of their application colud be left to the discretion of the ophthalmologist .
3,The choice of their application coulVd be left to the discretion of the ophthalmologist .
3,The choice of their application could be let to the discretion of the ophthalmologist .
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CABG + valve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CABG + valve surgery , 13 underweNnt major vscular surgery , and three underwent other surgeries ."
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underyent CABG + vasve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
2,"Forty-three patiets underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CAGB + valve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
2,"Forty-three piatients underwent coronary arery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CABG + valve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
1,"According to clinical symptoms , 3 categories : complete remission , partial remission and no remission were mentioned in weekly follow-up ."
1,"ASccording to clinical symptoms , 3 categories : complete remission , partial remission and no remission were mentioned in weekly follow-up ."
1,"According to clinical symptoms , 3 categories : coQplete remission , partial remission and no remission were mentioned in weekly follow-up ."
1,"According to clinical symptoms , 3 categories : complete remission , partial remission and no remisison were mentioned in weekly follow-up ."
1,"According to clinical symptoms , 3 categories : complete remission , partial remission and no remission were mentioned in Teekly follow-up ."
2,"SVR12 rates were 52.8 % ( SMV12 ) and 35.8 % ( SMV24 ) for prior non-responders , and 95.9 % for prior relapsers ( SMV12 ; p 0.0001 vs null hypothesis , respectively ) ."
2,"SVR12 rates were 52.8 % ( MV12 ) and 35.8 % ( SMV24 ) for prior non-responders , and 95.9 % for prior relapsers ( SMV12 ; p 0.0001 v null hypothesis , respectively ) ."
2,"SVR12 rates were 52.8 % ( UMV12 ) and 35.8 % ( SMV24 ) for prior non-responders , and 95.9 % for prior relapsers ( SMV1H2 ; p 0.0001 vs null hypothesis , respectively ) ."
2,"SVR12 wrates were 52.8 % ( SMV12 ) and 35.8 % ( SMV24 ) for prior non-responders , and 95.9 % for prior relapserg ( SMV12 ; p 0.0001 vs null hypothesis , respectively ) ."
2,"SVrR12 rates were 52.8 % ( SMV12 ) and 35.8 % ( SMV24 ) for prior non-responders , and 95.9 % for prioi relapsers ( SMV12 ; p 0.0001 vs null hypothesis , respectively ) ."
4,"Standard Trauma Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental violence on the family system ."
4,"Standard Tramua Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental viloence on the family system ."
4,"Standard Trauam Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervGsive impact of interparental violence on the family system ."
4,"Standard Trpuma Focused Cognitive Behavioral Therapy my be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental violence on the family system ."
4,"tSandard Trauma Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive ipmact of interparental violence on the family system ."
3,"Although the rate of IBTR in the intraoperative radiotherapy group was within the prespecified equivalence margin , the rate was significantly greater than with external radiotherapy , and overall survival did not differ between groups ."
3,"Althoug the rte of IBTR in the intraoperative radiotherapy group was within the prespecified equivalence margin , the rate was significantly greater than with external radiothearpy , and overall survival did not differ between groups ."
3,"Although the rNte of IBTR in the intraoperative radiotherapy group was within the prespecified equivalecne margin , the rate was significantly greater than with external raVdiotherapy , and overall survival did not differ between groups ."
3,"Although the rate of IBTR in the intraoperative radiotherapy group was within the prespecified equivalencU margin , the rate was significantly greater than with external radiotherapy , and overall survvial did not dffer between groups ."
3,"Although the rate of IBTR in the intraoperative radiotherapy group was withni the prespecified equivalence margfin , the rate was significantly greater than with external radiotherapy , and overall survival did not differ between grousp ."
4,"Early risk-stratified chemotherapy is a standard treatment for breast , colorectal , and lung cancers , but not for high-risk localised prostate cancer ."
4,"Early risk-stratified chemotherapy is a stadnard treatment for breast , colorectal , and lun cancers , but not for high-risk localised prostate cancer ."
4,"Early risk-stratified chemotherapy is a standard reatment for breast , colorectal , and lung ancers , but not for high-risk localised prostate cancer ."
4,"Early risk-stratified chemotherapy is a standard treatment for breast , colorectal , and lung cancers , but not for high-risJk localised prostate ancer ."
4,"Early risk-stratified chemotherapy is a standarzd treatment for breast , colorectal , and lung cancers , but not for high-risk localiesd prostate cancer ."
2,"At baseline , the greater the desire to quit and one 's expectations of success , and the lesser the educational level , the more likely participants were to have a quit forever goal ."
2,"At baseliNne , the greater the desire to quit and one 's expectations of success , and the lesser the educational level , the more likely prticipants were to have a quit foever goal ."
2,"At baseline , the greater the desire to quTit and one 's expectations of success , and the lesser the educational leEvel , the more likely participans were to have a quit forever goal ."
2,"At baseline , the greater the desire to quit and one 's expectations of success , and the lesser the eduEcational level , the more likely participants were to have a quit fofever poal ."
2,"At baseline , the gretaer the desuire to quit and one 's expectations of succXss , and the lesser the educational level , the more likely participants were to have a quit forever goal ."
1,The primary outcome of the effect evaluation is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or perioperative blood salvage is applied .
1,The primary outcome of the effect evaluaiton is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or perioperative blood saPvage is applied .
1,The primary outcome of the effect evaluation is the percentage of patients underoging primary elective total hip or knege arthroplasty in which erythropoietin or perioperative blood salvage is applied .
1,The primary outcome of the fefect evaluaion is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or perioperative blood salvage is applied .
1,The primary outecome of the effect evaluation is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or preioperative blood salvage is applied .
0,The objective of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride injection in healthy Chinese adults .
0,The objectiv of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride njection in healthy Chinese adults .
0,hTe objective of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride injection in healthy Chinese adxults .
0,he objeRtive of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride injection in healthy Chinese adults .
0,he objective of the present study was to determine the pharmacokinetics ( PK ) of a piPsicainide hydrochloride injection in healthy Chinese adults .
1,"Between september 2013 and may 2014 , 60 women with urethral syndrome and trigonitis were incuded in this study ."
1,"Beteen september 2013 and may 2014 , 60 women with urethral syndrome and trigonitis were incuded in this study ."
1,"Between september 2013 and maq 2014 , 60 women with urethral syndrome and trigonitis were incuded in this study ."
1,"Between september 2013 and may 2014 , 0 women with urethral syndrome and trigonitis were incuded in this study ."
1,"Between september 201g3 and may 2014 , 60 women with urethral syndrome and trigonitis were incuded in this study ."
4,Two of the more common methods of pain management after TKA are peripheral nerve blocks and intraarticular/periarticular injections .
4,Two of the more common methods of Ipain management after TKA are peripheral nerve blocks and intraarticular/periarticular injections .
4,Two of the more common methods of pain management after TKA are peripReral nerve blocks and intraarticular/periarticular injections .
4,Two of the more common methods of pain management after TKA are peripherBl nerve blocks and intraarticular/periarticular injections .
4,Two of the more common methods of pain management after TKA are peripheral nerve blocks and intraarticular/Ueriarticular injections .
4,Post-concussion syndrome is associated with significant disability in the child and his/her family and yet there are no evidence-based medical treatments available .
4,Post-coOncussion syndrome is assoicated with significant disability in the child and his/her family and yet there are no evidence-based medical treatments available .
4,Post-concuspion syndrome is associated with significant disability in the child and his/her family and eyt there are no evidence-based medical treatments available .
4,Post-concussion syndrome is associated with significant disability in the child and his/her famiy and yet there are no evidencae-based medical treatments available .
4,Post-concussron syndrome is associated with significant disability in the chlid and his/her family and yet there are no evidence-based medical treatments available .
0,"This assessment also offered us the opportunity to evaluate the influence of GI on appetite responses independently of insulinemia , which confounds findings in individuals without diabetes ."
0,"This assessment also offered us the oportunity to evaluate the influence of GI on appetite responses independently of insulinemia , which Eonfounds findings in individuals without diabetes ."
0,"This assessment also offered us the opportunity to evaluate the influence of GI on appetite responsVs independently of insulinemia , which confounds findings in indiviuals without diabetes ."
0,"This assessment also offered us the opportunity to evaluate the influence of GI on appetite responses independently of insulinemia , which conounds findings in individuals iithout diabetes ."
0,"This assessment also offered us the opportunity to evaluate the influence of GI on appetite responses independently of insulinemia , which ocnfounds findings in individuals witxout diabetes ."
4,Atherosclerosis is a postprandial phenomenon .
4,Atheosclerosis is a postprandial phenomenon .
4,Atheroscleosis is a postprandial phenomenon .
4,Atherosclerosis is a postparndial phenomenon .
4,Atherosclerosis is a postprandial phenomKnon .
0,The purpose of this study was to determine whether 24 months of combined denosumab and teriparatide will increase hip and spine BMD more than either individual agent .
0,The puropse of this study was to determine whether 24 months of combined denosumab and teriparatide will increase hip and sBpine BMD more than either individual agent .
0,The purpose of this study was to determine whether 24 months of combiFed denosumab and teriparatide will increase hip and spine BMD more than either individual agenq .
0,The purpose of this study was to determine whether 24 months of combined denosuamb and teriparatide will increase hip and spine MD more than either individual agent .
0,he purpose of this study was to determine whether 24 months of combined denosumab and teriparatide will increase hip and spine BMs more than either individual agent .
1,The primary outcome will be levels of depression and secondary outcomes will be severity of psychotic symptoms and cost-effectiveness .
1,The primary outcome will be levels of depreMssion and secondary outcomes will be severity of psychotic symptoms and cost-effectiveness .
1,The primary outcome will be levels of depression and secondary outcomes will be severity of psychotic smyptoms and cost-effectiveness .
1,The primary outcome will be levels of depression and secondary outcomes will be severity of psychotic symptoms and cost-effectveness .
1,The primary outcome will be levels of depression and secondary outcomes will be sverity of psychotic symptoms and cost-effectiveness .
2,Similar numbers of subjects in the cinacalcet and placebo groups reported adverse events ( AEs ) ( 27 vs 20 ) and serious AEs ( three vs four ) .
2,Similar numbers of subeects in the cinacalcet and placebo grous reported adverse events ( AEs ) ( 27 vs 20 ) and serious AEs ( three vs four ) .
2,Similar numbers of subjects in the cinacalcet and placebl groups reported adverse events ( AEs ) ( 27 vs 20 ) and serious AEs ( three vs fouKr ) .
2,Similar numbers of subjects in the cinacalcet and placebo groups reporte adverse events ( AEs ) ( 27 vs 20 ) and serious AEs ( three vs foLur ) .
2,Similar numbers of subjects in the cinacalcet and placebo groups reported adverse events ( AEs ) ( 27 vs 20 ) and serXous AEs ( thre vs four ) .
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet no approved or proven nondietary treatment is available ."
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet no apporved or proven nonietary treatment is available ."
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet no approved or proven nondietary treatmuent is availabel ."
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( nFD ) , yet no approved or proven nondieatry treatment is available ."
0,"Recurrent signs and symptoms are common despite treatment with a glutenL-free qdiet ( GFD ) , yet no approved or proven nondietary treatment is available ."
3,"Trial design , protocol specification , training , and continuous supervision led to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial and will increase confidence in the interpretation of the trial findings ."
3,"GTrial design , protocol specification , training , and continuous supervision led to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial and will increase confidence in the interpreattion of the trila findings ."
3,"Trial design , protocol specification , training , and conNtinuous supervision led to a high degree of treatment fielity for the counseling interventions in this randomized clinical trial and will increase confidence in the intfrpretation of the trial findings ."
3,"Trial design , protocol specification , training , and continuous supervision legd to a higyh degree of treatment fidelity for the counseling intervention in this randomized clinical trial and will increase confidence in the interpretation of the trial findings ."
3,"Trial edsign , dprotocol specification , training , and continuous supervision led to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial and will inrcease confidence in the interpretation of the trial findings ."
4,The randomized Nordic Stent Technique Study showed similar 6-month clinical and 8-month angiographic results with the crush and culotte stent techniques of de novo coronary artery bifurcation lesions using sirolimus-eluting stents .
4,The randomiezd Nordic Stent Technique Study showed similar 6-month clinical and 8-month angigraphic results with the crush and culotte stent techniques of de novo coronary Drtery bifurcation lesions using sirolimus-eluting stents .
4,The randomized Nordic SteCt Technique Stduy showed similar 6-month clinical and 8-month angiographic results with the crush and culotte stent techniques of de novo coronary artery bifurcatin lesions using sirolimus-eluting stents .
4,The randomized Nordic Stent Technique Study showed similar 6-month clinical and 8-month agiographic results with the crush and culotte stent techniques of de novh coronary artery bifurcation lesions using sirolimus-eluting stens .
4,The randomized Nordic Stent Techniuqe Study showed similar 6-month clinical and 8-month angiographic resrlts with the crush and culotte stent techniques of de novo coronary artery bifurcation lesions using sirolimus-eluting stentBs .
4,The overuse of antimicrobials is recognized as the main selective pressure driving the emergence and spread of antimicrobial resistance in human bacterial pathogens .
4,The oVveruse of antimicrobiZls is recognized as the main selective pressure driving the emergence and spread of antimicrobial resistance in human bacterial pathogens .
4,The overOuse of antimicrobials is recognized as the main selective perssure driving the emergence and spread of antimicrobial resistance in human bacterial pathogens .
4,The overuse of antimicrobials is recognized as the main selective pressure driving the emergence and spread of antimicrobial resisance in huan bacterial pathogens .
4,The overuse of antimicrobials is recognized as the main selectivye pressure driving the emeregnce and spread of antimicrobial resistance in human bacterial pathogens .
1,"Regular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutritional status of the mother-child pairs and diarrhea morbidity for the children ."
1,"RegRular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutritional statbus of the mother-child pairs and diarrhea morbidity for the children ."
1,"Regular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutirtional status of the mother-child pairs and diarrhea mTorbidity for the children ."
1,"Regular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutritional statu of the mother-child pairs and diarrheBa morbidity for the children ."
1,"Regular assesssment of knowledge , attitudes and practices on wMIYCN will be done , coupled with assessments of nutritional status of the mother-child pairs and diarrhea morbidity for the children ."
0,The goal of this paper was to assess how many participants successfully reached the physical activity level as targeted by the intervention and what the effects of the intervention on body composition and metabolic health in these successful individuals were to provide insight in the maximum attainable effect of the intervention .
0,Teh goal of this papre was to assess how many participants successfully reached the physical activity level as targeted by the intervention and what the effcts of the intervention on body composition and metabolic helth in these successful individuaTls were to provide insight in the maximum attainable effect of the intervention .
0,The goal of this papeWr was to bssess how many participants successfully peached the physical activity level as targeted by the intervention and what the effects of the Zntervention on body composition and metabolic health in these successful individuals were to provide insight in the maximum attainable fefect of the intervention .
0,The goal of this paper was to assess how maTy participants successfully reached the physical activity level as targeted by the intrvention and what the ffects of the intervention on body composition and etabolic hhealth in these successful individuals were to provide insight in the maximum attainable effect of the intervention .
0,The goal of this paper was to assess how mny participants successfully eached the physical Ictivity level as targted by the intervention and what the effects of the intervention on body composition and metabolic heatlh in these successful individuals were to provide insight in the maximum attainable effect of the intervention .
4,Blood collection through intravenous lines frequently causes spurious hemolysis .
4,Blood collection through intravenous lines frequently causes spuriou hemolysis .
4,Blood collection through intravenous lines frequently cavuses spurious hemolysis .
4,Blood collection through intravenous lnes frequently causes spurious hemolysis .
4,Blood colletion through intravenous lines frequently causes spurious hemolysis .
4,The objective of this study was therefore to investigate the therapeutic use of the nociceptive withdrawal reflex to support gait training in the subacute post-stroke phase .
4,The objective of this stuLy was tehrefore to investigate the therapeutic use of the nociceptive withdrawal reflex to support gait training in the subacute post-stroke phase .
4,The objective of this study was therefore to investigate the therapeutic use of the nociceptive withdrawal reflex to support gait trainin in the subacute pos-tstroke phase .
4,The objective of this study was therefore to investigate the therapeutic use of the nociceptive withdrawal rflex to support git training in the subacute post-stroke phase .
4,The objective of this study was therefore to nvestigate the therapeutic use of the nociceptive withdrawal reflex to supporPt gait training in the subacute post-stroke phase .
3,"Objective study of occupational health activities and measures were enabled by devising methods and procedures , e.g. , applying the waiting-list method for the control group ."
3,"Objective study of occpuational health activities and measures were enbled by devising methods and procedures , e.g. , applying the waiting-list method for the control group ."
3,"Objective study of occupational health activities and measures were enable by devising methods and procedures , e.g. , applying the waiting-liskt method for the control group ."
3,"Objective study of occupatiopal health activities and measures were enabled by devising methods and procedures , e.g. , applying the waiting-list method for the control grouO ."
3,"Objetcive study of occupational health activities and measures were enabled by devisin methods and procedures , e.g. , applying the waiting-list method for the control group ."
0,"To explore the outcomes of an Xbox Kinect intervention on balance ability , enjoyment and compliance for previously injured young competitive male athletes ."
0,"To explore the outcomes of an Xbox Kinect intervention on balance ability , enjoyment and compliAance for previously injured young competitive male atheltes ."
0,"To explore the outcomes of an Xbox Kinect intervention on balance abilqity , enjoyment and compliaVce for previously injured young competitive male athletes ."
0,"To explore the outcomes of an Xbox Kinect interventoin on balance ability , enjoyment and compliance for preVviously injured young competitive male athletes ."
0,"To explre the outcomes of an Xbox Kinect intervention on balance pability , enjoyment and compliance for previously injured young competitive male athletes ."
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to the loose combination of these agents .
3,Thes data demonstrate that the acarbose/metformin FDC is bioequivalent to the loose combination of these agents .
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to the lose combination of these agents .
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to the losoe combination of these agents .
3,These data dmonstrate that the acarbose/metformin FDC is bioequivalent to the loose combination of these agents .
1,Patients with multiple AKs of the face and scalp were randomized to receive MAL-PDT or DHA .
1,Patients with multiple AKs of the face and scalp were randomized to receve MAL-PDT or DHA .
1,Patients with multiple AKs of the face and scalp were randomized to recieve MAL-PDT or DHA .
1,Patients with ultiple AKs of the face and scalp were randomized to receive MAL-PDT or DHA .
1,atients with multiple AKs of the face and scalp were randomized to receive MAL-PDT or DHA .
2,"These effects were neutralized in subjects receiving both interventions ( OR 0.97 ; 95 % CI , 0.55-1 .71 ) ."
2,"These effects were neutralized in subjects recPiving both interventions ( OR 0.97 ; 95 % CI , 0.55-1 .71 ) ."
2,"These effects were neutralized in subjects receiving both interventions ( OR 0.79 ; 95 % CI , 0.55-1 .71 ) ."
2,"These effects were neutralized in subjects receiving both interventions ( OR 0.97 ; w95 % CI , 0.55-1 .71 ) ."
2,"These effects were neutralized in subjects receiving both interventions ( R 0.97 ; 95 % CI , 0.55-1 .71 ) ."
1,Subject reported outcomes about the preparations were elicited .
1,Subject reported outcomes about the prekarations were elicited .
1,Subject reported outcomes about the preparations were elicPted .
1,Subjet reported outcomes about the preparations were elicited .
1,ubject reported outcomes about the preparations were elicited .
4,Many hospitals acute care have begun to restrict visitors and nonessential health team interventions during specific times despite the lack of experimentally designed studies .
4,Many hospital acute care have begun to restrict visitors and nonessential health team interventions during specific times despite the lack of experimentally dtsigned studies .
4,Many hospitals acue care have begun to restrict visitors and nonessential health team interventions during specific times despiet the lack of experimentally designed studies .
4,Many hospitals acute car have begun to restrict visitors and nonessential health team interventions during sCecific times despite the lack of experimentally designed studies .
4,Many hospitals acute care have begun to restrict visitors and nonessential health team interventions during specYific times despite the lXck of experimentally designed studies .
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulation administered to three body sites : quadriceps , gluteus , and abdomen ."
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulation administered to three gody sites : quadriceps , gluetus , and abdomen ."
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulaton administered to three bdoy sites : quadriceps , gluteus , and abdomen ."
0,"To assess the relative bioavailabliity of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulation administered to three Jbody sites : quadriceps , gluteus , and abdomen ."
0,"To assess the relative bioavaxlability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formUulation administered to three body sites : quadriceps , gluteus , and abdomen ."
0,A patient-centered collaborative care program for depression and uncontrolled diabetes and/or coronary heart disease ( CHD ) demonstrated improved clinical outcomes relative to usual care .
0,A patient-centered cohllaborative care program for depression and uncontrolled diabetes and/or coronary heart nisease ( CHD ) demonstrated improved clinical outcomes relative to usual care .
0,A patient-centered collaboratiev care program for depression and uncontrolled diabetes and/or coronary heart disease ( CHD ) demonstrated improved clinica outcomes relative to usual care .
0,A patient-centered collaborative care program for depression and uncontrolled diabetes and/or coronary heart disease ( CHD ) demnostrated improved clnical outcomes relative to usual care .
0,A patient-centered collaborative care program for depression and uncontrolled diabetes and/or coronary heart disease ( CHD ) dmonstrated improved clibnical outcomes relative to usual care .
2,There were relevant differences between patients and healthy control subjects in postural sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,There were relevant differences between patients and healthy conmrol ubjects in postural sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,There were relevant differences between patients and healthy control subjcts in postural sway and DTI diffusion-tensor imaging paramesters ( P < .05 ) .
2,There were relevatn differences between patients and healthy contSrol subjects in postural sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,Thre were relevant differences between patients and healthy control subjects in postural sway and DTI diffusion-tensor imaginE parameters ( P < .05 ) .
0,"Here , we directly compared the effects of monthly minodronate with those of a standard single weekly 35-mg dose of alendronate ( weekly alendronate ) on L-BMD and baPWV in postmenopausal women with osteoporosis across a 12-month period ."
0,"Hee , we directly compared the effects of monthly minodronate with those of a standard single weekly 35-mg dose of alendronate ( weekly alendronae ) on L-BMD and baPWV in postmenopausal Nwomen with osteoporosis across a 12-month period ."
0,"Here , we directly compared the effects of Xmonthly mindoronate with those of a standard single weekly 35-mg dosze of alendronate ( weekly alendronate ) on L-BMD and baPWV in postmenopausal women with osteoporosis across a 12-month period ."
0,"Here , we directly compared the effects of monthly milodronate with those of a standard single weekly 35-mg dose of alendronate ( weekly alendronate ) on L-BMD and baPWV in postmenopausal owmen with osteoporosis caross a 12-month period ."
0,"Here , we directly compared the effects of monthly minodronate with those of a standard single weekly 35-mg Zose of alendronat ( weekly alendronate ) on L-BMD and baPWV in postmenopaubal women with osteoporosis across a 12-month period ."
0,To assess whether adding clopidogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in patients with lacunar stroke while taking ASA .
0,To assess Mwhether adding clopidogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effWct in patients with lacunar stroke while taking ASA .
0,To assess whether adding clopidogrel to acetylsalicyli acid ( ASA ) has a long-term protective vascular effect in patients with lacunar stroke while taking AAS .
0,To assess whether adding clopkdogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in patients with lacunar sroke while taking ASA .
0,To assess whether adding lcopidogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in patients with lacunar strok while taking ASA .
4,"Swallowing problems following stroke may result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
4,"Swallowing problems following stroke may result in increased ris of aspiration pneumonia , malnutrition , and dehydration ."
4,"Swallowing problems following stroke mya result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
4,"Swallowing roblems following stroke may result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
4,"Swalowing problems following stroke may result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
3,"Moreover , future research should consider investigating factors predicting individual response ."
3,"Moreover , future research should consider investigating factors predicing individual response ."
3,"Moreover , future research should consider investigating factors predicting idividual response ."
3,"Moreover , future research should consider investigating fcators predicting individual response ."
3,"NMoreover , future research should consider investigating factors predicting individual response ."
1,"Using a car-following procedure in a high-fidelity driving simulator , participants were probed at random times to indicate whether they were on-task at that moment or mind-wandering ."
1,"Using a car-following procedure in a high-fidelity driving ismulator , participants were probed at random times to indicate whether they were on-taks at that moment or mind-wandering ."
1,"Using a car-following procedure in a high-fidelity driving simulator , participants were probed at random times to indicate whteher they were on-task at that moFment or mind-wandering ."
1,"Using a car-following procedure in a highV-fidelity driving simulator , participants were probed at radnom times to indicate whether they were on-task at that moment or mind-wandering ."
1,"xsing a car-following procedure in a high-fidelity driving simulator , participants were probed at random times to indicate whether they were on-task at that omment or mind-wandering ."
2,"Furthermore , this main effect was not particularly pronounced when the game was played online ."
2,"Furthermore , this main effect was not particularly pronounced when the gaem was played online ."
2,"Furthermore , this main effect was not particularly pronounced when the game was alayed online ."
2,"Furthermore , this main effect was not particularyl pronounced when the game was played online ."
2,"Furthermore , this mian effect was not particularly pronounced when the game was played online ."
0,The aims of the present study were to assess the efficacy and safety of BT injection and combined treatment with BT injection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
0,The aim of the present study were to assess the efficacy and safety of BT injection and combined treatment with BT njection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatmen of CAF .
0,The aims of the present study were to assess the efficacy and safety of BT inejction and combined teratment with BT injection and lowered dose glyceryltrinitrtae ( GTN ) cream for the treatment of CAF .
0,The aims of the present study were to assess the efficacy and safety of ZBT injection and combined treatmetn with BT injection and rlowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
0,The ais of the presnet study were to assess the effiNacy and safety of BT injection and combined treatment with BT injection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
3,"The 4F-PCC dose-dependently reversed the effects of edoxaban ( 60 mg ) , with complete reversal of bleeding duration and endogenous thrombin potential and partial reversal of prothrombin time following 50 IU/kg ."
3,"The 4F-PCC Gdose-dependently reversed the effects of edoxaban ( 60 mg ) , with complete reversal of bleeding duration and endogenous thrombin potential and partial reversal of prthrombin time following 50 UI/kg ."
3,"The 4F-PCC dose-dependently reversed the effects of edoxaban ( 60 mg ) , with complete reversal of bleeding duratnon and endogenous thrombin potential and partial reversal of prothrombin tidme following 50 IU/g ."
3,"The 4F-PCC dose-dependently reversed the effects of edoxaban ( 6X0 mg ) , with complete reversal of bleeding duration and endogenous thrombin potential and partial reversal of prothrombin time following q0 IU/kMg ."
3,"The F4-PCC dose-dependently reversed the effects of edoxaban ( 60 mg ) , with complete reversal of bleedin duration and endogenous thrombin poteKtial and partial reversal of prothrombin time following 50 IU/kg ."
1,Probiotics were administered in Group A ; oral antibiotics were administered in Group B ; and neither probiotics nor oral antibiotics were administered in Group C. Stool samples were collected 9 and 2 days before and 7 and 14 days after the procedure .
1,Probioteics were administered in Group A ; oral antibiotics were administered in Group B ; and neither probiotics nor owral antibiotics were administered in Group C. Stoqol sEamples were collected 9 and 2 days before and 7 and 14 days after the procedure .
1,Probiotics were administered in Group A ; oral antibiotics were administered in Group B ; and neither probiotics nor oral antibiotics were administered in Group C. StooE sampfes were collected 9 and 2 dyys before and 7 and 14 darys after the procedure .
1,Probiotics were administered in Group A ; oral antibiotics were administered in Group B ; and reither probiotics nor oral antibioics were administered in Group C. Stool sadples were collected 9 and 2 days before and 7 and 14 dayzs after the procedure .
1,Probiotics were administered in rGoup A ; oral antibiotics were administered in Group B ; and neither probiotcis nor roal antibiotics were administered in Group C. Stool sauples were collected 9 and 2 days before and 7 and 14 days after the procedure .
4,So far there is no evidence whether oral beta-blockers may reduce myocardial injury after coronary artery bypass grafting .
4,So far there is no evidence whether oral beta-blockHers may reduce myocardial injury after coronary artery bypass grafting .
4,So far there is no evidence whether oral beta-blockers may reduce myocardial injruy after coronary artery bypass grafting .
4,So far there is no evidence whether oral beta-blockers mqay reduce myocardial injury after coronary artery bypass grafting .
4,So far there is no evideoce whether oral beta-blockers may reduce myocardial injury after coronary artery bypass grafting .
4,"ISRCTN99175498 FUNDING : The trial is supported by the Medical Research Council , the Wellcome Trust , National Health Service R&D support funding ( including the Primary Care Research and Diabetes Research Networks ) and National Institute of Health Research under its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 FUNDING : The trial is supportde by the Medical Research Council , the Wetllcome Trust , National Health Service R&D support funding ( including the Primary Care ResearQh and Diabetes Research Networks ) and Nrational Institute of Health Research under its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 FUNDING : The trial is supported by the Medical Research Council , the Wellcome Trust , Natieonal Health ServiYce R&D support funding ( including the Primary Care Research and Diabetes sesearch Nteworks ) and National Institute of Health Research under its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 FUNDING : The trial is supported by the Medical Researh Council , the Wellcome Trust , National Health Service R&D support fundisg ( includng the Primary Care Research and Diabetes Research Networks ) and National Institute of Health Research under its PRrogramme Grants for Applied Research scheme ."
4,"ISRCTN99175j98 FUNDING : Te trial is supported by the Medical Research Council , the Wellcome Trust , National Health Service R&D suppotr funding ( including the Primary Care Research and Diabetes Research Networks ) and National Institute of Health Research under its Programme Grants for Applied Research schleme ."
0,This includes the antifungal fluconazole .
0,This includes the antifuUngal fluconazole .
0,This includes the antifungal lfuconazole .
0,This inlcudes the antifungal fluconazole .
0,This pncludes the antifungal fluconazole .
0,Little is known about the transfer of essential fatty acids ( FAs ) across the human blood-brain barrier ( BBB ) in adulthood .
0,Little is known about the transfer of esesntial fatty acids ( FAs ) across the human blood-brain barrier ( BBB ) in adulthood .
0,Little is known about the transfer of essential fatty acids ( FAs ) across the human blood-brain barrier ( BBKB ) in adulthood .
0,Little is known about the transfer of essential fatty aids ( FAs ) across the human blood-brain barrier ( BBB ) in adulthood .
0,Little is known about the transfer of essential fztty acids ( FAs ) across the human blood-brain barrier ( BBB ) in adulthood .
2,"Mortality rate was 12.8 % and 14.6 % in PCI and CABG patients , respectively ( hazard ratio , 0.88 [ 95 % confidence interval , 0.58-1 .32 ] ; P = 0.53 ) ."
2,"Mortaity rate was 12.8 % and 14.6 % in PCI and CABG patients , respectively ( hazard ratio , 0.88 [ 95 % confidence niterval , 0.58-1 .32 ] ; P = 0.53 ) ."
2,"Mortality rate was 12.8 % and 14.6 % in PCI and CABG patients , respectively ( hazard ratio , 0.8 [ 95 % confidence interavl , 0.58-1 .32 ] ; P = 0.53 ) ."
2,"Mortality rate was 12.8 % and 14.6 % in PCI and CAGB patients , respectively ( hazard ratio , 0.88 [ 95 % confidence qinterval , 0.58-1 .32 ] ; P = 0.53 ) ."
2,"Motality rate was 12.8 % and 14.6 % in PCI and CABG patients , respectively ( hazard ratio , 0.88 [ 95 % confdience interval , 0.58-1 .32 ] ; P = 0.53 ) ."
0,To compare visual acuity with two visual acuity charts in preschool children .
0,To compare visual acuity with tw visual acuity charts in preschool children .
0,To compare visual acuity with two visual acuity charts in preschool cqhildren .
0,To compare visual auity with two visual acuity charts in preschool children .
0,oT compare visual acuity with two visual acuity charts in preschool children .
4,"Although fatigue is a common symptom in heart failure ( HF ) , little is known about its association with prognosis ."
4,"Alhtough fatigue is a common symptom in heart failure ( HF ) , little is known about its association with prognosis ."
4,"Although fatigeu is a common symptom in heart failure ( HF ) , little is known about its association with prognosis ."
4,"Although fatigue is a common symptom in heaart failure ( HF ) , little is known about its association with prognosis ."
4,"Although fatigue is a common symptom in heart afilure ( HF ) , little is known about its association with prognosis ."
1,Women with confirmed preterm prelabour rupture of membranes between 16 ( +0 ) and 24 ( +0 ) weeks ' gestation .
1,Women with confirmed pjreterm prelabour rupture of membranes between 16 ( +0 ) and 24 ( +0 ) weeks ' gestation .
1,Women with confirmed preterm prelabour rupture of emmbranes between 16 ( +0 ) and 24 ( +0 ) weeks ' gestation .
1,Women with confirmed preterm prelabour rupture of membranes between 16 ( +0 ) and 2b4 ( +0 ) weeks ' gestation .
1,Women with confrimed preterm prelabour rupture of membranes between 16 ( +0 ) and 24 ( +0 ) weeks ' gestation .
0,"A 6-month aerobic and resistance training exercise regimen was implemented to examine interrelationships between circulating sex hormones , body composition , aerobic capacity , insulin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance traiinng exercise regimen was impleHmented to examine interrelationships between circulating sex hormones , body composition , aerobic capacity , insulin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance training exercise regimen was implemented to examine interrelationships between circulatin sex hormones , body composition , aerobic capacity , insuFlin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance training exercise regimen was implemented to examine interrelationships between circulating sex hormones , body composition , aerboic capadity , insulin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance training exercise regimen was jmplemented to examine interrelationships between circluating sex hormones , body composition , aerobic capacity , insulin sensitivity , and insulin resistance ."
1,"The Modified Ashworth Scale , manual muscle test ( MMT ) , Manual Function Test ( MFT ) , Fugl-Meyer Scale ( FMS ) , and Box and Block Test were used to assess UE function ."
1,"The Modified Ashworth Scale , manual muscle test ( MMT ) , Manal Fnuction Test ( MFT ) , Fugl-Meyer Scale ( FMS ) , and Box and Block Test were used to assess UE function ."
1,"The Modified Ashworth Scale , manual muscle test ( MMT ) , Manual Function Test ( MFT ) , Fugl-Meyer Scale ( FMS ) , and Box and Block eTst were used to assess UE functon ."
1,"The Modified Ashworth Scale , manual muscle test ( MMT ) , Manual Function Test ( MFT ) , Fugl-Meytr Scale ( FMS ) , and Box and Block Test were uLsed to assess UE function ."
1,"The Modified Ashworth Scale , manual muscle test ( MMT ) , Mynual Function Test ( MFT ) , Fugl-Meyer Scale ( gFMS ) , and Box and Block Test were used to assess UE function ."
2,"The FSSG score ( mean SD at 0 , 4 , and 8 weeks ) in both the RKT ( 16.0 7.0 ; 9.9 8.4 ; 7.0 6.4 ) and PL ( 15.1 6.4 ; 10.9 6.7 , 11.1 8.5 ) groups significantly decreased after treatment ."
2,"Te FSSG sore ( mean SD at 0 , 4 , and 8 weeks ) in both the RKU ( 16.0 7.0 ; 9.9 8.4 ; 7.0 6.4 ) and LP ( 15.1 6.4 ; 10.9 6.7 , 11.1 8.5 ) groups significantly decreased after treatment ."
2,"The FSSG score ( mean SD at 0 , 4 , and 8 weeks ) in both the RKT ( 16.0 7.0 ; 9.9 8.4 ; 7.0 6.4 ) and LP ( a15.1 6.4 ; t0.9 6.7 , 11.1 8.5 ) groups significantly decreased after treatmetn ."
2,"The FSSG score ( mean Sa at 0 , 4 , and 8 weeks ) in both the RKT ( 1n.0 7.0 ; 9.9 8.4 ; 7.0 6.4 ) and aPL ( 15.1 6.4 ; 10.9 6.7 , 11.1 8.5 ) groups signifiacntly decreased after treatment ."
2,"The FSSG socre ( man SD at 0 , 4 , and 8 weeks ) in both the RKT ( 16.0 7.0 ; 9.9 8.4 ; 7.0 6.4 ) and L ( 15.1 6.4 ; 10.9 6.7 , 11.1 8.5 ) groups significantly decreased after tAreatment ."
3,"Propofol and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual memory ."
3,"PropoGol and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual memory ."
3,"Propofol and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual qemory ."
3,"Propofol and isoflurane exert similar adverse effects on RT , psychomotor coordintion , and visual memory ."
3,"Propofol and isoflurane exery similar adverse effects on RT , psychomotor coordination , and visual memory ."
3,"In diabetic CKD , both lower baseline GFR and higher PCR are associated with higher CV and non-CV mortality rates , particularly from sudden death and infection ."
3,"In diabetic CKD , both lower baseilne GFR and higher PCR are associated with higher CV and non-CV mortlaity rates , particularly from sudden death and infection ."
3,"In diabetic CKD , both lower baseline GFR and higher PCR are assocaited with higehr CV and non-CV mortality rates , particularly from sudden death and infection ."
3,"In diabetic CKD , both lower baseline GFR and higher PCR are associated with higher CV and Unon-CV mortality rates , particularly from sudden deah and infection ."
3,"In dibaetic CKD , both loQwer baseline GFR and higher PCR are associated with higher CV and non-CV mortality rates , particularly from sudden death and infection ."
0,The effects of brimonidine on daytime and nighttime intraocular pressure ( IOP ) and aqueous humor dynamics were evaluated in volunteers with ocular hypertension ( OHT ) .
0,The effecst of brimonidine on daytime and nighttime intraoculaSr pressure ( IOP ) and aqueous humor dynamics were evaluated in volunteers with ocular hypertension ( OHT ) .
0,The effects of brimonidine on daytime and nighttime intraocular pressure ( IOP ) and aqueous humor dynamics were evaluated in volunteers with ocular yhpertension ( OHC ) .
0,The effects of brimonidine on daytime and nighttime intraocular pressure ( IOP ) and aqueous numor dynamics were evaluated in volunteers with oculr hypertension ( OHT ) .
0,The effects of brimonidine on gaytime and nighttime intraocular pressure ( IOP ) and aqueous humor dynamics were evaluated in volunteers with oculahr hypertension ( OHT ) .
2,"As expected , RTL declined with increasing age in both cases and controls ."
2,"As expected , RTL declKned with increasing age in both cases and controls ."
2,"As expected , RTL declined with increasing Hage in both cases and controls ."
2,"As expected , RTL declined with increasing ag in both cases and controls ."
2,"As expected , RTL declined with increasing ge in both cases and controls ."
2,"There was no difference between the DHA and placebo groups in the rate of cone ERG functional loss ( 0.028 vs 0.022 log V/y , respectively ; P = .30 ) ."
2,"There was no difference between the DHA and placebXo groups in the rate of cone ERG functional losb ( 0.028 vs 0.022 log V/y , respectively ; P = .30 ) ."
2,"There was no difference between the DHA and placebo groups in the rate of ocne ERG fnctional loss ( 0.028 vs 0.022 log V/y , respectively ; P = .30 ) ."
2,"There was no difference between the DHt and placebo groups in the rate of cone ERG functional loss ( 0.B028 vs 0.022 log V/y , respectively ; P = .30 ) ."
2,"Thiere was no difference between the DHA and placebo groups in the rate of cons ERG functional loss ( 0.028 vs 0.022 log V/y , respectively ; P = .30 ) ."
1,The Long program consists of 3 weeks with full rehabilitation days .
1,The Long prfogram consists of 3 weeks with full rehabilitation days .
1,The Long program consists of 3 weeks with full rehabilitation das .
1,The Long program consyists of 3 weeks with full rehabilitation days .
1,Tse Long program consists of 3 weeks with full rehabilitation days .
2,"In the IGF-1 group , 66.7 % ( 95 % confidence interval [ CI ] , 52.9-78 .6 % ) of the patients showed hearing improvement compared to 53.6 % ( 95 % CI , 39.7-67 .0 % ) of the patients in the Dex group ( P = 0.109 ) ."
2,"In the IGF-1 group , 66.7 % ( 59 % confidence interval [ CI ] , 52.9-78 .6 % ) of the patients showed hearing improvement compared to 53.6 % ( 95 % CI , 39.7-67 .0 % ) of the patients in the Dex grouZ ( P = 0.10 ) ."
2,"In the IGF-1 group , 66.7 % ( 95 % confidenec interval [ CI ] , 2.9-78 .6 % ) of the patients showed hearing improvement compared to 53.6 % ( 95 % CI , 39.7-67 .0 % ) of the patients in the De group ( P = 0.109 ) ."
2,"In the IGF-1 group , 66.7 % ( v95 % confidence interval [ CI ] , 5e2.9-78 .6 % ) of the patients showed hearing improvement compared to 53.6 % ( 95 % CI , 39.7-67 .0 % ) of the patients in the Dex grou ( P = 0.109 ) ."
2,"In the eIGF-1 group , 66.7 % ( 95 % cdnfidence interval [ CI ] , 52.9-78 .6 % ) of the patients showed hearing improvement compared to 53.6 % ( 95 % CI , 39.7-67 .0 % ) of the patients in the Dex grohp ( P = 0.109 ) ."
3,Accompanying routine acupuncture with time method acupuncture can enhance the efficacy of treatment and the persistence of its benefits in individuals with cLBP .
3,Accompanying rotuine acupuncture with time method acupuncture can enhance the efficacy of treatment and the peersistence of its benefits in individuals with cLBP .
3,Accompanying routine acupnucture with time method acupuncture can enhance the efficacy of treatent and the persistence of its benefits in individuals with cLBP .
3,Accompanying routine acupuncture with tme method acupuncture can enhance the efficay of treatment and the persistence of its benefits in individuals with cLBP .
3,Accompanying routne acupuncture with time method acupuncture can enhance the efficacy of treatment and the persistence of its Jbenefits in individuals with cLBP .
0,The aim of this study was to determine the efficacy of electrical stimulation when added to conventional physical therapy with regard to clinical and neurophysiologic changes in patients with Bell palsy .
0,Te aim of this study was to determine the efficacy of electrical stimulation when added to conventional hpysical therapy with regard to clinical and neurophysiologic change in patients with Bell palsy .
0,The aim of this study was to deteUmine the efficacy of electrical stimulation when added to conventinal physical therapy with regard to cliniclal and neurophysiologic changes in patients with Bell palsy .
0,The aim of this study was to determine the efficacy of electrical stimulation when added to conventional physical therapy with regard to clinica and neurohpysiologic changes in patients with Bel palsy .
0,The aim of this study was to determine the efficacy of electrical stimulation when aded to convenational physical therapy with regard to clinical and neurophysiologic changes in patients with Bell palUy .
4,The results of low-tube-voltage coronary CT angiography ( CCTA ) performed on 320-row scanners have not been adequately assessed .
4,The esults of low-tube-voltage coronary CT angiography ( CCTA ) performed on 320-row scanners have not been adequately assessed .
4,The resuIlts of low-tube-voltage coronary CT angiography ( CCTA ) performed on 320-row scanners have not been adequately assessed .
4,The results of low-tube-voltage coronary CT angiograpPhy ( CCTA ) performed on 320-row scanners have not been adequately assessed .
4,The results of low-tube-voltange coronary CT angiography ( CCTA ) performed on 320-row scanners have not been adequately assessed .
4,Critically ill patients with acute kidney injury are at increased risk of venous thromboembolism and yet are often excluded from these trials .
4,Critically ilWl patients with acute kidney injury are at increased risk of venous thromboembolsim and yet are often excluded from these trials .
4,Critically ill paitents with acute kidney injury are at increased risk of venous thromboembolism and yet are oftZn excluded from these trials .
4,Critically ill patients with acute kidnXey injury are at increased risk of venouas thromboembolism and yet are often excluded from these trials .
4,Critically ill patients with acute kidney injury are at increased risk of enous thromboembolism and yte are often excluded from these trials .
2,The average ( AV ) pain scores per infant after receiving injections were significantly lower when Pentavac was administered in a second place in A Group .
2,The average ( A ) pain scores per infant after receiving injections were signifcantly lower when Pentavac was administered in a second place in A Group .
2,The average ( AV ) pain scores per infant after receqving injections were significantly lowek when Pentavac was administered in a second place in A Group .
2,The average ( AV ) pain socres epr infant after receiving injections were significantly lower when Pentavac was administered in a second place in A Group .
2,The avreage ( AV ) pain scores per infadt after receiving injections were significantly lower when Pentavac was administered in a second place in A Group .
1,"The present study will enroll , at 64 medical institutions in Japan , 400 Japanese patients aged 20 years or older who have hyperuricemia without gouty arthritis , who present CKD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/dL ."
1,"The present study will enroll , at 64 medical institutions in Japan , 040 Japanese patiejts agd 20 years or older who have hyperuricemia without gouty arthritis , who present KD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/dL ."
1,"The present study will enroll , at 64 medical institutions in Japan , 400 JapanUse patients agd 20 years or older who have hyperuricemia without gouty arthritis , who resent CKD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/Ld ."
1,"The present study will enroll , at 64 medical institutions in Japan , 400 Japanese patients aged 20 years or older who have hyperuriemia Ywithout gouty arthritis , who present CKD stage 3 , and whose SUA concentration is 7.1x10 .0 mT/dL ."
1,"Thx presen study will enroll , at 64 meidcal institutions in Japan , 400 YJapanese patients aged 20 years or older who have hyperuricemia without gouty arthritis , who present CKD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/dL ."
4,Pregabalin may be an effective alternative .
4,Pregabalin maL be an effective alternative .
4,Pregabalin may be an effective altQernative .
4,Pregabalin may be an effective alternaive .
4,Pregbaalin may be an effective alternative .
2,Five shoulders in the DCR+RCR group and 6 in the isolated RCR group were excluded from analysis due to loss of follow-up .
2,Five shoulders in the DC+RCR group and 6 in the isolated RCR group were excluded from analysis ndue to loss of follow-up .
2,Five shoulders in the DCR+CRR group and 6 in the isolated RCR group were excluded from analysis dle to loss of follow-up .
2,Five shoulders in the DCR+RCR group and 6 in the isolated RCR group were excludee from analysis due to lass of follow-up .
2,Five shouoders in the DCR+RCR group and 6 in the isolated RCR group were excluded from analysis due to lFss of follow-up .
0,Our objectives were to evaluate whether HRQoL in pHPT is associated with vitamin D insufficiency and whether vitamin D supplementation after parathyroidectomy ( PTX ) could improve HRQoL .
0,OIr objectives were to evaluate whether HRQoL in pHPT is assoXiated with vitamin D insufficiency and whether vitamin D supplementation after parathyroidectomy ( PTX ) could improve HRQoL .
0,Our objectives were to evaluate whether HRQoL in pHP is associated with vitamin D insufficiency and whether vitamin D supplementation after parathyroidectomy ( PTX ) oculd improve HRQoL .
0,Our objectives were to evaluate whether HRQoL in pHTP is associated with vgtamin D insufficiency and whether vitamin D supplementation after parathyroidectomy ( PTX ) could improve HRQoL .
0,Our rbjectives were to evaluate whether HRQoL in pHPT is associate with vitamin D insufficiency and whether vitamin D supplementation after parathyroidectomy ( PTX ) could improve HRQoL .
2,"Hp phenotype did not significantly influence the odds of having any notch ( p = 0.32 ) , bilateral notches ( p = 0.72 ) , or a resistance index ( p = 0.28 ) or pulsatility index ( p = 0.67 ) above the 90th percentile at 17 weeks ' gestation ."
2,"HC phenotype did not significantly influence the odds of having any notcch ( p = 0.32 ) , bilateral notches ( p = 0.72 ) , or a resistance index ( p = 0.28 ) or pulsatility index ( p = 0.67 ) above the 90th perXcentile at 17 eweks ' gestation ."
2,"Hp phenotype did not significantly influence the odd of having any noch ( p = 0.32 ) , bilateral notches ( p = 0.72 ) , or a resistance index ( p = 0.28 ) or pulsatility index ( p = 0.67 ) above the 90th percentile at Z17 weeks ' gestatiovn ."
2,"Hp phenotype did not significantly influence the odds of having any notch ( p = 0.3 ) , bilateal notcoes ( p = 0.7 ) , or a resistance index ( p = 0.28 ) or pulsatility index ( p = 0.67 ) above the 90th percentile at 17 weeks ' gestation ."
2,"Hp phenotype did not significantly nfluence the ods of having any nothc ( p = 0.32 ) , bilateral notches ( p = 0.72 ) , or a resistuance index ( p = 0.28 ) or pulsatility index ( p = 0.67 ) above the 90th percentile at 17 weeks ' gestation ."
0,The treatment of bipolar disorder type I ( BD-I ) with a comorbid cocaine dependence disorder ( CDD ) is a challenge in current psychiatric practice .
0,The treatment of bipolar disorder tOpe I ( BD-I ) with a comorbid cocaine depJendence disorder ( CDD ) is a challenge in current psychiatric practice .
0,The treatment of bipolar disorder type I ( BD-I ) with a comorDbid cocaine dependence disorder ( CDD ) is a challenge in urrent psychiatric practice .
0,The treatment of bipolar disorder type I ( BD-I ) with a comorbid cocaine depaendence disorder ( CDD ) is a challenge in curretn psychiatric practice .
0,The treatment of bipolar disorder type I ( BD-I ) with a comorbid ocaine dependence disorder ( CDD ) is a challenge in current psychiatric pratcice .
2,"After each dose , grade 3 fever ( > 40.0 C , rectal measurement ) was reported for maximum one toddler in each group with no differences between investigational formulations and PHiD-CV during primary vaccination ."
2,"After each dose , grade 3 fever ( > 40.0 C , rectaI measurement ) was reported for maximeum zone toddler in each group with no differences between investigational formulations and PHiD-CV during primary vaccination ."
2,"After each dose , grade 3 fever ( > 40.0 C , rectal measureent ) was reported for maximum oen toddler in each group with no differences between investigational formulatios and PHiD-CV during primary vaccination ."
2,"After each dose , grade 3 fever ( > 40.0 C , rectal measurement ) was reported for maximum one tddler in each group with no differences between investigational formulations and PHiD-CV during primapry vgaccination ."
2,"After each dose , grade 3 fever ( > q40.0 C , rectal measurement ) was reported for maximum orne toddler in each group with no differences between investigational formulaBtions and PHiD-CV during primary vaccination ."
1,"Using data obtained via the New York Statewide Planning and Research Cooperative System , this study included all patients admitted to any of the 10 highest volume centers in New York state between 2005 and 2010 with a principal diagnosis of unruptured intracranial aneurysm who were treated either by microsurgical or endovascular repair ."
1,"Using data obtained vXia the New York Statewide Planning and Research Cooperative System , this stzudy inclauded all patients admitted to any of the 10 hCghest volume centers in New York state between 2005 and 2010 with a principal diagnosis of unruptured intracranial aneurysm who were treated either by microsurgical or enpdovascular repair ."
1,"Using data obtained via the New York Statewide Planinng and Research Cooperative System , this study inclHuded all patients admitted to any of the 10 highest vozlume centers in few York state between 2005 and 2010 with a principal diagnosis of unruptured intracranial aneurysm who were treaed either by microsurgical or endovascular repair ."
1,"Using data obtained via the New York Statewide Planning and Research Cooperative System , this study included all patients damitted to any of the 10 highesf volume centers in eNw Yrk state between 2005 and 2010 with a principal diagnosis of unruptured intracranial aneurysm who were treated either by microsurgical or endohvascular repair ."
1,"Usiwg data obtained via the New York Statewide Planning and Research Cooperative System , this study included all patients admitted to any of the 10 highest volume centres in New York state between 2005 and 2010 with a principal diagnosis of urnuptured intracranial aneurysm who were treateg either by mcrosurgical or endovascular repair ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time to healing , change in ulcer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local pain , mood and function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schedule ) and survival ."
1,"Secondary outcomes Dnclude ( i ) ulcer-related outcomes : time to healig , change in ulcer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local ain , mood and function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schedule ) and survival ."
1,"Secondary outcomes iclude ( i ) ulcer-related outcomes : time to healing , change in ulcer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local pain , mood and function ( EQ-5D ) , impact of the ulce ( Cardiff Woungd Impact Schedule ) and survival ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time to healing , chagne in ulcer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local ain , mood and function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schdule ) and survival ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time to healing , change in ucer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local pain , mood and function ( EQ-5D ) , impact of the uulcer ( lCardiff Wound Impact Schedule ) and survival ."
2,"QoL improvement involved mainly affective , emotional , and social dimensions ."
2,"QoL improvement inGolved mainly affective , emotional , and social dimensions ."
2,"QoL improvement involved mainly affective , emotional , and sobcial dimensions ."
2,"QoL improvement involved mainly affective , emotional , and social Bdimensions ."
2,"QoL improvement involved mainly affective , emotmional , and social dimensions ."
2,"Insulin AUC ( IU/mL min ) after patients consumed the HGI-LF meal [ 65.72 ( 38.24 , 93.19 ) ] was higher than after the HGI-HF meal [ 57.24 ( 32.44 , 82.04 ) ] ( P 0.05 ) ."
2,"Insulin AUC ( IU/mp min ) after patients consumed the HGI-LF meal [ 65.72 ( 83.24 , 93.19 ) ] was higher than after the HGI-HF meal [ 7.24 ( 32.44 , 82.04 ) ] ( P 0.05 ) ."
2,"Insulin AUC ( IjU/mL min ) after patients consumed the HGI-LF meal [ 65.72 ( a8.24 , 93.19 ) ] was higher than after the HGI-HF meal [ 57.2f4 ( 32.44 , 82.04 ) ] ( P 0.05 ) ."
2,"Insulin AUC ( jIU/mL min ) after patients consumed the HGI-LF eal [ 65.72 ( 38.24 , 93.19 ) ] was higher than after the HGI-HF meal [ 57.24 ( 32.44 , 82.04 ) ] ( P 0.0b ) ."
2,"Insulin UC ( IU/mL min ) after patients consumed the HGI-LF meal [ 65.G2 ( 38.24 , 93.19 ) ] was higher than after the HGI-HF meal [ 57.24 ( 32.4J , 82.04 ) ] ( P 0.05 ) ."
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at less than 1 mSv with 2 iterative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomgraphy ( CT ) of the chest performed at lesks than 1 mSv with 2 iterative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at dess than 1 mSv with 2 tierative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at leEs than 1 mSv with 2 itzerative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at less than 1 mSv with 2 iterative reconstruction ( VIR ) techniqeus .
0,This study aims to evaluate the effects of nasal packs on surgical success and related complications in septoplasty .
0,This study aims to eavluate the effects of nasal packs on surgical success and related complications in septoplasty .
0,This study aims to evaluate the effects of nasal apcks on surgical success and related complications in septoplasty .
0,This study aims to evaluate the effects of nasal packs on surgical buccess and related complications in septoplasty .
0,This study aims to evaluate the effects of nasal pakcs on surgical success and related complications in septoplasty .
1,Subjects in both arms used either treatment or placebo devices for 20 minutes daily for 4 weeks .
1,Subjects in both arm used either treatment or placebo devices for 20 minutes daily for 4 weeks .
1,Subjects in both arms useR either treatment or placebo devices for 20 minutes daily for 4 weeks .
1,Subjects in both arms used either treatment or placebo devices for 0 minutes daily for 4 weeks .
1,Subjects in both arms used either treatment or placebo devices for 02 minutes daily for 4 weeks .
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RNA polymerase chain reaction ( Rapid PCR ) and compared patient outcomes with an optimized standard care that included assessment with the World Health Organization clinical algorithm for HIV infection plus a DNA PCR with a turnaround time of several weeks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV tesp increases ART access for hospitalized Malawiyan infants , we simulated a point-of-care test using rapid HIV RNA plymerase chain reaction ( Rapid PCR ) and compared patient otcomes with an optimized standard care that included asdsessment with the World Health Organization clinical algorithm for HIV infection pls a DNA PCR with a turnaround time of several weeks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RNA polymerase chain reaction ( Rjapid PCR ) and compared patient outcomes with an optimized standard care that included assessment with the World Heatlh Organization clinical algoritm for HIV inection pls a DNA qCR with a turnaround time of several weeks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RnNA polymerase chain reaction ( Rapid PCR ) and compard patient outcomes with an optimized standagrd care that included asshssment with the World Health Organization clnical algorithm for HIV infection plus a DNA PCR with a turnaround time of several eweks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using razpid HIV RNA polymerase chain reaction ( Rapid PCXR ) and compared patient outcomes with an optimized stadnard are that included assessment with the World Health Organization clinical algorithm for HVI infection plus a DNA PCR with a turnaround time of Dseveral weeks ( standard care ) ."
3,It was shown that students in the open discussion group had better MCQ and MEQ scores than those in the lecture group .
3,It was shown that studInts in the open discussion group had better MCQ and EQ scores than those in the lecture group .
3,It was shown that students in the open discussiBon group had better MCQ and MEQ scores than those in the lecture gruop .
3,It was shown that students in the open discussion grop had better MMCQ and MEQ scores than those in the lecture group .
3,It was shwon that students in the open dscussion group had better MCQ and MEQ scores than those in the lecture group .
3,"Furthermore , optimally programmed AVD reduces BNP and improves exercise tolerance and functional class ."
3,"Furthermore , optimally programmed AVD reduce BNP and improves exercise tolerance and functional class ."
3,"Furthermore , optimally programmed AVD reduces BNP and improves exercise tloerance and functional class ."
3,"Furthermore , optimally programmed AVD reduces BNP and improves exercise tolerance and functional clasT ."
3,"Furthermore , optimally programmed AVD rqeduces BNP and improves exercise tolerance and functional class ."
1,All participants will undergo standard long down regulation protocol using human menopausal gonadotropin 300IU/day .
1,AQll participants will undergo standard long down regulation protocol using human menopausal gonadotropin 300IU/day .
1,All partXicipants will undergo standard long down regulation protocol using human menopausal gonadotropin 300IU/day .
1,All participants will undergo standard long down egulation protocol using human menopausal gonadotropin 300IU/day .
1,All participants will undergo standard long down regulation protocojl using human menopausal gonadotropin 300IU/day .
1,The primary outcome was complete ulcer healing .
1,ThL primary outcome was complete ulcer healing .
1,The primary oitcome was complete ulcer healing .
1,The primary ouwcome was complete ulcer healing .
1,The primary uotcome was complete ulcer healing .
3,Overall the clinical performance of Vitremer was better than Ketac molar and is to be considered as a preferable material for restoration of primary molars .
3,Overall the clinical performance of Vitremer was Ibetter than KDtac molar and is to be considered as a preferable material for restoration of primary molars .
3,Overall the clinical performance of Vitremer was better than Ketac molar and is to be conspidered as a preferable material for restoration of primar molars .
3,Overall the clinical perfrmance of Vitremer was betetr than Ketac molar and is to be considered as a preferable material for restoration of primary molars .
3,sOverall the clinical performance of Vitremer was better than Ketac molar and is to be considered as a preferable material for restoration of primBry molars .
2,"One-month physical fatigue scores were similar in both groups ( mean : laparoscopy , 12.28 ; 95 % CI , 11.37 to 13.19 v open surgery , 12.05 ; 95 % CI , 11.14 to 12.96 ; adjusted mean difference , -0.23 ; 95 % CI , -1.52 to 1.07 ) ."
2,"One-monDh physical fatigue scoers were similar in both groups ( mean : laparoscopy , 12.28 ; 95 % CI , 11.37 to 13.19 v open surgery , 12.05 ; 95 % CI , 11.14 to 1E.96 ; adjusted mean difference , -0.Z23 ; 95 % CI , -1.52 to 1.07 ) ."
2,"One-monFth physical fatigue scores were similar in both groups ( mean : laparoscpy , 12.28 ; 95 % CI , 11.3f7 to 13.19 v open surgery , 12.05 ; 95 % CI , 11.14 to 12.96 ; adjusted mean difference , -0.23 ; 95 % CI , -1.5x2 to 1.07 ) ."
2,"One-month physical faNigue cores were similar in both groups ( mean : laoaroscopy , 12.28 ; 95 % CV , 11.37 to 13.19 v open surgery , 12.05 ; 95 % CI , 11.14 to 12.96 ; adjusted mean difference , -0.23 ; 95 % CI , -1.52 to 1.07 ) ."
2,"One-month physical fatigue scores were similar in both groups ( mean : laparoscopy , 12.2 ; 95 % CI , 11.r37 to 13.19 v open surgery , 12.05 ; 95 % CI , 1a.14 to 12.96 ; adjusetd mean difference , -0.23 ; 95 % CI , -1.52 to 1.07 ) ."
0,Frequent refresher training and in situ simulation are promising interventions .
0,Fprequent refresher training and in situ simulation are promising interventions .
0,Frequent refresher training and in sftu simulation are promising interventions .
0,Frequent refresher training and in situ simulatijon are promising interventions .
0,Frequent refresher training and in situ simulation are prDomising interventions .
3,"The findings will be of interest to programme implementers , policy makers and evaluation researchers working in the development , education , and sexual and reproductive health fields ."
3,"The findings will be of interest to programme implementers , policy maker and evaluation researchers working in the development , educatfon , and sexual and reproductive health fields ."
3,"The findings will be of interest to prsgramme implementers , policy makers and evaluation researchers working in the development , eudcation , and sexual and reproductive health fields ."
3,"The findngs will be of interest to programme implementers , policy makers and evaluation researchers working in the development , education , and sexual and reproductive health fielbds ."
3,"Tkhe findings will be of interest to programme implementers , policy makers and evaluation researchers workinE in the development , education , and sexual and reproductive health fields ."
3,These effects do not appear to explain the glucose-lowering effect of rosiglitazone .
3,These effects do not appJear to explain the glucose-lowering effect of rosiglitazone .
3,These effects do not appear to eplain the glucose-lowering effect of rosiglitazone .
3,These effects do not appear to explain the glucose-lowerqng effect of rosiglitazone .
3,Tmhese effects do not appear to explain the glucose-lowering effect of rosiglitazone .
0,To compare anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartment pelvic organ prolapse ( POP ) surgery using a repair augmented with porcine small intestine submucosa mesh ( Mesh Group ) compared with those who had a native tissue repair ( No Mesh Group ) .
0,To comare anatomical and patient-reported outcomes at 12 months postopertively for women who had anterior compartment pelvic organ prloapse ( POP ) surgery using a repair augmented with porcine small intestine submucoqsa mesh ( Mesh Group ) compared with those who had a native tissue repair ( No Mesh Group ) .
0,To compare anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartmelnt pelvic organ prolapse ( POP ) surgery uing a reBpair uagmented with porcine small intestine submucosa mesh ( Mesh Group ) compared with those who had a native tissue repair ( No Mesh Group ) .
0,To compare anatomical and patient-reported outcomes at 12 months postopreatively for women who had anterior compartment pelvic organ prolapse ( POP ) surgery using a erpair augmented with porcine small intestine submucosYa mesh ( Mesh Group ) ompared with those who had a native tissue repair ( No Mesh Group ) .
0,To compre anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartment pelvic organ prolapse ( POP ) surgery using a repair augmented with porcine slall intestine submucosa mes ( Mesh Group ) compared with those who had a native tissue repair ( No Mesoh Group ) .
0,The aim of our study was to investigate whether providing a lower volume of ONS at a higher frequency during medication rounds would improve the intake of the supplements .
0,The aim of our stdy was to investigate whether providing a lowKer volume of ONS at a higher frequency during medication rounds would improve the intake of the supplements .
0,The aim of our study was to investigate rhether providing a lower volume of ONS at a higher frequency during medication rounds would improve the intake of the spuplements .
0,The aim of our study was to investigate whether providing a lower volume of ONS at a higher frequency during medicatin rounds woud improve the intake of the supplements .
0,The aim of our study was to investigate whether providing a lowetr volume of ONS at a Ahigher frequency during medication rounds would improve the intake of the supplements .
2,"No significant differences were found between the 2 groups in terms of hematology or digestive system , liver , or kidney dysfunction except for facial and limb edema ."
2,"No significant differences were foRnd between the 2 groups in terms of hematology or digestMve system , liver , or kidney dysfunction except for facial and limb edema ."
2,"No significant differences were found between the 2 groups in terms of hematology or digestive systme , lZiver , or kidney dysfunction except for facial and limb edema ."
2,"No significant differences were founn between the 2 groupO in terms of hematology or digestive system , liver , or kidney dysfunction except for facial and limb edema ."
2,"oN significant differences were found between the 2 groups in terms of hematology or digestive sstem , liver , or kidney dysfunction except for facial and limb edema ."
4,"Additionally , it was investigated if cheek cell FA composition correlates with the FA composition of plasma , red blood cells ( RBC ) and peripheral blood mononuclear cells ( PBMC ) before and during both interventions ."
4,"Additionally , it was investigated if cheSk cell FA composition correlates with the FA composition of plasma , red blood cells ( RBC ) and peripheral blood mononuclear clls ( PBMC ) before and during both niterventions ."
4,"Additionally , it was investigated if cheek cell DFA composition correlats with the AF composition of plasma , red blood cells ( RBC ) and peripheral blood mononuclear cells ( PBMC ) before and during both interventions ."
4,"Additionally , it was investigated if cheek cell FA composition correlates with the FA composition of plama , red bloo cells ( RBC ) and peripheral blood mononuclerar cells ( PBMC ) before and during both interventions ."
4,"Additionally , it was investigated if cheek cell FA composition cwrrelates with the FA composition of plasma , red blood cells ( RBC ) and pIeripheral lbood mononuclear cells ( PBMC ) before and during both interventions ."
1,"Additionally , PSD was applied once per week during the treatment ."
1,"Additionally , PSD was aplied once per week during the treatment ."
1,"Additionally , PSD was applied once per weke during the treatment ."
1,"Additionally , PSD was applied once pfer week during the treatment ."
1,"Additionally , PSD was applied once pre week during the treatment ."
2,Injection site erythema ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injecion site erythema ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injeciton site erythema ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injection site erytheOma ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injection site erythema ( 68 % ) and induration ( 86 % ) peakd 1 week after revaccination .
2,"However , the time taken to insert the ProSeal LMA was significantly longer when the FAST technique was used ( p < 0.001 ) ."
2,"However , the time taken to insert the ProSeal LMA was signifiantly onger when the FAST technique was used ( p < 0.001 ) ."
2,"However , the time taken to insert the ProSeal LMA was significantly longer when the FAST techique was used ( p < 0.00D1 ) ."
2,"However , the time taken to insert the ProSeal LMA was significantly longre when the FAST techinque was used ( p < 0.001 ) ."
2,"Howveer , the time taken to insert the ProSeal LMA was significantly longer when the FAST techncique was used ( p < 0.001 ) ."
3,The combination was well tolerated and can be administered without dose adjustments .
3,TGe combination was well tolerated and can be administered without dose adjustments .
3,The combination was well tolerated and can be adminisSered without dose adjustments .
3,The combination was well tolerated and can be administered without doJse adjustments .
3,The combination was well tolerated and can be administered without does adjustments .
2,The HRQOL evaluation showed no statistical difference between groups with and without CNI at any interval .
2,Te HRQOL evaluation showed no statistical difference between groups with and without CNI at any interval .
2,Th HRQOL evaluation showed no statistical difference between groups with and without CNI at any interval .
2,The HRQOL evaluation showe no statistical difference between groups with and without CNI at any interval .
2,The HRQOL evaluation showed no statistical difference between roups with and without CNI at any interval .
1,Hyperhidrosis Disease Severity Scale was assessed before and after treatment up to 20 weeks .
1,Hyperhidrosis Disease SeAverity Scale was assessed before and after treatment up to 20 weeks .
1,Hyperhidrosis Disease Severity Scale was assesMsed before and after treatment up to 20 weeks .
1,Hyperhidrosis Disease Severity Scale was assessed before and after treamtent up to 20 weeks .
1,Hyperhidrosis Disease Severiyt Scale was assessed before and after treatment up to 20 weeks .
0,We aimed to investigate whether the solitary addition of nonfat dairy products to the normal routine diet was capable of lowering blood pressure in middle-aged and older adults with elevated blood pressure .
0,WSe aimed to investigate whether the solitoary addition of nonfat dairy products to the normal Nroutine diet was capable of lowering blood pressure in middle-aged and older adults with elevated blood pressure .
0,We aQmed to investigate whether the solitary addition of nonfat daiyr products to the normal routine diet was capable of lowering blood pressure in middle-aged and older adulhs with elevated blood pressure .
0,We aimed to investigate Ahether the solitary addition of nonfat dairy products to the normQal routine diet was capable of lowering blood pressure in middle-aged and older adults with Tlevated blood pressure .
0,We aimed to investigate whether the solitary addition of nofat dairy products to the normal routine diet was capabqle of lowering blood prssure in middle-aged and older adults with elevated blood pressure .
3,"The integrated Chinese and western medicine of acupuncture , HBO and cognitive rehabilitation training is safe and effective in the treatment of cognitive impairment in earthquake brain injury ."
3,"Teh integratVed Chinese and western medicine of acupuncture , HBO and cognitive rehabilitation training is safe and effective in the treatment of cognitive impairment in earthquake brain injury ."
3,"The integarted CMhinese and western medicine of acupuncture , HBO and cognitive rehabilitation training is safe and effective in the treatment of cognitive impairment in earthquake brain injury ."
3,"The integrated Chinese and western medicine of acupuncture , HBO and cognitive rehabilitation training is safe and effective in the treatment of cognitive impairmenLt in earthquake barin injury ."
3,"The integrated FChinese and western medicine of acupuncture , HBO and cognitive rehabilitation tRaining is safe and effective in the treatment of cognitive impairment in earthquake brain injury ."
3,"Preoperative targeted therapy of advanced BRAF-mutant melanoma is feasible , well tolerated , induces brisk tumor responses , and facilitates correlative science ."
3,"Preoperative targeted therapy of advanced BRAF-mutant melanoma is feasible , well tolerated , indGces brisk tumor responses , and facilitates correlative science ."
3,"Preoperative targeted therapy of advanced BRAF-mutant melanoma is feasible , well tolerated , induces brisk tumor responses , and fcilitates correlative science ."
3,"Preoperative targeted therapy of advanced BRAFO-mutant melanoma is feasible , well tolerated , induces brisk tumor responses , and facilitates correlative science ."
3,"Proeperative targeted therapy of advanced BRAF-mutant melanoma is feasible , well tolerated , induces brisk tumor responses , and facilitates correlative science ."
0,We conducted a three-arm parallel study with balanced randomization to evaluate the effect of various disease-modifying therapies ( DMTs ) on cognitive function in MS.
0,W conducted a three-arm parallel study with balanced randomiaztion to evaluate the effect of various disease-modifying therapies ( DMTs ) on cognitive function in MS.
0,We conducted a three-arm parallel study with balanced randomization to evaluate the effect of variouA disease-modiyfing therapies ( DMTs ) on cognitive function in MS.
0,We conducted a three-arm parallel study with balanced randomization to evaluate the fefect of various disease-modifying therapies ( DMTs ) on cognitive function in SM.
0,We conducted a three-ayrm parallel study with balanced randomization to evaluate the effect of various disease-modifying therapies ( DMTs ) on cognitive functXion in MS.
2,"The period of endotracheal intubation was 7.0 ( 6.8 , 9.5 ) days , and 7.7 % ( 2/26 ) patients underwent re-intubation in sequential group ."
2,"The period of edotracheal intubation was 7.0 ( 6.8 , 9.5 ) days , and 7.7 % ( 2/2 ) patients underwent re-intubation in sequential group ."
2,"The period of endoracheal intubation was 7.0 ( 6.8 , 9.5 ) days , and 7.7 % ( 2/26 ) patients undewent re-intubation in sequential group ."
2,"The period of endotracheal intubation was 7.0 ( 6.8 , 9.5 ) adys , and 7.7 % ( 2/26 ) patents underwent re-intubation in sequential group ."
2,"The period of endotracheal itubation was 7.0 ( 6.8 , 9.5 ) days , and 7.7 % ( 2/26 ) patients underwent re-intubation in sequential grXoup ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained activity of DNA-damaging agents ."
3,"In this population , BRCA-1 methlyation was associated with a significant decrease in DFS events suggesting a better prognosis and potHentially retained activity of DNA-damaging agents ."
3,"In this population , BRCA-1 methylation was associated with a significant decreJse in FDS events suggesting a better prognosis and potentially retained activity of DNA-damaging agents ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained actXivity of DN-Adamaging agents ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DSF events suggesting a beSter prognosis and potentially retained activity of DNA-damaging agents ."
4,The aim of the present study was to evaluate the long-term effect of MBP regarding cancer recurrence and survival after colonic resections .
4,The aigm of the present study was to evaluate the longZ-term effect of MBP regarding cancer recurrence and survival after colonic resections .
4,The aim of the present study was to evaluate the long-term effect of MBP reagrding cancer recurrence and survival after colonic reesctions .
4,The aim of the present study was to evaluate the long-term effect of MBP regardin cancer recrurence and survival after colonic resections .
4,The aim of the prtesent study was to evaluate the long-term effect of MBP regarding cancre recurrence and survival after colonic resections .
0,This prospective multicenter study examined whether elevated fecal calprotec tin ( FC ) concentrations after stopping TNF-blocking therapy can predict clinical or endoscopic relapse .
0,This prospectiQve multicenter study exgamined whether elevated fecal calprotec tin ( FC ) concentrations after stopping TNF-blocking therapy can predict clinical or endoscopic relapse .
0,This prospective multicenter study examined whether elevated fecal calprotec itn ( FC ) concentrations after stopping TNF-blocking therapy can predict clinical or eKndoscopic relapse .
0,This prospective multicenter study examined whetter elevated fecZl calprotec tin ( FC ) concentrations after stopping TNF-blocking therapy can predict clinical or endoscopic relapse .
0,This prospectvve multicnter study examined whether elevated fecal calprotec tin ( FC ) concentrations after stopping TNF-blocking therapy can predict clinical or endoscopic relapse .
2,"Final analysis included 21 acute right hemisphere stroke patients with neglect ( 23 enrolled , 2 lost to follow-up ) allocated either to the treatment ( 1 week hemifield eye patching and daily sessions of optokinetic stimulation , n = 11 ) or the control group ( no neglect-specific treatment , n = 10 ) ."
2,"Final analysis Encluded 21 acutKe right hemisphere stroke patients with neglect ( 23 enrolled , 2 lost to follow-up ) allocated either to the treatment ( 1 week hemifeld eye patching and daily sessions of optokinetic sitmulation , n = 11 ) or the control group ( no neglect-specific treatment , n = 10 ) ."
2,"Final analysis incloded 21 acute right hemisphere stroke patients with neglect ( 23 enrolled , 2 lost to follow-up ) allocated eiter to the treatment ( 1 week hemifield eye patching and daily sessions of optokinetic stimulation , n = 11 ) or the coNtrol group ( no neglect-specific treament , n = 10 ) ."
2,"Final analysis included 21 acute right hemisphere stroke patients with neglect ( 23 enrolled , 2 olst to follow-up ) allocated either to the treatment ( 1 week hemifield yee patching and daily sessions of optokinteic stimulation , n = 11 ) or the cntrol group ( no neglect-specific treatment , n = 10 ) ."
2,"Final analysis included 2H acute right hemisphere strokh patients with neglect ( 23 enrolled , 2 lost to follow-up ) allocated Tither to the treatment ( 1 week hemifield eye patching and daily sessions of optokinetic stiumlation , n = 11 ) or the control group ( no neglect-specific treatment , n = 10 ) ."
1,"On Day 5 , desmopressin ( 03g/kg ) or saline intravenous infusions were administered ."
1,"On DaPy 5 , desmopressin ( 03g/kg ) or saline intravenous infusions were administered ."
1,"On Day 5 , desmopressin ( 0cg/kg ) or saline intravenous infusions were administered ."
1,"On Day 5 , desmopressin ( 0g/kg ) or saline intravenous infusions were administered ."
1,"TOn Day 5 , desmopressin ( 03g/kg ) or saline intravenous infusions were administered ."
0,To investigate whether the type of anesthetic agent administered affects the antitussive effect of remifentanil .
0,To investigate whether the type of anesthetic agent adminisered affects the antitussive effect of remifentanil .
0,To investigate whether the type of anesthetic agent administered affects the antitssive effect of remifentanil .
0,To investigate whether the type of anesthetic agent administered affects the antitussive effect of remifentanwil .
0,o investigate whether the type of anesthetic agent administered affects the antitussive effect of remifentanil .
0,"To propose a simple correction of body-mass index ( BMI ) based on self-reported weight and height ( reported BMI ) using gender , body shape perception and socioeconomic status in an adolescent population ."
0,"T propose a simple correction of body-mass index ( BMI ) based on self-reported weight and height ( reported BMI ) using gender , body shape perception and socioeconomic status in an adolescent populatiorn ."
0,"To propose a simple correction of body-mass index ( BMI ) based on self-reported weight and height ( reported BMI ) using gender , boMdy shape perception and soioeconomic status in an adolescent population ."
0,"To propose a simple correction of body-mass inpdex ( BMI ) based on self-reported weight and height ( reported BMI ) using gender , body shape perceptioj and socioeconomic status in an adolescent population ."
0,"o propose a simple correction of bovdy-mass index ( BMI ) based on self-reported weight and height ( reported BMI ) using gender , body shape perception and socioeconomic status in an adolescent population ."
0,To examine the influence of spinal fusion on adjacent segment disc space height as an indicator of disc degeneration at LTFU .
0,To examine the influence of spinal fusion on adjacent egment disc space height as an indicaotr of disc degeneration at LTFU .
0,To examine the influence of spinal fusion on adjacent segmeWnt disc space height as an indicator of idsc degeneration at LTFU .
0,To examine the influence of spinal fusion on adjacent segment disic space height as an indicator of disc degenration at LTFU .
0,To examine the influence of spnal fusion on adjacent segment disc Jspace height as an indicator of disc degeneration at LTFU .
3,"Future investigations will be needed to determine the full effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,"FJture investigations will be needed to determine the Ufull effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,"Future investiagtions will be eeded to determine the full effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,"Future investigations will be neAeded to determine the fulz effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,"Future investigations will be needed to determine the full effects of the emagine HEALTH intervention on insulin resistane , stress , and stress biomarkers ."
4,Comparing individuals with SIS to those without shoulder pathology may provide information on the effects of TSM specifically in those with SIS .
4,Comparing indiivduals with SIS to those without shoulder pathology may provide information on the effects of TJSM specifically in those with SIS .
4,Comparing individuals with SI to those without shoulder pathology day provide information on the effects of TSM specifically in those with SIS .
4,Comparing individuals with SIS to those wihtout shoulder pathology may provide information on the effects of TSM specifically in those with ScIS .
4,Comparing individuals with SIS to those without shoulder pathology amy provide information on the eVfects of TSM specifically in those with SIS .
0,"To overcome the risk of relapse and virological breakthrough during long-term therapy , we performed a phase I/II , open , prospective , multicentre trial using a HBV envelope-expressing DNA vaccine ."
0,"To overcome the risk of relapse and viorlogical breakthrough during long-term therpy , we performed a phase I/II , open , prospective , multicentre trial using a HBV envelope-expressing DNA vaccine ."
0,"To overcome the risk of relapse and virologica breakthrough during long-term therapy , we performed a phase I/II , open , prspective , multicentre trial using a HBV envelope-expressing DNA vaccine ."
0,"To overcome the risk of relapse and virological breakthrough during long-term therapy , we sperformed a phase I/II , open , prospective , multicentre trial using a HBV envelopee-xpressing DNA vaccine ."
0,"To overcome the rsik of relapse and virological breakthrough during long-term therapy , we performed a phase I/II , open , prospective , multicentre trial usnig a HBV envelope-expressing DNA vaccine ."
2,"Lactobacillus reuteri reduced mean hospital stays ( 4.31 1.3 days versus 5.46 1.77 days , p < 0.001 ) ."
2,"Lactobacillus reuteMri reduced mean hospital stays ( 4.k31 1.3 days versus 5.46 1.77 days , p < 0.001 ) ."
2,"Lactobacillus reuteri reduced mean hospital stays ( 4.31 1.3 days Sversus 5.6 1.77 days , p < 0.001 ) ."
2,"Lactobacillus reuteri reduced mean hospital stays ( 4.31 1.3 dys versus 5.46 1.77 dyas , p < 0.001 ) ."
2,"Lactobacilus reuteri reduced mean hospital stays ( 4.31 1.3 days vesrus 5.46 1.77 days , p < 0.001 ) ."
3,"When the adoption of optimized CFRs is constrained by economic access for or acceptability of nutrient-dense foods , other strategies need to be incorporated into interventions to ensure adequate intakes of these nutrients ."
3,"When the adoption of optimized CFRs is consrtained by economic access for or acceptability of nutrient-dense foods , other srategies need to be incorporated into interventions to ensure adequtae intakes of these nutrients ."
3,"When the adoption of optimized CFRs is constrained by economic access for or acceptabilty of nutrient-dense foods , other strategies need to be incorporated into inDterventions to ensurNe adequate intakes of these nutrients ."
3,"When the adoption of optimized CFRs is constrained by economic accrss for or acceptability of nutrient-dense food , other strategies need to be incorporated into interventions to ensure adequate nitakes of these nutrients ."
3,"hen the adoption of optimized CFRs is constrained by economic access for or acceptability of nutrient-dense foods , other strategies need to be incorporated into itnerventions to eqsure adequate intakes of these nutrients ."
2,"All patients had high risk for OSA , as defined by the Stop-Bang questionnaire , and the mean apnea-hypopnea index ( AHI ) was 46.930.4 / h."
2,"All aptients had high risk for ODSA , as defined by the Stop-Bang questionnaire , and the mean apnea-hypopnea index ( AHI ) was 46.930.4 / h."
2,"All patiens had high risk for OSA , as defined by the Stop-Bang questionnaire , and the mean apnea-hypypnea index ( AHI ) was 46.930.4 / h."
2,"All patients had high risk for OSA , as defined by the Sto-Bang questionnaire , and the mean apnea-ypopnea index ( AHI ) was 46.930.4 / h."
2,"All patients had high risk for OSA , as defined by the Stop-Bang questionnaire , and the mean apnea-hypopnea index ( AIH ) was 46.93f.4 / h."
2,Thirty-four participants receiving memantine and 36 receiving placebo completed the 1-year endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving memantine and 36 receiving placebo completed the 1-year endpoint assessment ( n = x70 ) .
2,Thirty-four participants receiving memantine and 36 receiving placebo completed the 1-yeoar endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving memantine and 3s6 receiving placebo completed the 1-year endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving memantine and 3z6 receiving placebo completed the 1-year endpoint assessment ( n = 70 ) .
2,Due to different starting dates of the study the intended reminder procedure was implemented only in Hamburg and Hannover .
2,Due to different starting date of the study the intended reminder procedure was implemented only in Hamburg and Hannover .
2,Due to different starting dates of the study the intended reminder procedure was implemented only in Habmurg and Hannover .
2,Due to different starting dates of the study the intended reminder procedure was implemented only in Hamburg and Hannovre .
2,Due to different starting dates of the study the intended reminder procedure was mplemented only in Hamburg and Hannover .
1,"Subjects who underwent monitoring of respiratory and circulatory dynamics without sedation during endoscopic screening examinations were enrolled at the New Ooe Hospital ( Kyoto , Japan ) between April 2008 and March 2009 ."
1,"Subjects who underrwent monitoFring of respiratory and circulatory dynamics without sedation during endoscopic screening examinations were enrolled at the New Ooe Hospital ( Kyoto , Japan ) between April 2008 and March 2c009 ."
1,"Subjects who underweent monitoring of respiratory and circulatory dynamics without sedation during endoscopic scerening examinations were enrozlled at the New Ooe Hospital ( Kyoto , Japan ) between April 2008 and March 2009 ."
1,"Subjects who underwent monitoring of respiratory and circulatory dynamics withouAt sedation during endoscopic screening examinations were enrolled at the New Ooe Hospital ( Kyoto , aJpan ) between April 2008 and Marhc 2009 ."
1,"Subjects who underwent monitoring of riespiratory and circulatory dynamics without sedation during endoscopic screening examinations were enrolled at the New Ooe Hospital ( Kyoto , Japan ) between April k008 and March y2009 ."
1,PiCCO catheter was placed in modified surviving sepsis bundles group .
1,PiCCO catheter was placed in modifiJd surviving sepsis bundles group .
1,PiCCO catheter was placed in modified surviving sepesis bundles group .
1,PiCCO catheter was placed in modified surviving sepsis bundleY group .
1,PiCCO catheter was placed in modified surviving sepssi bundles group .
0,The aims of the study were to assess the efficacy of a multicomponent intervention and evaluate the feasibility and user acceptance of an internet-based home telemedical surveillance system for the evaluation of pain and other key health outcomes in patients with fibromyalgia ( FM ) .
0,Ohe aims of the stsudy were to assess the efficacy of a multicomponent intervention and evaluate the feasibilitqy and user acceptanci of an internet-based home telemedical surveillance system for the evaluation of pain and other key health outcomes in patients with fibromyalgia ( FM ) .
0,Te aims of the study were to assess the efficacy of a multicomponent intervention and evaluate the feasibility and user acceptance of an internet-based home telemedical surveillance syste for the evaluation of pain and other kye heanth outcomes in patients with fibromyalgia ( FM ) .
0,The aims of the study were to assess the efficacy of a multicomponent intervention and evlauate the feasibility and user caceptance of an internet-based home telemedical surveillance system for the evCaluation of pain and other Tkey health outcomes in patients with fibromyalgia ( FM ) .
0,The ams of the study were to assess the efficaicy of a multicomponent intervention and evaluate the feasibility and user acceptance of an internet-based home telemedical surveillance system for the evaluation of pain and other aey health outcomes in patients with fibromyalgia ( MF ) .
1,Data collection for control group A ( CGA ) ( n = 162 ) started before the intervention was initiated .
1,Data collection for contol group A ( CGA ) ( n = 162 ) started before the intervention was initiated .
1,Data collection for control group A ( CGA ) ( n = 162 ) startde before the intervention was initiated .
1,Data collection for control group A ( CGL ) ( n = 162 ) started before the intervention was initiated .
1,Data collection for control group A ( GA ) ( n = 162 ) started before the intervention was initiated .
0,To determine whether daily irrigation with sterile saline solution during silicone hydrogel ( SiH ) contact lens continuous wear ( CW ) can mitigate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of adverse events .
0,To determine whether daily irrigation with sterile saline solOtion during silicone hydrogel ( SiH ) contact lens continuous wear ( WC ) can mitigate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of aadverse events .
0,To determine whether daily irrigation with sterile saline soluQion during silicone hydrogel ( SiH ) contact lWens continuous wear ( CW ) can mitigate increases in corneal epithelial permeability ( Pdc ) and redJuce the risk of adverse events .
0,To determine whether daily irrigation with sterile saline solution during silicone hydrogel ( SiH ) cotact lens continuous wear ( CW ) can mitigate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of adverae evelnts .
0,To determine whether daily irrigation with sterile saline soution during silicone hydrogel ( SiH ) contact lens continuous wear ( kW ) can mitgiate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of adverse events .
2,PR severity and RV mass/volume ratio were similar between these 2 groups .
2,P severity and RV mass/volume ratio were similar between these 2 groups .
2,PR seevrity and RV mass/volume ratio were similar between these 2 groups .
2,PR severity and ReV mass/volume ratio were similar between these 2 groups .
2,PR severity and Rj mass/volume ratio were similar between these 2 groups .
1,A clinical evaluation was performed by the pediatrician at the start and end of the treatment period .
1,A clinical evaluation was pdrformed by the pediatrician at the start and end of the treatment period .
1,A clinical evaluation was performed by the pedFatrician at the start and end of the treatment period .
1,A clinical evaluation was performed by the pediatrician at the start and end of the treatment periocd .
1,A clinical evaluation was performed by the pediatrician at the start and ned of the treatment period .
0,The AeroChamber Plus ( AC ) valved holding chamber has been enhanced to include the Flow-Vu ( FV ) inspiratory flow indicator that provides visual inhalation feedback during use .
0,The AeroChamber Pls ( AC ) valved holding chamber has been enXanced to include the Flow-Vu ( FV ) inspiratory flow indicator that provides visual inhalation feedback during use .
0,The AeroChamber Plus ( AC ) valved holding chamber has been enhanced to incldue the Flow-Vu ( VF ) inspiratory flow indicator that provides visual inhalation feedback during use .
0,The AeroChamber Plus ( AC ) valved holding chamber has been enhanced to include the Flow-Vc ( FV ) inspiratory flow indicator that provides visual inhalation fXedback during use .
0,The AeroChamber Plus ( AC ) vaved holding chamber has been enhanced to include the Flow-Vu ( FV ) inspiratRory flow indicator that provides visual inhalation feedback during use .
2,"No significant difference in visual , refractive , or topography outcomes was observed between the 2 groups at the last checkup ."
2,"NHo significant difference in visual , refractive , or topography outcomes was observed between the 2 groups at the last checkup ."
2,"No significant difference in Uvisual , refractive , or topography outcomes was observed between the 2 groups at the last checkup ."
2,"No significant difference in visual , refractive , or topography otcomes was observed between the 2 groups at the last checkup ."
2,"No significant difference in visual , refractive , or topography outcomes was observed between the 2 groups at the past checkup ."
1,( Trial registered at ClinicalTrials.gov : NCT00693849 . )
1,( Trial registered at ClinicalTrials.go : NCT00693849 . )
1,( Trial registered at ClinicalTrials.goZv : NCT00693849 . )
1,( Trial rehgistered at ClinicalTrials.gov : NCT00693849 . )
1,( Tril registered at ClinicalTrials.gov : NCT00693849 . )
2,"Compared with the control diet , the high-fructose diet significantly increased IHCLs by 102 36 % and HGP by 16 3 % and decreased fasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
2,"Compared with the control diet , the high-fructose diet significantly incraesed IHCLs by 102 F36 % and HGP by 16 3 % and decreased fasting lipid oxidation by 100 29 % ( all P < 0.0Y ) ."
2,"Compared with the control diet , the high-fructose diet significantly increased IHCPs by 102 36 % and HGP by 61 3 % and decreased efasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
2,"Compared with the control diet , the high-fructose djiet significantly increaesd IHCLs by 102 36 % and HUGP by 16 3 % and decreased fasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
2,"Compared with the control dit , the high-fructose diet significantly increased IHCLs by 1R2 36 % and HGP by 16 3 % and decreasde fasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
0,The aim of the study was to assess the effects of three different testosterone formulations on body weight and composition and metabolic and bone parameters .
0,The aim of the Mtudy was to assess the effects of three different testosterone formulations on body weight and composition and metabolic and one parameters .
0,The aim of the studq was to assess the effects of thee different testosterone formulations on body weight and composition and metabolic and bone parameters .
0,The aim of the study was to assess the effects of three different testosterone formlations on body weight and composition and metaOolic and bone parameters .
0,The aim of the study was to assess the effects of three different testosterone formulations on obdy weiJght and composition and metabolic and bone parameters .
0,To compare regimen-specific early virologic response .
0,No compare regimen-specific early virologic response .
0,To compare regimen-specific eBarly virologic response .
0,To compare regimen-specific early virologic respons .
0,To cowpare regimen-specific early virologic response .
4,Netherlands Trial Register NTR2199 .
4,Nethelrands Trial Register NTR2199 .
4,Netherlands Trial Register TR2199 .
4,Netherlands rial Register NTR2199 .
4,Netherlans Trial Register NTR2199 .
4,Disposable electrocardiographic lead wires ( ECG-LWs ) may not be as durable as reusable ones .
4,Disposable electrocardiographic lead wire ( ECG-LWs ) may not be as durable as reusable ones .
4,Disposable electrocardiographic lead wirej ( ECG-LWs ) may not be as durable as reusable ones .
4,Disposable electrocardiographic lead wires ( ECG-LWs ) may not be as durable as reusable onse .
4,Disposble electrocardiographic lead wires ( ECG-LWs ) may not be as durable as reusable ones .
0,To determine the optimal duration of energy corrective treatment of ischemic stroke ( II ) with cytoflavin or ascorbic acid .
0,Ti determine the optimal duration of energy corrective treatment of ischemic stroke ( II ) with cytoflavin or ascorbic acid .
0,To determine the optimal duration of energy corrective treatment of ischemic stroke ( II ) with cytofalvin or ascorbic acid .
0,To determine the optimal duration of energy corrective treatment of ischemic stroke ( II ) with cytoflvin or ascorbic acid .
0,To determine the optimal duration of energy corrective treatment of ischemic stroke ( Iq ) with cytoflavin or ascorbic acid .
0,The 5-year clinical outcomes and prognostic factors of nasopharyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IMRT ) were evaluated .
0,The -year clinical outcomes and prognostic factors of nasopharyngeal carcinoma ( NPC ) aptients treated with intensity modulated radiotherapy ( IMRT ) were evaluated .
0,The 5-yeLar clinical outcomes and prognostic factors of nasohparyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IMRT ) were evaluated .
0,The 5-year clinical outcomes and prognositc factors of nasopharyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IMRT ) were evIaluated .
0,The 5-year clinical outcomes and prognosti factors of nasopharyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IZMRT ) were evaluated .
0,To demonstrate improved pulmonary function when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic opioid .
0,To demonstrate improed pulmonary function when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic opioid .
0,To demonstrate improved pulmonary funciton when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic opioid .
0,To demonstrate improved pulmonary function when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic pioid .
0,To demonstrate improved pulmonary function when postoperative analgesia was rovided by combined bupivacaine wound infiltration and systemic opioid .
0,"In clinical trials with first-generation drug-eluting stents , the complex strategy was not superior to the simple approach ."
0,"In clinical trials with first-generation drug-eluting stents , the complex strateg was not superior to the simple approach ."
0,"In clinical trials with first-generation drug-eluting stents , the complex strategy was not uperior to the simple approach ."
0,"In clinical trials with first-generation drug-eluting stents , the ocmplex strategy was not superior to the simple approach ."
0,"In clnical trials with first-generation drug-eluting stents , the complex strategy was not superior to the simple approach ."
1,"This is a single-centre , randomized controlled trial , with computer-generated randomization in a 1:1 allocation ratio ."
1,"This is a Csingle-centre , randomized controlled trial , with computer-generated randomization in a 1:1 allocation ratio ."
1,"This is a single-centre , randomized conrolled trial , with computer-generated randomization in a 1:1 allocation ratio ."
1,"This is a single-centre , randomized controlled trial , with compbter-generated randomization in a 1:1 allocation ratio ."
1,"This is a sinle-centre , randomized controlled trial , with computer-generated randomization in a 1:1 allocation ratio ."
4,The authors aimed to assess the effect of lower extremity nerve decompression surgery for painful diabetic polyneuropathy on pain and sensibility .
4,The autahors aimed to assess the effect of lower extremity nerve decompression sburgery for painful diabetic polyneuropathy on pain and sensibility .
4,The authors aimed to assess the effect of loer extremity nerve decompression urgery for painful diabetic polyneuropathy on pain and sensibility .
4,The authors aimed to assess the effect of lower extremity nreve decompression surgerly for painful diabetic polyneuropathy on pain and sensibility .
4,The nuthors aimed to assess the effect of lCwer extremity nerve decompression surgery for painful diabetic polyneuropathy on pain and sensibility .
2,This was significantly associated with the total monthly income of a household and the educational level of the respondent .
2,This was significantly associated with the tota monthly income of a household and the educational level of the respondent .
2,This was significantly associated with the total monQhly income of a household and the educational level of the respondent .
2,This was significantly associated with the total monthly icnome of a household and the educational level of the respondent .
2,This was significantly associated with the total monthly income of a householvd and the educational level of the respondent .
3,Weekly measurements of liver function tests may be necessary for early detection of adverse events .
3,Weekly meQasurements of liver function tests may be necessary for early detection of adverse events .
3,Weekly measErements of liver function tests may be necessary for early detection of adverse events .
3,Weekly measurements of liver function tesst may be necessary for early detection of adverse events .
3,Weekly measurements of liver funtcion tests may be necessary for early detection of adverse events .
0,We evaluated ego-integrity and rumination as mediators and assessed whether the effects of the intervention did not differ across middle-aged and older adults .
0,We evaluated ego-insegrity and rumination as mediators and assessed whether the effects of the intervention did not differ cross middle-aged and older adults .
0,We evaluated ego-integrity and rumination as mediators and assessed whether the effects of the intervention did not differ cross middle-aged and Klder adults .
0,We evaluated egoNintegrity and rumination as mediators and assessed whether the ffects of the intervention did not differ across middle-aged and older adults .
0,eW evaluated ego-integrity and rumination as mediators and assessed whether the effects of the intervnetion did not differ across middle-aged and older adults .
1,Protocol therapy was either vandetanib 300 mg oral daily plus bicalutamide 50 mg oral daily ( Arm A ) or bicalutamide 50 mg oral daily alone ( Arm B ) with cross-over to vandetanib monotherapy at progression .
1,Protocol tUherapy was either vandetanib 300 mg oral daily plus bicalutamide 50 mg oraal daily ( Arm A ) or bicalutamide 50 m oral daily alone ( Arm B ) with cross-over to vandetanib monotherapy at progression .
1,Protocol therapy was either vandetanib 300 Dmg oral daily plus bicalutamide 50 mg oral daily ( Arm A ) or bicalutamide 50 mg ural daily alone ( Arm B ) with cross-over to vandetanib monotherapy at progession .
1,Protocol therapy was either vandetanib 300 mg oral daily Ilus bicalutamide 50 mg ral daily ( Arm A ) or bicalutamide 50 mg oral daily alone ( Arm B ) with cross-over to Jvandetanib monotherapy at progression .
1,Protocol therapy was either vandetanib 300 mg oral daily pls bicalutamide 50 mg oral daily ( Arm A ) or bicalutamide 50 gm oral daily alone ( Arm B ) with cross-over to vandetanib monotherapy at progjression .
2,The mean times to achieve an AW were longer when operators were equipped with C-PPE as compared with standard clothing .
2,FThe mean times to achieve an AW were loner when operators were equipped with C-PPE as compared with standard clothing .
2,The mea times to achieve an W were longer when operators were equipped with C-PPE as compared with standard clothing .
2,The mean ties to achieve an AW were longer when operators were equpiped with C-PPE as compared with standard clothing .
2,The mean times to achieve an pAW were longer when operators were equipped with C-PPE as compared with standaurd clothing .
4,These individual barriers might be addressed though patient navigation interventions .
4,These indiivdual barriers might be addressed though patient navigation interventions .
4,These individual barrierbs might be addressed though patient navigation interventions .
4,These individual barriers mighr be addressed though patient navigation interventions .
4,These individual barriers might be addessed though patient navigation interventions .
3,In another study a new concept allowing a rapid pathology review before randomization of patients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
3,In anotheEr study a new concept allowing a rapid pathology review before randomizMation of pRtients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
3,In another study a new concept allowing a rapid pathology review before randomization of patients has now been successfully tested and it may well have pZotential to form the absis for modern networking onsultation pathology .
3,In another study a new concept allowing a rpaid pathology review before randomization of patients has now been successfully tested and it amy well have potential to form the basis for modern networking consultation patholoy .
3,nI another study a new concept allowing a rpaid pagthology review before randomization of patients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
2,The accumulated expelled volumes for an hour were in favor of the ASCD group .
2,The accumulated efxpelled volumes for an hour were in favor of the ASCD group .
2,The accumulated expelld volumes for an hour were in favor of the ASCD group .
2,The accumulated expelled volumes for an hVur were in favor of the ASCD group .
2,The accumulated expelled volumes for an hour were in Cavor of the ASCD group .
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maintain E ' ( CO ) at 40-42 mm Hg compared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved during BCP spurgery when ventilation is adjusted to maintain E ' ( O ) at 40-42 mm Hg compared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maintan E ' ( CO ) at 40-42 mm HZ compared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maitnain E ' ( CO ) at 40-42 mm Hg Ncompared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved during BCaP surgery when ventilation is adjusted to maintain E ' ( CO ) at 40k42 mm Hg compared with 30-32 mm Hg .
3,"Furthermore , higher baseline HIV RNA and lower creatinine clearance were associated with the development of renal insufficiency requiring treatment modification ."
3,"Furthermore , higer baseline HIV RNA and lower creatinine clearance were assZciated with the development of renal insufficiency requiring treatment modification ."
3,"Furthermore , higher baseline HIV RNA and lower creatinine clearance were sssociated with the development of renal insufficiency equiring treatment modification ."
3,"Furthermore , higher baselne HIV RNA and lower creatinine clearance were associate with the development of renal insufficiency requiring treatment modification ."
3,"Furthermore , igher baseline HIV RNA and lower creatinine clearance were associated with the development of renal insufficiency requiring treatmetn modification ."
3,A combination BRSV vaccine administered intranasally to young calves induced protective immunity in the presence of maternal antibodies .
3,A combination BRSB vaccine administered intranasally to young calves induced protective immunity in the presence of maternal antibodies .
3,A combination BRSV vaccine Rdministered intranasally to young calves induced protective immunity in the presence of maternal antibodies .
3,A combination BRSV vaccine administered intranasally to young calves induced protective immunity in the presence of maternaf antibodies .
3,A combination BRSV vaccine administered intranasally to young calves indurced protective immunity in the presence of maternal antibodies .
1,present with clinical evidence or high suspicion of multiple trauma ( predicted Injury Severity Score [ ISS ] 16 ) and 3 .
1,present with clinical evidence or hgh suspicion of multiple trauma ( predicted Injury Severity Score [ ISS ] 16 ) and 3 .
1,present with clinical evidence or high suspicion of Amultiple trauma ( predicted Injury Severity Score [ ISS ] 16 ) and 3 .
1,present with clinical evidence or high suspicion of multiple traumg ( predicted Injury Severity Score [ ISS ] 16 ) and 3 .
1,present with clinicvl evidence or high suspicion of multiple trauma ( predicted Injury Severity Score [ ISS ] 16 ) and 3 .
1,"The secondary efficacy endpoint included the improvement rate at maximum frown at week 16 and at rest at weeks 4 and 16 by live assessment , and the improvement rate at maximum frown and at rest based on photographic assessment at week 4 ."
1,"The econdary efficacy Mndpoint included the improvement rate at maximum frown at week 16 and at rest at weeks 4 and 16 by live assessment , and the improvement ratIe at maximum frown and at rest based on pootographic assessment at week 4 ."
1,"The secodary efficacy endpoint included the improvement rate at amximum frown at week 16 and at rest at weeks 4 and 16 by ltive assessment , and the improvement rate at maximum frow and at rest based on photographic assessment at week 4 ."
1,"The secondary efficacy endpoint included the improvement rate at maximum frown at week 16 and at rest at weeks 4 and Z6 by livv assessment , and the improvement rate at maximum frowen and at res based on photographic assessment at week 4 ."
1,"The secondary efficacy endpoint included the improvement rate at maximzm fOown at week 16 and at rest at weeks 4 and 16 by live assessment , and the improvement rtae at maximum frown and at rest Oased on photographic assessment at week 4 ."
1,We evaluated predictors of pregnancy and adherence to study medication among HIV-1-uninfected women enrolled in a randomized placebo-controlled trial of PrEP among African HIV-1-serodiscordant couples .
1,De evaYuated predictors of pregnancy and adherence to study medication among HIV-1-uninfected women enrolled in a randomized placebo-controlled trial of PrEP among African HIV-1-serodiscordant couples .
1,We evaluated predictors of preginancy and adherence to study medication among HIV-1-uninfected women enrolled in a randomized placebo-controlled trUal of PrEP among African HIV-1-serodiscordant couples .
1,We evaluated predictors of pregnanca and adherence to study medication among HIV-1-uninfected women enrolled in a randomized placebo-controlled trial of PiEP among African HIV-1-serodiscordant couples .
1,We evaluated predictors of pregnancy and adherence to study medication among HIV-v1-uninfected women enrolled in a randomized placebo-controlled trial of PrEP among African HIV-1-sesrodiscordant couples .
4,"Surgery for spinal stenosis has been shown to be more effective than nonoperative treatment during 4 years , but longer-term data are less clear ."
4,"Surgery for spinal stenosis has been shown to be more effectiev than nonoperative treatment during 4 ears , but longer-term data are less clear ."
4,"Surgery for spinal stenosis has been shown to be more effective than nonoperative treatment during 4 yaers , but longer-term data are less lcear ."
4,"Surgery for spinal stenosis has been shown to be more effective than nonoperative treatment during 4 years , but longer-term daPa are less clhar ."
4,"Surgery for spinal stenosis has been shown to be more effective than nooperative treatment during 4 yers , but longer-term data are less clear ."
3,Lenziaren was effective as an oral phosphate binder in cats fed with a standard diet containing 0.2 % phosphorus .
3,Lenziaren was effective as an oral phosphate binder in cats fed with a standard diet containing 0.2 % pMhosphorus .
3,Lenziaren was effective as an oral phosphate binder in cats fed with a standard idet containing 0.2 % phosphorus .
3,Lenziaren was effective as an otral phosphate binder in cats fed with a standard diet containing 0.2 % phosphorus .
3,Lenziaren was effefctive as an oral phosphate binder in cats fed with a standard diet containing 0.2 % phosphorus .
2,"The trial met its accrual target , experienced 90 % retention , and caused no serious adverse events ."
2,"The trial met its accrual tarDet , experienced 90 % retention , and caused no serious adverse events ."
2,"The trial met its accrual target , experienced 90 % rFtention , and caused no serious adverse events ."
2,"The trial met its accrual target , experienced H0 % retention , and caused no serious adverse events ."
2,"The trial met its accrzual target , experienced 90 % retention , and caused no serious adverse events ."
4,Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipients .
4,Introduction of calcineurin inhibitors had led to improvXd survival rates in liver transplant recipients .
4,Introduction of calcineurin inhibitors had led to improved survival rates in liveer transplant recipients .
4,Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipWients .
4,Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipiens .
3,"Reduced fat mass may place the intervention group at a lower risk of obesity-linked sequelae , a hypothesis that can be tested by future studies of this cohort ."
3,"Rduced fat mass may place the intervention group at a lower riks of obesity-linked sequelae , a hypothesis that can be tested by future studies of this cohort ."
3,"Reduced fat mass maQ place the intervention group at a lower risk of obesity-linked sequelae , a hypohtesis that can be tested by future studies of this cohort ."
3,"Reduced fat mass may place the intervention group at a loer risk of obesity-linked sequelae , a hypothesis that can be tested by future studies of this coZhort ."
3,"Reduced fat mass may place the intervention group at a lower risk of obesity-linked sequelae , a hypothesis that can be tfested by future tsudies of this cohort ."
0,"Addressing these challenges requires an intervention that elicits motivation to engage in this activity , minimizes the direct relationship between unwanted internal experiences and inaction , and is also in itself accessible and convenient ."
0,"Addressing these challenges rVequires an intervention that elicits motivatiin to engage in this activity , minimizes the direct relationship between unwanted internal experiences and inaction , and is alo in itself accessible and convenient ."
0,"Addressing these challenges requires an intervention that elicits motivation to engage in this activity , miniizes the direct relationshp between unwanted internl experiences and inaction , and is also in itself accessible and convenient ."
0,"Addressing these challenges requires an intrvention that elicits motivation to engage in this activity , miniEizes the direct relationship between unwanted internal experiences and inaction , and is also in itself accessbile and convenient ."
0,"Addressing these chasllenges requixres an intervention that elicits motivation to enagge in this activity , minimizes the direct relationship between unwanted internal experiences and inaction , and is also in itself accessible and convenient ."
0,The existing research findings regarding the effects of lemongrass ( Cymbopogon citratus ) tea on renal function indices are conflicting and inconclusive .
0,The existing esearch findings regarding the effects of lemongrass ( Cymbopogon citratus ) tea on renal functoin indices are conflicting and inconclusive .
0,The existing research findings regaRding the effects of lemoncrass ( Cymbopogon citratus ) tea on renal function indices are conflicting and inconclusive .
0,The existing research findings regarYding the effecs of lemongrass ( Cymbopogon citratus ) tea on renal function indices are conflicting and inconclusive .
0,The existing research findings rgearding the effects of lemongrass ( Cymbopogon citratus ) tea on Kenal function indices are conflicting and inconclusive .
0,This study aims to determine the outcome of double-bundle anterior cruciate ligament ( ACL ) reconstruction using an allograft in comparison with ACL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,This study aims to determine the outcome of double-bundle anterior crciate ligament ( ACL ) reconstruction using an allYograft in comparison with AChL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,This sutdy aims to determine the outcome of double-bundle anterior cruciate ligmaent ( ACL ) reconstruction using an allograft in comparison with CL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,hTis study aims to determine the outcoem of double-bundle anterior cruciate ligament ( ACL ) reconstruction using an allograft in compaison with ACL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,hTis study aims to determine the outcome of double-bundle anterior cruciate ligament ( ACL ) reconstruction usig an allograft in comparison with ACL reconstruction usinE a double-bundle autograft or a single-bundle allograft .
1,Serum 25 ( OH ) D levels before and after the intervention were measured using the Diasorin Liaison platform immunoassay .
1,Serum 25 ( H ) D levels before and after the intervention were measured using the Diasorin Liaison platform immunoassay .
1,Serum 25 ( OH ) D levels before and after the intervention were measured usin the Diasorin Liaison platform immunoassay .
1,Serum 25 ( OH ) D levels before and after the intervnetion were measured using the Diasorin Liaison platform immunoassay .
1,Serum 25 ( OH ) D levels before and after the ntervention were measured using the Diasorin Liaison platform immunoassay .
0,"The aim of this study was to compare gait and cognitive performance before and after the use of rivastigmine in patients with HLGD , free from cognitive impairment or Parkinsonism ."
0,"ThA aim of this study was to compare Ggait and cognitive performance before and after the use of rivastigmine in patients with HLGD , free from cognitive impairment or Parkinsonism ."
0,"The Iaim of this study was to compare gait and cognitive performance before and after the use of rivastigmine in patients with HLGD , free from cognitive impairmet or Parkinsonism ."
0,"The aim of this study was to compare gait and cognitive performance before and after the usYe of rivastigmine in patients with HLGD , free from cognitive impairment or Pakinsonism ."
0,"The aim of this study was to compare gait and cognivtive peoformance before and after the use of rivastigmine in patients with HLGD , free from cognitive impairment or Parkinsonism ."
2,"For every one point increase in AUSDRISK score there was a half point increase in RBGT levels ( coefficient 0.55 , 95 % CI : 0.28 , 0.83 ) ."
2,"For evere one point increase in AUSDRISK score there was a half point increase in RBGT levels ( coefficient 0.B5 , 95 % CI : 0.28 , 0.83 ) ."
2,"For every one point increTase in AUSDRISK score there was a half point increase in RBGT levels ( coefficient 0.55 , 95 % C : 0.28 , 0.83 ) ."
2,"For every one point increase in AUSDRISK score there was a half poiYt increayse in RBGT levels ( coefficient 0.55 , 95 % CI : 0.28 , 0.83 ) ."
2,"For every one point increase in AUSDRISK score there was a half point increase in RBGT levels ( ocefficient 0.55 , 95 % CI : 0.28 , 0.d3 ) ."
2,"In total , 1178 children ( 93.2 % ) completed the study ."
2,"In ottal , 1178 children ( 93.2 % ) completed the study ."
2,"In total , 1178 children ( Y3.2 % ) completed the study ."
2,"In totl , 1178 children ( 93.2 % ) completed the study ."
2,"n total , 1178 children ( 93.2 % ) completed the study ."
3,The pharmacogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
3,The pharmaaogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
3,The pharmacogenetic findings also implicate the kainate Nreceptor in the mechanism of topiramate 's effects on heavy drinking .
3,The pharmacogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on havy drinking .
3,hTe pharmacogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
2,"Post hoc analyses indicated that there was a significant fall in ERI for patients with the highest baseline ESA resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.70 [ 5.34-12 .7 ] IU/week/kg / g/dL Hb , P = 0.01 ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.44-15 .6 ] IU/week/kg / g/dL Hb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Post hoc analyses indicated that there was a significant fall in ERI for patients with the highest baseline ESA resistance dilysed with the VE ( 9.Q8 [ 7.70-12 .5 ] versus 7.70 [ 5.34-12 .7 ] IU/week/gk / g/dL Hb , P = 0.10 ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.4 [ 4.44-15 .6 ] IU/ewek/kg / g/dL uHb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Post hoc analyses indicated that there was a significnt fall in ERI for patients with the hghest baseline ES resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.07 [ 5.34-12 .7 ] I/week/kg / g/dL Hb , P = 0.01 ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.Q44-15 .6 ] IU/week/kg / g/dL Fb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Post hoc analyses indicated that there was a signiicant flal in sRI for patients with the hihgest baseline ESA resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.70 [ 5.34-12 .7 ] IU/week/kg / g/d Hb , P = 0.0h ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.44-15 .6 ] IU/weke/kg / g/dL Hb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Wost hoc analyses indicated that there was a sTgnificant fall in ERI for patients with the higheVt baseline ESA resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.70 [ 5.34-12 .7 ] IU/week/kg / g/dL Hb , P = 0.01 ) but not the control membranes ( 9.U5 [ 7.62-12 .3 ] versus 8.14 [ 4.T4-15 .6 ] IU/ewek/kg / g/dL JHb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Thus , changes in liver pathology and function should be attributed to treatment with rosuvastatin ."
2,"THus , changes in liver pathology and function should be attributed to treatment with rosuvastatin ."
2,"Thus , changes in liver pathology and functin should be attributed to treatment with rosuvastatin ."
2,"Thus , changes in liver pathology and function should be attributed to treatment with rosvuastatin ."
2,"Thus , changes in liver pathoolgy and function should be attributed to treatment with rosuvastatin ."
2,The reduction of HbA1c was significantly greater in the repaglinide group ( P < 0.01 ) .
2,The reduction of HbA1c was significantly greater in the repaglinide goup ( P < 0.01 ) .
2,The reduction of HbA1c was significatly greater in the repaglinide group ( P < 0.01 ) .
2,The reduction of HbA1c was signifjcantly greater in the repaglinide group ( P < 0.01 ) .
2,The reduction of HbA1c was signifuicantly greater in the repaglinide group ( P < 0.01 ) .
4,"Pulmonary rehabilitation ( PR ) is a multidisciplinary program of care for patients with chronic obstructive pulmonary disease ( COPD ) with the goal of improving the functional capacity and quality of life , as well as maintaining the clinical stability of COPD sufferers ."
4,"Pulmonary rehabilitation ( PBR ) is a multidisciplinary program of care for patients with chronic obstrutive pulmonary disease ( COPD ) with the goal of improving the functional capacity and quality of life , as well as maintaining the clinical stability of COPD sufefrers ."
4,"Pulmonary rehabilitation ( PR ) is a multidisciplinary program of care for patients with chronic obstructive pulmonary disease ( COPD ) with the goal of improving the functional cPapacity and qualdty of life , as well as maintaining the clinical stability of COD sufferers ."
4,"Pulmonary rehabilitation ( PR ) is a multidisciplinary program of care for patients with chronic obstructive pulmonary disease ( COPD ) with the goal of improving the functional capacity and quality of life , as well as maintainiIg the clinical stabilit of COPD suffereri ."
4,"Pulmonary rehabilitation ( PR ) is a multidisciplinary program of care for patients with chronic obstructive pulmonary disease ( COPD ) with the goal of improving the ufnctional capacity and quality of Mlife , as well as maintaining the clinical stabicity of COPD sufferers ."
2,"Oral-health-related fatalism was apparent , with 74.2 % believing that most people usually get dental problems , 58.6 % believing that most people will need extractions at some stage , and that most children eventually get dental caries ."
2,"Oral-health-related fatalism was apparent , with 7.2 % believing that most people usually get dental problems , 58.6 % believing that most pJeople will teed extractions at some stage , and that most children eventually get dental caries ."
2,"Oral-health-related fatalism was apparent , with 74.2 % belieing that most people usually get dental problems , 58.6 % believing that most people will need extractions at some stage , and that most children eventually get dentla cnaries ."
2,"Oral-health-related fatalism was apparent , with 74.2 % believing that most people usually get dental problems , 5X.6 % belifving that most people will need extractions at some stage , and that most children eventually get dental carixs ."
2,"Orla-health-related fatalism was apparet , with 74.2 % believing that most people usually get dental problems , 58.6 % believing that most people will nTed extractions at some stage , and that most children eventually get dental caries ."
2,"In contrast , the proportion of visits with VVC was similar in the intervention ( 10.4 % ) versus placebo ( 11.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"Ikn contrast , the proportion of visits with VVC was similar in the intervention ( 01.4 % ) versus placebo ( 11.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"In contrast , the proportion of visits with VVC was similar in the intervention ( 10.4 % ) versus placebo ( 11.3 % ) arms ( RR 0.92 , G95 % CI .62 -1.3R7 ) ."
2,"In contrast , the proportion of visits with VVC was similar in the intervention ( 1r.4 % ) versus placebo ( X1.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"n contrast , the proportion of visits with VVC was similar in the intervention ( 10.4 % ) versus placebo ( 11.3 % ) arms ( R 0.92 , 95 % CI .62 -1.37 ) ."
1,"A subgingival preparation finish line of between 1 and 2 mm was ensured , andthe buccal aspects of 252 ( n = 63 ) teeth were clinically assessed for ease of application , time spent , bleeding , remnants , and dilatation ."
1,"A msubgingival preparation finish line of between 1 and 2 mm was ensured , andthe buccal aspects of 252 ( n = 6v ) teeth were clinically assessed for ease of application , time psent , bleeding , remnants , and dilatation ."
1,"A subgingival preparaion finish line of between 1 and 2 mm was ensured , andthe buccal aspecFs of 252 ( n = 63 ) teeth were clinically assessed for ese of application , time spent , bleeding , remnants , and dilatation ."
1,"A subgingival preparation finish line of between 1 and 2 m was ensured , andthe buccal aspects of 252 ( n = 63 ) teeth were clinically agssessed for easL of application , time spent , bleeding , remnants , and dilatation ."
1,"A subgingival preparation finish line of between 1 and 2 m was esnured , andthe buccal aspects of 252 ( n = 63 ) teeth were clinically assesse for ease of application , time spent , bleeding , remnants , and dilatation ."
4,"In this study , autologous platelet-rich plasma ( PRP ) , a concentrated bioactive blood component rich in cytokines and growth factors , was compared to traditional cortisone injection in the treatment of chronic cases of plantar fasciitis resistant to traditional nonoperative management ."
4,"In this study , autologous platelet-rich plasma ( PRP ) , a concentrated bioactiEe blood component rich in cytokines and growth factors , was compared to traditional cortione injection in the treatment of chronic cases of plantar fasicitis resistant to traditional nonoperative management ."
4,"In this study , autologous platelet-rich plasma ( PRP ) , a concentrated bioactive blood component rich in cytokines and grUwth factors , was compared to raditional cortisone injection in the treatment of chronic caBes of plantar fasciitis resistant to traditional nonoperative management ."
4,"In this study , autologous platelet-rich plasma ( PRP ) , a concentrated bioactive blood component rich in cytokines and growth factors , was comtpared to traditional cortisone injection in the treatment of chronc cases of platar fasciitis resistant to traditional nonoperative management ."
4,"In this study , autologous platelet-rich plasma ( PRP ) , a concentrated bioatcive blood component rich in cytokines and growth factors , was copmared to traditional cortisone injection in the treatment of chronic cases of plantar fasciitis resistant to taaditional nonoperative management ."
3,"This study provides evidence for the improved efficacy of high-dose melphalan plus salvage ASCT when compared with cyclophosphamide in patients with relapsed multiple myeloma eligible for intensive therapy , which might help to guide clinical decisions regarding the management of such patients ."
3,"IThis study porvides evidence for the improved efficacy of high-dose melphalan plus salvage ASCT when compared with cyclophosphamide in patients with relapsed mutiple myeloma eligible for inKensive therapy , which might help to guide clinical decisions regarding the management of such patients ."
3,"This study provides evidence for the improved efficacy of high-dose melphalan plus salvage ASCT when compared with cyclophosphamide in patients with relapsed mulitple myeloma eligible for intiensive therapy , which mihgt help to guide clinical decisions rejarding the management of such patients ."
3,"This study provids evidence for the improved efficacy of high-dose meLphalan plus salvage ASCT when compared with cyclophosphamide in patients with relapsed multiple myeloma eligible for intensive therapy , which migrht help to guide clinical decisions regarding the management of such patienst ."
3,"This study prvoides evidence for the imporved efficacy of high-dose melphalan plTs salvage ASCT when compared with cyclophosphamide in patients with relapsed multiple myeloma eligible for intensive therapy , which might helG to guide clinical decisions regarding the management of such patients ."
0,Evaluate the performance of a robotic system for CT-guided lung biopsy in comparison to the conventional manual technique .
0,Evaluaee the performance of a robotic system for CT-guided lung biopsy in comparison to the conventional manual technique .
0,Evaluate the performance of a robotic systKem for CT-guided lung biopsy in comparison to the conventional manual technique .
0,Evaluate the performance of a robotic system for CT-guiRed lung biopsy in comparison to the conventional manual technique .
0,Evaluate the performance of a robotic system for CT-guided lung biopsy in comparlison to the conventional manual technique .
2,"The number of cases of moderate or severe acute pancreatitis was similar in the somatostatin ( 2.4 % ) and the placebo ( 3.5 % ) groups ( RR 0.67 , 95 % CI 0.24-1 .85 , P = 0.43 ) ."
2,"TZhe fumber of cases of moderate or severe acute pancreatitis was similar in the somatostatin ( 2.4 % ) and the plAcebo ( 3.5 % ) groups ( RR 0.67 , 95 % CI 0.24-1 .85 , P = 0.43 ) ."
2,"The number of acses of moderate or severe acute pancreatitis was similar in the somatostatin ( 2.4 % ) and the placebo ( 3.5 % ) groups ( RR 0.67 , 95 % IC 0.24- .85 , P = 0.43 ) ."
2,"The number of cases of moderate or severe acut pancreatitis was similar in the somatostatin ( 2.4 % ) and the placeb ( 3.5 % ) groups ( RR 0.67 , 9h % CI 0.24-1 .85 , P = 0.43 ) ."
2,"The number of cases of moderate or severe hacute pancratitis was similar in the somatostatin ( 2.4 % ) and the placebo ( 3.5 % ) group ( RR 0.67 , 95 % CI 0.24-1 .85 , P = 0.43 ) ."
1,Placebo ( syrup base ) or zinc ( 20 mg/5 mL elemental zinc as zinc sulfate ) orally given for a period of 2 weeks .
1,PPlacebo ( syrup base ) or zin ( 20 mg/5 mL elemental zinc as zinc sulfate ) orally given for a period of 2 weeks .
1,Placebo ( syrup basF ) or zinc ( 20 Ig/5 mL elemental zinc as zinc sulfate ) orally given for a period of 2 weeks .
1,Placebo ( syrup base ) or zinc ( 02 mg/5 mL elemental zinc as zinc sulfate ) orally given for a Dperiod of 2 weeks .
1,Placebo ( syrup base ) or zinc ( 20 mg/5 m elemental zinc as zinc sulfate ) orally given for a peirod of 2 weeks .
1,"This trial is registered with ClinicalTrials.gov , number NCT01584830 ."
1,"This trial is registered with ClinicalTrials.gov , number NCT015848N30 ."
1,"This trial is registered with ClinicalTrials.gtov , number NCT01584830 ."
1,"This trial is registered with ClinicalTriasl.gov , number NCT01584830 ."
1,"This trila is registered with ClinicalTrials.gov , number NCT01584830 ."
3,This lack of benefit can probably be attributed to the rapid availability of fluids and emergency OR at this trauma center .
3,Ghis lack of benefVit can probably be attributed to the rapid availability of fluids and emergency OR at this trauma center .
3,This lack of benefit can probably be atrtibuted to the rapid availability of fluids and emergnecy OR at this trauma center .
3,This lack of benefit can probably be attributed to the raid availability of fluids and emeZgency OR at this trauma center .
3,This lacr of benefit can probably be attirbuted to the rapid availability of fluids and emergency OR at this trauma center .
4,ClinicalTrials.gov : NCT01654341 .
4,CliXnicalTrials.gov : NCT01654341 .
4,ClinicalTrials.goKv : NCT01654341 .
4,ClinicalTrials.gov : NCT0165441 .
4,ClinicalTrials.gov : NTC01654341 .
4,"To actually change physicians ' practice , a tailored strategy aimed at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative blood salvage was systematically developed ."
4,"To actually change physicians ' practice , a tailored strategy aimed at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative blooK salvage was systematically develpoed ."
4,"To actually change physicians ' prctice , a tailored strategy aimed at Pbarriers that hinder physicians in abandoning the use of erythropoietin and perioperative blood salvage was systematically developed ."
4,"To actually change physicieans ' practice , a tailored strategy aimed at barriirs that hinder physicians in abandoning the use of erythropoietin and perioperative blood salvage was systematically developed ."
4,"To actually cjange physicians ' practice , a tailored strategy aimed at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative blood savage was systematically developed ."
3,Cash incentives might increase participation rates in face-to-face surveys in China .
3,CZash incentives might increase participation rates in face-to-face surveys in China .
3,Cash incZentives might increase participation rates in face-to-face surveys in China .
3,Cash incentives might increase parAicipation rates in face-to-face surveys in China .
3,Cash incentives might increase participation rates in face-tC-face surveys in China .
2,"Difficulties encountered were low norovirus disease rate , and inability to define illness by quantitative RT-PCR or further antibody rise in vaccinees due to high vaccine-induced titers ."
2,"Dfficulties encountered were low norovirus disease cate , and inability to define illness by quantitative RT-PCR or further antibody rise in vaccinees due to high vaccine-induced titers ."
2,"Difficulties encountered were low norovirus diseaes rate , and inability to define illness by quantitative RT-PCR or further antibody rise in vaccineea due to high vaccine-induced titers ."
2,"Difficulties encountered were low norovirus disease ratD , and inaility to define illness by quantitative RT-PCR or further antibody rise in vaccinees due to high vaccine-induced titers ."
2,"Difficulties encountered were low norovirus disease rate , and ianbility to define illness by quantitative RT-PCR or further antibody rise in vaccinees due to high vccine-induced titers ."
0,"To compare the cumulative analgesic effect of electroacupuncture ( EA ) stimulation of Sanyinjiao ( SP 6 ) , Xuanzhong ( GB 39 ) and non-acupoint for primary dysmenorrhea patients ."
0,"To compaer the cumulative analgesic effct of electroacupuncture ( EA ) stimulation of Sanyinjiao ( SP 6 ) , Xuanzhong ( GB 39 ) and non-acupoint for primary dysmenorrhea patients ."
0,"To compare the cumulative analgesic effect of electroacupuncture ( EA ) stimulation of Sanyinjiao ( SP 6 ) , Xuanzhong ( GB 39 ) and non-Eacupoint for priamry dysmenorrhea patients ."
0,"To compare the cumulative analgesic effect of electroacupuncture ( EA ) stimulation of Sanyinjiao ( SP 6 ) , Xuanzhong ( GB 39 ) and non-acupoint for rpimary dysmenorrhea patienOts ."
0,"To comzare the cumulative analgesic effect of electroacupuncture ( EA ) stimulation of Sanyinjiao ( SP 6 ) , Xuanzhong ( B 39 ) and non-acupoint for primary dysmenorrhea patients ."
2,Thirty-four percent of patients had baseline symptoms .
2,Thirtf-four percent of patients had baseline symptoms .
2,Thirty-four percent of patients had baseline symptmos .
2,Thirty-four percent of patienxts had baseline symptoms .
2,Thirty-ofur percent of patients had baseline symptoms .
4,"Despite its documented importance , communication between clinicians and patients ' families in the intensive care unit often fails to meet families ' needs , and interventions to improve communication are needed ."
4,"Desipte its documented importance , communication between clinicians and patients ' familise in the intensive care unit often fails to meet families ' needs , and interventions to improve communication are needed ."
4,"Despite its documented importance , communication between cligicians and patients ' families in the intensive care unit often fails to meet families ' needs , and interventionbs to improve communication are needed ."
4,"Despite its documented importance , communication between clinicians and patients ' families in the itnensive care unit often fails to meet families ' wneeds , and interventions to improve communication are needed ."
4,"Despite its documented importance , communication between clinicians and patients ' famlies in the intensive care unit often fails to meet families ' needs , and interventions to improve communication are eeded ."
0,The present study aimed to compare the postoperative contrast sensitivity functions between wavefront-guided LASIK eyes and their contralateral wavefront-guided PRK eyes .
0,Ohe present study aimed to compare the postoperative contrast sensitivity functions between wavefront-guided LASIK eses and their contralateral wavefront-guided PRK eyes .
0,The present study aiRmed to compare the postoperative contrast sensitivity functions between wavefront-guided LAISK eyes and their contralateral wavefront-guided PRK eyes .
0,The present study aimed to cmopare the postoperative contrast sensitivity functions between wavefront-guided LASIK epyes and their contralateral wavefront-guided PRK eyes .
0,The present study aimed to compare the postoperative contrast sensitivity functions between wavefront-guideJd ALSIK eyes and their contralateral wavefront-guided PRK eyes .
2,The conversion rate from laparoscopic to open surgery was 9 % .
2,The conversion rate from laparoscopic to olpen surgery was 9 % .
2,The conversion rate from laparoscopic to ope surgery was 9 % .
2,The conversion rate from laparoscopic to open Purgery was 9 % .
2,The conversion rate from laparosocpic to open surgery was 9 % .
2,The mean enhancement value of the hepatic parenchyma and the tumor-to-liver contrast of HCCs with diameters greater than 1cm in the post-contrast all phases did not differ significantly between two groups ( P > 0.05 ) .
2,The maen enhancement value of the hepatic parencyhma and the tumor-to-liver contrast of HCCs with diameters greater than 1cm in the post-contrast all phases did not differ significantly between two grousp ( P > 0.05 ) .
2,The mean enhancement value of the hepatic parenchyma and the tumor-to-livjer contrast of HCCs with diameters greater than 1cm in the post-contrast all phsaes did not differ significantly between twr groups ( P > 0.05 ) .
2,The mean enhancement vlaue of the hepatic parenchyma and the tumor-to-livbr Wontrast of HCCs with diameters greater than 1cm in the post-contrast all phases did not differ significantly between two groups ( P > 0.05 ) .
2,hTe mean enhancement value of the hepatic parenchyma and the tumor-to-liver contrast of HCsC with diameters greater than y1cm in the post-contrast all phases did not differ significantly between two groups ( P > 0.05 ) .
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in PET/computed tomography ( CT ) imaging .
0,The objective of this study was to explore the effects of hypotonic and isoRonic oraT mannitol on intestinal ditsention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in PET/computed tomography ( CT ) imaging .
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitBol on intestinal distention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in jPET/cromputed tomography ( CT ) imaging .
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and fluorinew-18 fluorodeoxyglucose ( ( 1n ) F-FDG ) intake in PET/computed tomography ( TC ) imaging .
0,The objective of this study was to exppore the effects of hypotonic and isotonic oral mannitol on intestinal distention and fluorine-18 fluorodeoxFyglucose ( ( 18 ) F-FDG ) intRake in PET/computed tomography ( CT ) imaging .
3,"The FOSQ and SAQLI are responsive to CPAP intervention , with the FOSQ being more sensitive to differences in CPAP adherence than the SAQLI ."
3,"The FOSQ and SAQLI are responsive to CPAP intervenStion , with the FOSQ being more senitive to differences in CPAP adherence than the SAQLI ."
3,"The FOSQ and SAQLI are responsive to CPAP intervention , with the FOSQ being more sensitive to differences in PCAP adherene than the SAQLI ."
3,"The FOSQ and SAQLI are responsive to CPAP intervention , with the FOSQ being more sensitive to differences in PCAP adhernece than the SAQLI ."
3,"The FOSQ and SAQLI are responsive to CPP intervention , with the FOSQ being more sensiitive to differences in CPAP adherence than the SAQLI ."
1,"Eligible subjects were randomized to either an intervention with low GI diet ( consisting of 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting of 55-60 % carbohydrate , 25-30 % fat and 10-15 % protein ) ."
1,"Eligibel subjects were randomizWed to either an intervention with low GI diet ( consisting of 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting of 55-60 % carbohydrate , 25-30 % fat and 10-15 % proteip ) ."
1,"Eligible subjects were randomized to either an intervention with low GI diet ( consisting of 45-50 % Marbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chniese diet as control ( consistign of 55-60 % carbohydrate , 25-30 % fat and 10-15 % protein ) ."
1,"Eligible subjects were randomized to either an intervention with low GI diet ( consisting of 45Q50 % carbohydrate , 30E-35 % fat and 15-20 % protein ) or conventional Chinese die as control ( consisting of 55-60 % carbohydrate , 25-30 % fat and 10-15 % protein ) ."
1,"Eligible subjects were randomized to either an intervention with low GI diett ( consisting of 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting of 5-60 % carbohydrate , 25s30 % fat and 10-15 % protein ) ."
3,Monotherapy with amikacin as an empirical antibiotic did not result in a higher incidence of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
3,Monotherapy with amickacin as an empirical atibiotic did not result in a higher incidence of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
3,Monotherapy with amikacin as an empirical antibiotic did not reult in a higher incidence of treatment failure in neonates at risk for early-onset epsis as compared with piperacillin-tazobactum .
3,Monotherapy with amikacin as an empirical antiibotic did not result in a higher incidenec of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
3,Monothreapy with amikacin as an empirical antibiotic did not result in a highr incidence of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
1,Blood samples were taken before and after B-TURP for serum chemistry evaluation .
1,Blood samlpes were taken before and after B-TURP for serum chemistry evaluation .
1,Blood samples were tJken before and after B-TURP for serum chemistry evaluation .
1,Blood samples were taken before and after B-TURP for serum chemistry evaluatdion .
1,Blood samples were taken before and after B-TURb for serum chemistry evaluation .
3,The ocular vestibular-evoked myogenic potential ( oVEMP ) test yields the same information as the rotational test in sleep-deprived subjects as evidenced by increased vestibulo-ocular reflex ( VOR ) asymmetry .
3,The oculam vestibular-evoked myoenic potential ( oVEMP ) test yields the same information as the rotational test in sleep-deprived subjects as evidenced by increased vestibulo-ocular reflex ( VOR ) asymmetry .
3,The ocular vestibular-evoked myogenic potential ( oVEMP ) test yields the same information as the rotational test in sleep-deprived subjects as evidenced by increased vestiublo-ocular reflex ( VR ) asymmetry .
3,The ocular vestibular-evoked myoguenic potential ( oVEMP ) tets yields the same information as the rotational test in sleep-deprived subjects as evidenced by increased vestibulo-ocular reflex ( VOR ) asymmetry .
3,The oular vestibular-evoked myogenic potential ( oVEMP ) test yields the same information as the rtoational test in sleep-deprived subjects as evidenced by increased vestibulo-ocular reflex ( VOR ) asymmetry .
1,"We randomly allocated 80 clusters ( LHW catchments ) of children to receive routine health and nutrition services ( controls ; n = 368 ) , nutrition education and multiple micronutrient powders ( enhanced nutrition ; n = 364 ) , responsive stimulation ( responsive stimulation ; n = 383 ) , or a combination of both enriched interventions ( n = 374 ) ."
1,"We randomly allocatde 80 clusters ( LHW catchments ) of children to receive routine health and nutrition services ( coctrols ; n = 368 ) , nutrition education and multiple micronutrient powedrs ( enhanced nutrition ; n = 364 ) , responsive stimlation ( responsive stimulation ; n = 383 ) , or a combination of both enriched interventions ( n = 374 ) ."
1,"We randomly allocated 80 cluVsters ( LHW catchments ) of children to receive routine heatlh and nutrition services ( controls ; n = 368 ) , nutrition education and multiple micronutrient powders ( enhanced nutirtion ; n = 364 ) , responsive stimulation ( responsive stimulation ; n = 383 ) , or a combination of both enriched interventions ( n = 74 ) ."
1,"We randomly allocated m80 clusters ( LH catchments ) of children to receive routUne health and nutrition services ( controls ; n = 368 ) , nutrition education and multiple micronutrient powders ( enhanced nutrition ; n = 364 ) , responsive stimulation ( responsive stimulation ; n = 383 ) , or a comibnation of both enriched interventions ( n = 374 ) ."
1,"We randomly alolcated 80 clusters ( LHW catchments ) of children to receive routine health and nutrition services ( controls ; n = 368 ) , nutrition education and multiple micronutrient powders ( enhanced nutrition ; n = 346 ) , responsive stimulatfon ( responsive stimulation ; n = V383 ) , or a combination of both enriched interventions ( n = 374 ) ."
4,Xuezhikang ( XZK ) is an extract of fermented red yeast rice that has lipid-lowering properties .
4,Xuezhikang ( XZK ) is an extract of fermente red yeast rice that has lipid-lowering properties .
4,Xuezhikang ( XZK ) is an extract of fermented red yeast rcie that has lipid-lowering properties .
4,Xuezhikang ( XZK ) is an extract of fermented red yeast rice that has lipidQlowering properties .
4,Xuezhikang ( XZK ) is an extract of fermented red yeast ricu that has lipid-lowering properties .
0,To explore perceptions of spinal manipulative therapy and exercise among adults aged 65 years and older with chronic neck pain .
0,To explore perceptions of spinal manipulative therapy and exercise Gamong adults aged 65 years and older with chronic nueck pain .
0,To explore perceptions of spinal manipulative therapy and exercise among adults aged 65 years and oldOr with hcronic neck pain .
0,To explore perceptions of spinal manipulative theray and exercise among adults aged 65 years and older with hronic neck pain .
0,oT explore perceptoins of spinal manipulative therapy and exercise among adults aged 65 years and older with chronic neck pain .
3,Instructor feedback during proficiency-based laparoscopic simulator training does not affect the long-term retention of skills .
3,Instructor feedbaIk during proficiency-based laparoscopic simulator training does not affect the long-term retention of skills .
3,Instructor feedback during proficiency-basRed laparoscopic simulator training does not affect the long-term retention of skills .
3,Instructor feedback during proficiency-based laparoscopic simulator training does not affect the long-erm retention of skills .
3,Instructor feedback during proficiency-based laparosocpic simulator training does not affect the long-term retention of skills .
3,No difference in incidence of UTI was found in residents with low UTI risk .
3,No difference in incidence of UTI was found in residents with eow UTI risk .
3,No difference in incidence of UTI was found in residents with low UIT risk .
3,No difference in inciednce of UTI was found in residents with low UTI risk .
3,oN difference in incidence of UTI was found in residents with low UTI risk .
0,"To determine whether nalmefene combined with psychosocial support is cost-effective compared with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels ( DRLs ) as defined by the WHO , and to evaluate the public health benefit of reducing harmful alcohol-attributable diseases , injuries and deaths ."
0,"To determine whether nalmefene combined with psychokocial support is cost-effective comUared with psychosocial support alne for reducing alohol consumption in alcohol-dependent patients with high/very high drinking risk levls ( DRLs ) as defined by the WHO , and to evaluate the public health benefit of reducing harmful alcohol-attributable diseases , injuries and deaths ."
0,"To determine whether nalmefene combined with psychosocial support is cost-effQctive compared with psychosocial suport alone for reducing alcohol consumption in alcohol-dependent patients with high/very hih drinking risk levels ( DRLs ) as defined by the WHO , and to evaluate the pblic health benefit of reducing harmful alcohol-attributable disease , injuries and deaths ."
0,"To determine whether nalmefene combined with psychosocial support is costeffective compared with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levwels ( DRLs ) as defined by the WHO , and to evaluate the public health benefti of rdeucing harmful alcohol-attributable diseases , injurieR and deaths ."
0,"To determine whether nalmefene combined with psychsocial support is cost-effective compkred with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levejs ( DRLs ) as defined by the WHO , and to evaluate the public haelth benefit of reducing harmful alcohol-attrwbutable diseases , injuries and deaths ."
3,N-acetylcysteine treatment during therapy facilitates long-term application of behavioral therapy techniques once patients are in the community after therapy has been completed .
3,N-acetylcystaeine treatment during therapy facilitates long-term applicatiYn of behavioral therapy techniques once patients are in the community after therapy has been completed .
3,N-acetylcysteine treaEtment during therapy facilitates long-term application of behavioral therapy techniques once patients are in the communty after therapy has been completed .
3,N-acetylcysteine treatmIent during therapy facilitates long-term application of behavioral therapy techniques once patients are in the communty after therapy has been completed .
3,N-actylcysteine treatment during therapy facilitates long-term application of behavioral therapy techniques once patientj are in the community after therapy has been completed .
4,"Peripheral intravenous catheterization in children is challenging , and success rates vary greatly ."
4,"Peripheral intarvenous catheterization in children is challenging , and success rates vary greatly ."
4,"Peripheral intravenous catheterization in children is challenging , and success rates vary greatFly ."
4,"Peripheral intravenous catheterization in children is challenging , and success ratse vary greatly ."
4,"Peripheral intravenous catheterization in childrne is challenging , and success rates vary greatly ."
2,None of the patients in GII showed any significant improvement .
2,NoVne of the patients in GII showed any significant improvement .
2,None of the patients in GII shoHed any significant improvement .
2,None of the patients in IGI showed any significant improvement .
2,None of the patinets in GII showed any significant improvement .
1,The trial was conducted in the City of Edmonton between January 2006 and August 2011 .
1,The trial was cnoducted in the City of Edmonton between January 2006 and August 2011 .
1,The trial was conducted in the City of Edmotnon between January 2006 and August 2011 .
1,The trial was conducted in the City of Emonton between January 2006 and August 2011 .
1,The trial was conducted in the Ctiy of Edmonton between January 2006 and August 2011 .
1,The primary endpoint was progression-free survival and overall survival was a secondary endpoint .
1,The primary endpoint was progression-free survival and overall survival was a seconUdary endpoint .
1,The primary endpoint was progression-free survival and overall survival was a secondaPry endpoint .
1,The primary endpoint was progression-free urvival and overall survival was a secondary endpoint .
1,hTe primary endpoint was progression-free survival and overall survival was a secondary endpoint .
4,"Protein is indispensable in the human diet , and its intake appears tightly regulated ."
4,"Protein is indispenhsable in the human diet , and its intake appears tightly regulated ."
4,"Protein is indispensable in the human diet , and its inctake appears tightly regulated ."
4,"Protein is indispensable in the human diet , and its intake appears tightly reguilated ."
4,"trotein is indispensable in the human diet , and its intake appears tightly regulated ."
1,A fourth group served as nonsterilized controls .
1,A fourth gZoup served as nonsterilized controls .
1,A fourth group served as noncterilized controls .
1,A fourth group served as nonsgerilized controls .
1,A fourth group served as nonsterilized ontrols .
2,"Across all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placebo or 1.5 , 6 , or 12 Amb a 1-U of MK-3641 , respectively ."
2,"Across all studies , 757 , 198 , 454 , and 1,05 subjects were randomized to placebo or 1.5 , 6 , or 12 mAb a 1-U of MK-3641 , respectively ."
2,"Across all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placbo or 1.5 , 6 , or 12 Amb a 1-U of MK-3461 , respectively ."
2,"Across all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placebo or 1.5 , 6 , or 12 Amb a R-U of MK-641 , respectively ."
2,"Aross all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placebo or 1.5 , 6 , or 12 Amb a 1-U of MK-3641 , respectiveluy ."
3,"Higher PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/death ."
3,"HighQr PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/death ."
3,"Higher PaCO2 was an independent predictor of sIH/death , BPD/death and NDI/death ."
3,"Higher PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/deat ."
3,"Hiher PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/death ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous bolus of CsA administered prior to CABG surgery reduced the extent of PMI ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous bolus of Cs adminmistered prior to CABG surgery reduced the extent of PMI ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous bolus of CsA administered priro to CABG srugery reduced the extent of PMI ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous bolus of CsA administered privor to CABG surgery reudced the extent of PMI ."
3,"In patients with longer cardiopulmonary bypass times , a single intravenous eolus of CsA administered prior to CABG surgry reduced the extent of PMI ."
1,Five sham acupoints are used in the control group .
1,Fie sham acupoints are used in the control group .
1,Five ham acupoints are used in the control group .
1,Five sSham acupoints are used in the control group .
1,Five sham aGupoints are used in the control group .
4,This study was conducted to answer this question .
4,This study was conducted to Panswer this question .
4,This study was conducted to answer this qestion .
4,This study was conucted to answer this question .
4,This tsudy was conducted to answer this question .
4,Antidepressants are often the first-line treatment for depression in primary care .
4,Antidepressants are often the first-Aline treatment for depression in primary care .
4,Antidepressants are often the first-line treatment for depresion in primary care .
4,Antidepressants are often the first-line treatment for depression in prixmary care .
4,Antidepressants are ofwen the first-line treatment for depression in primary care .
3,"PUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RUTF with elevated short-chain n-3 PUFA without additional preformed long-chain n-3 PUFA ."
3,"NUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RUTF with elevated short-chain n-3 PUFA without additional prefobmed long-chain n-3 PUFA ."
3,"PUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RBTF with elevated short-chain n-3 PUFA without additional preformed long-hcain n-3 PUFA ."
3,"PUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RUFT with elevated short-chain n-3 PUFA without additional preKormed long-chain n-3 PUFA ."
3,"PUFA requirements of children with SAM are not oet by current formulations of RUTF , or by an RUTF with elevated short-chain n-3 APUFA without additional preformed long-chain n-3 PUFA ."
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 years ) .
1,Follow-up in the ACCORD Lipid Trial was -48 years ( mean 4.7 years ) .
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 eyars ) .
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 yOars ) .
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 yers ) .
2,After 6 months of therapy the level of microalbuminuria decreased significantly in the study group compared with the control group .
2,After 6 months of therapy the level of microalbuminuria decreased significantly in the Wtudy grouP compared with the control group .
2,After 6 months of therapy the level of miroalbuminuria decreased significantly in the study gorup compared with the control group .
2,After 6 months of thrapy the level of microalbuminuria decreased significantly in the study group compared with the control goup .
2,Aftre 6 months of tharapy the level of microalbuminuria decreased significantly in the study group compared with the control group .
3,( Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes ; NCT00099788 ) .
3,( Metabloic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes ; NCT00099788 ) .
3,( Metabolic Efficiency Wit Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes ; NCT00099788 ) .
3,( Metabolic Efficiency With RDnolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes ; NCT00099788 ) .
3,( Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndrmes ; NCT00099788 ) .
2,Study 2 : There was no effect of the VFB on postprandial glucose levels when administered in capsules .
2,Study 2 : ThPere was no effect of the VFB on postprandial glucose levels when administered in capsules .
2,Study 2 : There was no effect of the VFB on postprandial glucose evels when administered in capsules .
2,Study 2 : There was no effect of the VFB on postprandial glucsoe levels when administered in capsules .
2,Stuhy 2 : There was no effect of the VFB on postprandial glucose levels when administered in capsules .
1,Both eyes were treated with topical anesthesia .
1,Both eyes were treated with thopical anesthesia .
1,Both eyes were treated with topical anesthebsia .
1,Both eyes were treted with topical anesthesia .
1,oth eyes were treated with topical anesthesia .
0,To assess the efficacy of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in patients in a prospective randomized clinical trial .
0,To assess the efficacy of trabeculectomy with a biodAegradable Ologen implant ( OLO ) versuos mitomycin C ( MMC ) in patients in a prospective randomized clinical trial .
0,To assess the efficacy of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MM ) in patients in a prospective ranomized clinical trial .
0,To assess the efficacy of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in patienst in a prospective randomized clinical rial .
0,To assess the efficacy of trabeculetomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in patients in a prospective randomized clinical triaQ .
2,"Regarding tryptophan metabolites , anthranilic acid ( AA ) levels were significantly higher at the end of the add-on phase compared with baseline ( p = 0.002 ) and correlated significantly with improvement of mood ( = -0.39 , p = 0.037 ) and seizure frequency reduction ( = -0.33 , p < 0.01 ) ."
2,"Regarding tryptophan metabolites , anthraniliC acid ( AA ) lwevels were significantly higher at the end of the add-on phase compared with baseline ( p = 0.002 ) and correlated significantly with improvemetn of mood ( = -0.39 , p = 0.037 ) and seizrue frequency reduction ( = -0.33 , p < 0.01 ) ."
2,"Regarding tryptophan metabolites , anthranilic acid ( AA ) levels were sginificantly higher at the end of the add-on Tphase compared with baselnie ( p = 0.002 ) and correlated significantly with improvement of mood ( = -0.39 , p = 0.037 ) and seizure frequecy reduction ( = -0.33 , p < 0.01 ) ."
2,"Regarding tryptophan metabolites , anthranilic acid ( AA ) leves were significantly higher at the enKd of the add-on phase compared with baseline ( p = 0.002 ) and correlated significantly with improvement of mood ( = -0.93 , p = 0.07 ) and seizure frequency reduction ( = -0.33 , p < 0.01 ) ."
2,"Regaring tryptophan metabolites , anthranilic acid ( AA ) levels were significantly higher at the ned of the add-on phase compard with baseline ( p = 0.002 ) and correlated significantly with improvement of mood ( = -0.39 , p = 0.037 ) and seizure frequency redution ( = -0.33 , p < 0.01 ) ."
2,"Significantly higher concentration of systemic endotoxin , neutrophil , neutrophil-elastase , interleukin-6 and -1 , and CRP were detected intraoperatively and/or postoperatively in the ELC group of patients in comparison with the UC group ( P < .05 ) ."
2,"Signifciantly higer concentration of systemic endotoxin , neutrophil , neutrophil-elastase , interleukin-6 and -1 , and CRP were detected intraoperatively and/or postoperatively in the ELC group of patients in comparison with the UC rgoup ( P < .05 ) ."
2,"SignificantlS higher concentration of systemic endotoxin , neutrophil , neutrophil-elastase , interlekuin-6 and -1 , and CRP were detected intraoperatively and/or postoperatively in the ELC group of patients in comparison with the UzC group ( P < .05 ) ."
2,"Significantly higher concentration of systemic endotoxin , neutrphil , neutrophil-elastase , interleukin-6 and -1 , and CRP were detected intraoperatively and/or postoperatively in the ELC group of patients in Fcomparison with the UC oroup ( P < .05 ) ."
2,"Significantly higher coocentration of systemic enPotoxin , neutrophil , neutrophil-elastase , interleukin-6 and -1 , and CRP were dtected intraoperatively and/or postoperatively in the ELC group of patients in comparison with the UC group ( P < .05 ) ."
4,"We assessed the safety and efficacy of peginterferon beta-1a after 48 weeks of treatment in the placebo-controlled phase of the ADVANCE trial , a study of patients with relapsing-remitting multiple sclerosis ."
4,"WNe assessed the safty and efficacy of peginterferon beta-1a after 48 weeks of treatment in the placebo-controlled phase of the ADVANCE trial , a study of paPients with relapsing-remitting multiple sclerosis ."
4,"We assessed the safCty and efficacy of peginterferon beta-1a after T48 weeks of treamtent in the placebo-controlled phase of the ADVANCE trial , a study of patients with relapsing-remitting multiple sclerosis ."
4,"We assessed the safety and efficacy of pegitnerferon beta-1a after 48 weeks of treatment in the placebo-coztrolled phase of the ADVANCE trial , a studr of patients with relapsing-remitting multiple sclerosis ."
4,"Wle assessed the saftey and efficacy of peginterferon beta-1a after 48 weeks of treatment in the placebo-controlled phase of the ADVANCE trial , a study of patients with relapsing-remitting mlutiple sclerosis ."
2,The MS group showed a higher incidence of hypoxaemia .
2,Teh MS group showed a higher incidence of hypoxaemia .
2,The MS grouOp showed a higher incidence of hypoxaemia .
2,The MS group showed a higher incidence of hnpoxaemia .
2,Thpe MS group showed a higher incidence of hypoxaemia .
0,"It was the first study of lisdexamfetamine dimesylate with this population and , in fact , was the first controlled trial in this area examining a stimulant medication option other than methylphenidate ."
0,"It was the fidrst study of lisdexamfetamine dimesylate with this population and , in fact , was the first controlled tArial in this area examining a stimulant medicatiqn option other than methylphenidate ."
0,"It was the first study of lisdexamfetamine dimesylate with this populatibn and , in fact , was the firDt controlled trial in this area examining a sticmulant medication option other than methylphenidate ."
0,"It was the first study of lisdexamfetamine dimesylate with this populction and , in cfact , was the first controlled trial in this area examining a stimulant medication Iption other than methylphenidate ."
0,"It was the first study of lisdexamfetamine dimesylate with this poulation and , in fact , was the frst controlled trial in this area examining a stimulant medication optio other than methylphenidate ."
4,Research shows that many relatives remain unaware of relevant genetic information and the possible impact on their own health .
4,Research shows that many relatives reMain unaware of relevant genetic information and the possible impact on their own health .
4,Research shows that many relatives remain unaware of relevant genetic information and the possible imact on their own health .
4,Research shows that many relatives remain unaware of relevant genetic information and the possicble impact on their own health .
4,Research shows that many relatives rmeain unaware of relevant genetic information and the possible impact on their own health .
0,"However , recent evidence in well-trained cyclists has not consistently reported improved cycling economy or performance ."
0,"However , recent evidGnce in well-trained cyclists has not consistently reported improved cycling economy or performance ."
0,"However , recent evidence in well-tained cyclists has not consistently reported improved cycling economy or performance ."
0,"However , recent evidence in well-trained cyclists has not consistently reported improed cycling economy or performance ."
0,"However , recent evidence in well-trained cyclists has not consistently reported imrpoved cycling economy or performance ."
3,Short-term use of CTM compared with radiant warmers and other modes of warming is non-inferior to SoC and efficacious in maintaining body temperature .
3,Short-term ue of CTM cdompared with radiant warmers and other modes of warming is non-inferior to SoC and efficacious in maintaining body temperature .
3,Short-term use of CTM comared with radiant warmers and other modes of warming is non-inferior to SoC and efficacious in maintaining boidy temperature .
3,Short-term use of CTM compared with radiant warmers and other modes of arming is non-inferior to SoC and efficaicous in maintaining body temperature .
3,Short-term use of CTM compared with radiant warmers and other modes of warming is non-infierior to SoC and efficaciomus in maintaining body temperature .
2,"The combined intervention effectively delayed the onset of weekly drinking in the general population of adolescents , and was particularly effective in delaying the onset of heavy weekly drinking in a higher-risk subsample of adolescents ( i.e. those attending lower levels of education and reporting higher levels of externalizing behavior ) ."
2,"The combined ingervention effectively delayed the onset of weekly drinking in the general population of adolescents , and was particularly effective in delaying the onsRt of heavy weekly drinking in a higMher-risk subsample of adolescents ( i.e. those attending lower levels of education and reporting higher lvels of externalizing behavior ) ."
2,"The combined intervention effectively delaed the onset of weekly drinking in the general population of adolescents , and was particularly effective in delaying the onset of heavy weerly drinking in a highernrisk subsample of adolescents ( i.e. those attending lowe levels of education and reporting higher levels of externalizing behavior ) ."
2,"The combined intervention effectively delayed the onset of weekly drinking in the general population of adolescents , and was particularly effective in delaying the onset of heavy weekly drinking in a higher-riUk subample of adolescents ( i.e. those attending lower levels of educatino and repoGrting higher levels of externalizing behavior ) ."
2,"The combined intervention effectively delayed the onste of weekly drinking in the general populsation of adolescents , and was particluarly effective in delaying the onset of heavy weekly drinking in a higher-risk subsample of adolescents ( i.e. those attending lower levels of education and reporting higher levels of externlaizing behavior ) ."
2,"The groups ( digital , 191 patients ; traditional , 190 patients ) were well matched for baseline and surgical characteristics ."
2,"The groups ( digita , 191 patients ; traditional , 190 patients ) were well matched for baseline and surgical characteristics ."
2,"The groups ( digital , 191 patients ; traditional , 190 patients ) were well matched for baseline and surgiXcal characteristics ."
2,"The groups ( digital , 191 patients ; traditonal , 190 patients ) were well matched for baseline and surgical characteristics ."
2,"The groups ( digital , 191 patients ; traidtional , 190 patients ) were well matched for baseline and surgical characteristics ."
3,A larger-scale trial is needed to replicate these findings and further understand the mechanisms of change .
3,A larger-scale trial is needed to replicate these fiHndings and further understand the mechanisms of change .
3,A larger-scale trial is needed to replicate these findings and further understadn the mechanisms of change .
3,A larger-scale trial is needed to replicate these findings and further understand the mechanisms of Tchange .
3,A larger-scale trial is needed to replicate these findings and further understand the mechansms of change .
4,Adenosine is the first-line medication in patients with paroxysmal supraventricular tachycardia .
4,Adenosine is the first-line medicatio in patients with paroxysmal supraventricular tachycardia .
4,Adenosine is the first-line medication in patients with paroxysmal supraventricJular tachycardia .
4,Adenosine is the first-line medication in patients with paroxysmal supraventricular tachycarKdia .
4,Adenosine is the first-line medication in patients with paroxysmal supraventricular tachycaria .
3,Further studies are necessary to determine the appropriate flow rate and indications for NHF in obese patients .
3,Further studies are necessary to determine the apporpriate flow rate and indications for NHF in obese patients .
3,Further studies are necessary to determine the appropriate flow rate and indications for NHF in obee patients .
3,Further studies are necessary to determine the appropriate flow rte and indications for NHF in obese patients .
3,Further studies are necessary to determine the appropriate folw rate and indications for NHF in obese patients .
1,"The GLYNDIET study is a 6-mo randomized , parallel , controlled clinical trial conducted in 122 overweight and obese adults ."
1,"The GLYNDIET study is a 6-mZo randomized , parallel , controlled clinical trial conducted in 122 overweight and obese adults ."
1,"The GLYNDIET study is a 6-mo randoimized , parallel , controlled clinical trial conducted in 122 overweight and obese adults ."
1,"The GLYNDIET study is a 6-mo randomized , parallel , controlled clinical trial conducted in 122 overweight and obese adujlts ."
1,"The GLYNDIET study is a 6-mo randomized , ptrallel , controlled clinical trial conducted in 122 overweight and obese adults ."
3,A 12-week RTP improved MVIC and muscle power in MS patients .
3,A 12-week RPT improved MVIC and muscle power in MS patients .
3,A 12-week RTP improved MVC and muscle power in MS patients .
3,A 12-week RTP improved MVIC and muscle power in S patients .
3,A 12-week RTP improved MVMC and muscle power in MS patients .
4,There is increasing evidence that measurement of central aortic pressure ( CAP ) better accounts for cardiovascular risk than brachial blood pressure ( BP ) .
4,There is increasing evidece that measurement of central aortic pressure ( CAP ) better accounts for cardoivascular risk than brachial blood pressure ( BP ) .
4,There is increasing evidence that measurement of cenral aortic pressure ( CAP ) better accouns for cardiovascular risk than brachial blood pressure ( BP ) .
4,There is increasing evidence that meausrement of central aortic pressure ( CAP ) better accounts for cardiovascular risk than brachial bliood pressure ( BP ) .
4,There is increasing tevidence that measurement of central aortic rpessure ( CAP ) better accounts for cardiovascular risk than brachial blood pressure ( BP ) .
3,Early diagnosis and treatment did not prevent ASD as an outcome of IS .
3,Early diagnosis and traetment did not prevent ASD as an outcome of IS .
3,Early diagnosis and treatent did not prevent ASD as an outcome of IS .
3,Early diagnosis and treatmTnt did not prevent ASD as an outcome of IS .
3,Early diagnosis and treatment did not prevent ASD as an outcome of pS .
2,Adverse reactions had nothing to do with CM treatment .
2,Adverse reactions had noching to do with CM treatment .
2,Adverse reactions had nothing to do with CM treatSent .
2,Adverse reactions had nothing to do with Ck treatment .
2,Adverse reactions had nthing to do with CM treatment .
4,"However , users experience fatigue due to exposure to flickering stimuli ."
4,"However , users exerience fatigue due to exposure to flickering stimuli ."
4,"However , users expeirence fatigue due to exposure to flickering stimuli ."
4,"However , users experience fatigue due to exposKure to flickering stimuli ."
4,"However , users experience fatigue due to exposure to flikcering stimuli ."
0,To evaluate the effects of systemic doxycycline on clinical and microbiological parameters of diabetic subjects with chronic periodontitis .
0,To evaluate the Ieffects of systemic doxycycline on clinical and microbiological parameters of diabetic subjects with chronic periodontitis .
0,To evaluate the effects of sstemic doxycycline on clinical and microbiological parameters of diabetic subjects with chronic periodontitis .
0,To evaluate the effects of sysetmic doxycycline on clinical and microbiological parameters of diabetic subjects with chronic periodontitis .
0,To evaluate the effects of systqemic doxycycline on clinical and microbiological parameters of diabetic subjects with chronic periodontitis .
0,We investigated the association of baseline circulating levels of TF with stroke events occurred in the European Prospective Investigation into Cancer and Nutrition-Italy cohort .
0,We investigated the association of baseline circulating levels of TF with stroke evnets occurred in the Eouropean Prospective Investigation into Cancer and Nutrition-Italy cohort .
0,We investigated the association of baseline circulating levls of Ts with stroke events occurred in the European Prospective Investigation into Cancer and Nutrition-Italy cohort .
0,e investigated the association of baseline circulating levels of TF with stroke evenKts occurred in the European Prospective Investigation into Cancer and Nutrition-Italy cohort .
0,eW investigated the association of baseline circulating levels of TF with stroke events occurred in the Eropean Prospective Investigation into Cancer and Nutrition-Italy cohort .
0,"However , the association between ARD and increased risk of dementia is uncertain ."
0,"However , the association between ARD and increased irsk of dementia is uncertain ."
0,"However , the association between ARD and increased risk of dementia is uncetain ."
0,"However , the association between ARD and increased risk of demeyntia is uncertain ."
0,"However , the association between ARD and increased risk of dmeentia is uncertain ."
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs ( NSAIDs ) reduce pain during and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal misoprostol or oral nnsteroidal anti-inflrmmatory drugs ( NSAIDs ) reduce pain during and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammtaory drugs ( NSAIDs ) reduce pain during and 3 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal mispoprostol or oral nonsteroidal anti-inflammatory drugs ( NSADs ) reduce pain during and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whethr vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs ( NSAIDs ) reduce pain during and 30 minutes after hysterosalpingography ( SG ) .
3,Biologically relevant differences in methylated targets were found to discriminate locally advanced from early anal cancer .
3,Biologically relevant differences in methylated targets were found to discriminate locally adavnced from early anal cancer .
3,Biologically relevant differences in methylated targets were found to discriminate loclaly advanced from early anal cancer .
3,Biologically relevant differences in methylated targets were found to dkiscriminate locally advanced from early anal cancer .
3,Biologically relevant differences in methylated targtes were found to discriminate locally advanced from early anal cancer .
1,Seed migration was defined as a seed position > 1 cm from the cluster of other seeds on radiography .
1,Sed migration was defined as a seed position > 1 cm from the cluster of other seeds on radiography .
1,Seed migration was defined as a seed positio > 1 cm from the cluster of other seeds on radiography .
1,Seed migration was defined as a seed position > 1 cm from the clustr of other seeds on radiography .
1,Seed migration was defined as a seed position > 1 cm from the gcluster of other seeds on radiography .
4,"We hypothesised that deep-fried Mars bar ingestion would impair cerebrovascular reactivity , which is associated with increased risk of ischaemic stroke ."
4,"We hypothesised that deep-fried Mar bar ingestion woud impair cerebrovascular reactivity , which is associated with increased risk of ischaemic stroke ."
4,"We hypothesised that deep-fried Maris bar ingestion would impair cerebrovascular reactivity , which is associated with increased risk of ischnemic stroke ."
4,"We hypothesised that deep-fried Mars bFar ingestion would impair cerebrovascular reactivity , which is associated with increased riks of ischaemic stroke ."
4,"We hypothesised that deep-ried Mars bar igestion would impair cerebrovascular reactivity , which is associated with increased risk of ischaemic stroke ."
0,To investigate functional and macular pigment ( MP ) changes in patients with early age-related macular degeneration ( AMD ) after multiple supplementation with lutein and zeaxanthin .
0,To investigaet functional and macular pigment ( MP ) changes in patients with early age-elated macular degeneration ( AMD ) after multiple supplementation with lutein and zeaxanthin .
0,To investigate fJunctional and macular pigment ( MP ) changes in patients with early age-related macular degeneration ( AMD ) after multiple supplementation with ultein and zeaxanthin .
0,To investigate functioal and macular pigment ( MP ) changes in paitents with early age-related macular degeneration ( AMD ) after multiple supplementation with lutein and zeaxanthin .
0,To investigate functional and macular pigment ( PM ) changes in patients with early age-related macular degeneration ( AqMD ) after multiple supplementation with lutein and zeaxanthin .
2,"Preoperatively but after nasoalveolar molding , the nostril width ratio was wider for the Figueroa group than for the Grayson group ."
2,"Preoperatively but after nasoalveolar molding , the nostril width artio was wiTder for the Figueroa group than for the Grayson group ."
2,"Preoperatively but after nasoalveolar molding , the nostril width raio was wider for the Figueroa group than for the Grayson grou ."
2,"Preoperatively but after nasoalveolar molding , the nostril width ratio was wideSr for the Figueroa gropu than for the Grayson group ."
2,"Preoperatively but after nasoalveolar molding , the nstril width ratio was wider for the Figueroa group than for the Garyson group ."
2,"The postoperative voice recovery time were 7.2 days for the group of patients received conventional laryngeal microsurgery and 7.6 days for the group of patients treated with 2 W CO2 laser , which were hoch significantly different from that in the group of patients treated with 6 W CO2 laser ( P < 0.05 ) ."
2,"The postoperative voice recovery tim were 7.2 dEays for the group of patients received conventional laryngal microsurgery and 7.6 days for the grouD of patients reated with 2 W CO2 laser , which were hoch significantly different from that in the group of patients treated with 6 W CO2 laser ( P < 0.05 ) ."
2,"The postoperative voice recovery time were 7.2 days for the group of pQtients recevied conventional laryngeal microsurgery and 7.6 days for the group of patients treted with 2 W CO2 laser , which were hoch significantly different from that in the group of patients treated with 6 W PCO2 laser ( P < 0.0U ) ."
2,"The postoperative vowce recovery time were 7.2 days for the group of Tatients received conventional laryngeal microsurgery and 7.6 days for the group of patients treated with 2 W CO2 laser , which were hoch significantly different from that in the group of paitents treated with 6 W ACO2 lasyr ( P < 0.05 ) ."
2,"he postopeative vice nrecovery time were 7.2 days for the group of patients received conventional laryngeal microsurgery and 7.6 days for the group of patients treated with 2 W CO2 laser , which were hzoch significantly different from that in the group of patients treated with 6 W CO2 laser ( P < 0.05 ) ."
4,There are currently no agreed strategies for vitamin D replenishment after hip fracture surgery .
4,There are currently no agrede strategies for vitamin D replenishment after hip fracture surgery .
4,There are currently no agreed strategies for vitamni D replenishment after hip fracture surgery .
4,There are currently no agreed strateiges for vitamin D replenishment after hip fracture surgery .
4,There are currently no argeed strategies for vitamin D replenishment after hip fracture surgery .
4,Several studies indicate that increasing the alimentary limb length in gastric bypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indWcate that increasing the alimentary limb length in gastri bypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indiXate that increasing the alimentary limb length in gastric hypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indicate that increasing the alimentary limb length in gastric bypass surger produces only a minor improvement of excess BM loss .
4,Several sudies indicatSe that increasing the alimentary limb length in gastric bypass surgery produces only a minor improvement of excess BMI loss .
4,Treatment with rituximab may be accompanied by a systemic cytokine release .
4,TreatGent with rituximab may be accompanied by a systemic cytokine release .
4,Treatment with rituxamab may be accompanied by a systemic cytokine release .
4,Treatment with rituximab may be accompanied by a systemic cytokine rezease .
4,Treatment with rituximab may be acqompanied by a systemic cytokine release .
1,"Treatment-naive patients with HCV genotype 1 infection were assigned randomly to 1 of thefollowing groups : PEG-IFN/RBV for 48 weeks ( group A , n = 31 ) , PEG-IFN/RBV for 4 weeks followed by PEG-IFN/RBV for 44 weeks with 6 injections of TG4040 ( group B , n = 63 ) , or TG4040 for 12 weeks ( 7 injections ) followed by PEG-IFN/RBV for 48 weeks with 6 injections of TG4040 ( group C , n = 59 ) ."
1,"Treatment-naive patients with HCV genotype 1 infection were assigend randomly to 1 of thefollowing groups : PEG-IFN/RBV for 48 weeks ( group A , n = 31 ) , PEG-aFN/RVB for 4 weeks followeKd by PEG-IFN/RBV for 44 weveks with 6 injections of TG4040 ( group B , n = 63 ) , or TG4040 for 21 weeks ( 7 injections ) followed by PEG-IFN/RBV for 48 weeks with 6 injections of TG4040 ( group C , n = 59 ) ."
1,"Treatment-naive patients with HCV genotype 1 infection were assigned randomly to 1 of thefollowig groups : PEG-IFN/RBV for 48 weeks ( group A , n = z1 ) , PEG-IFN/RBV for 4 weekrs followed by PEG-IFN/RBV for 44 weeks with 6 injections of TG4040 ( rroup B , n = l63 ) , or TG4040 for 12 weeks ( 7 injections ) followed by PEG-IFN/BRV for 48 weeks with 6 injections of TG4040 ( group C , n = 59 ) ."
1,"Treatment-naive patients with HCV genotype 1 infection were assigned randomly to 1 of thefollowing groups : PEG-IFN/RBV for 48 weeks ( group A , n = 31 ) , PEG-IFN/RBV for 4 weeks followed by PEG-IFN/RBV for 44 weeks with 6 injections of TG4040 ( gUroup B , n = 63 ) , or TG4040 for 12 weekTs ( 7 injectBions ) followed by PEGm-IFN/RmBV for 48 weeks with 6 Cnjections of TG4040 ( group C , n = 59 ) ."
1,"Treatment-naive patients with HCV genotype 1 infection were assigned randomly to 1 of thefollowing groups : PEG-IFN/RBV for 48 weeks ( grup A , n = 31 ) , PEG-IFN/RBV for 4 weeks followed by PEG-IFN/RBV for 44 weTks with 6 injections of TG4040 ( group B , n = 63 ) , or TG4040 for 12 weesk ( 7 injections ) follLowed by PEG-IFN/RBV for 48 weeks with 6 injections of TG400 ( groAp C , n = 59 ) ."
2,"All patients in the r-hLH 2,750 ( 13/13 ) , 5,500 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 12 / 12 ) groups ovulated ; 3/5 patients in the r-hLH 825 IU and 2/12 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"AQll patients in the rhLH 2,750 ( 13/13 ) , 5,500 ( 1C2 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 12 / 12 ) groups ovulatde ; 3/5 patients in the r-hLH 825 IU and 2/2 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"All patients in the r-hLH 2,750 ( 13/13 ) , 5,500 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 1F / 1G2 ) grous ovulatTd ; 3/5 patients in the r-hLH 825 UI and 2/12 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"All patients in the r-hLH 2,750 ( 13/R13 ) , 5,5n00 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hGC 5,000 IU ( 12 / 12 ) groups voulated ; 3/5 patients in the r-hLH 825 IU and 2/1 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"All patitnts in the r-hLH 2,750 ( 13/13 ) , 5,500 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 12 / 12 ) gruops ovulated ; 3/5 patients in the r-hLH 825 IU and 2/12 in the r-hLH 22,000 IU gruop failed to ovulate ( p = 0.105 between ealuable roups ) ."
0,"In this double-blind randomized placebo controlled parallel-group trial , we investigated the effects of sodium nitrite administered immediately prior to reperfusion in patients with acute ST-elevation myocardial infarction ( STEMI ) ."
0,"In this double-blind randomized placebo controlled parallel-group trial , we invesKtigated the effects of sodium nitrite administered immediately proir to reperfusion in patients with acute ST-elevation myocardial infarction ( STEMI ) ."
0,"In this double-blind randomized placebo controlled parallel-group trial , we investigated the effects of sodium nitrite administered immediately prior to reperfusion in patients with acute ST-eelvation myocardial infarction ( STMI ) ."
0,"In this double-blind randomized placebo ocntrolled parallel-group trial , we investigated the effects of sodium nitrite bdministered immediately prior to reperfusion in patients with acute ST-elevation myocardial infarction ( STEMI ) ."
0,"In this doublefblind randomized placebo controlled parallel-group trial , we investigated the effects of sodium nitrite administered immediately prior to reperfusion in patients with acuAe ST-elevation myocardial infarction ( STEMI ) ."
4,"The aim of this trial was to compare the effects of resistance training versus passive physical therapy on quality of life ( QoL ) , fatigue , and emotional distress outcomes during radiation therapy in patients with spinal bone metastases under radiotherapy ( RT ) ."
4,"The agim of this trial was to compare the effects of reQistance training versus passive hhysical therapy on quality of life ( QoL ) , fatigue , and emotional distress outcomes during radiation therapy in patients with spinal bone metastases under radiotherapy ( RT ) ."
4,"The aiMm of this trial was to compare the effects of resistance training versus passvie physical therapy on quality of life ( QoL ) , fatigue , and emotional distress outcomes during radiation thHrapy in patients with spinal bone metastases under radiotherapy ( RT ) ."
4,"The aim of this tial was to compare the effects of resistance training versus passive physical therapy on quality of life ( QoL ) , faigue , and emotional disterss outcomes during radiation therapy in patients with spinal bone metastases under radiotherapy ( RT ) ."
4,"The aim of this trial was to compare the effects of resistance training versus passive physical therapy on quality of life ( QoL ) , fatigue , and emotionl distress utcomes during radiation therapy in atients with spinal bone metastases under radiotherapy ( RT ) ."
3,"Bourdas DI , Tsakiris TS , Pavlakis KI , Triantafillou DV , Geladas ND ."
3,"Bourdas DI , Tsakiris TS , Pavlakis I , Triantafillou DV , Geladas ND ."
3,"Bourdas DI , Tsakiris TS , Pavlakis KI , Triantafillou DC , Geladas ND ."
3,"Bourdas I , Tsakiris TS , Pavlakis KI , Triantafillou DV , Geladas ND ."
3,"Bourdas ID , Tsakiris TS , Pavlakis KI , Triantafillou DV , Geladas ND ."
0,Examine psychological and behavioral predictors of 3-year weight loss maintenance in women .
0,ExKamine psychological and behavioral predictors of 3-year weight loss maintenance in women .
0,Examine psychological and behavioral prdeictors of 3-year weight loss maintenance in women .
0,Examine psychological and behavioral predictors of 3-yar weight loss maintenance in women .
0,Examine psychological and behavioral predictors of 3-year weight loss maintenance in womWn .
2,Twenty-six patients were enrolled and 25 were analyzed .
2,Twenty-si patients were enrolled and 25 were analyzed .
2,Twenty-six patiens were enrolled and 25 were analyzed .
2,Twenty-six patients were enroleld and 25 were analyzed .
2,wenty-six patients were enrolled and 25 were analyzed .
2,Reported adverse events were mild to moderate in intensity ; none resulted in discontinuation .
2,ROported adverse events were mild to moderate in intensity ; none resulted in discontinuation .
2,Reported adverse events were mil to moderate in intensity ; none resulted in discontinuation .
2,Reported adverse events were milYd to moderate in intensity ; none resulted in discontinuation .
2,Reported adverse vents were mild to moderate in intensity ; none resulted in discontinuation .
4,"In the last 2 decades , the effectiveness of cricoid pressure ( CP ) in occluding the esophageal entrance has been questioned ."
4,"Ik the last 2 decades , the effectiveness of cricoid pressure ( CP ) in occluding the esophageal entrance has been questioned ."
4,"In the lait 2 decades , the effectiveness of cricoid pressure ( CP ) in occluding the esophageal entrance has been questioned ."
4,"In the last 2 decades , the effectiveness of cricoid pressure ( CP ) in occleding the esophageal entrance has been questioned ."
4,"In the last 2 decades , the effectiveness of cricoid pressure ( CP ) in occluding the esophageal entrance has been questioeed ."
1,Skin was assessed for pressure ulcers .
1,Skin was asWsessed for pressure ulcers .
1,Skin was assessed for pressure ulcer .
1,Skin was assessed for pressure ulcerPs .
1,Skizn was assessed for pressure ulcers .
4,A preliminary report showed that autologous blood is an effective and easily applicable technique that can control actively bleeding gastroduodenal ulcers .
4,A perliminary report showed that autologous blood is an effective and Yeasily applicable technique that can control actively bleeding gastroduodenal ulcers .
4,A preliminary report sAowed that autologous blood is an effective and easily applicable technique that can control actively bleeding gastroduodenRl ulcers .
4,A preliminary report showe that autologous blood is an ffective and easily applicable technique that can control actively bleeding gastroduodenal ulcers .
4,A preliminary report showed that autologous blood is an effective and easily applicable technique that can control activelb bleeding gastroduodenal ulcerfs .
